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CHAPTER 1 
INTRODUCTION 
1.1 Long-Term Goals 
Analytical technologies for biological compounds have developed rapidly and 
become essential and indispensable in life science, pharmaceutical chemistry, clinical, 
and health care fields. For example, diseases are driven by molecular modifications in the 
cell, such as some cancers that result from the phosphorylational modification on amino 
acid residues of proteins.
1,2
 Analyses on the cellular levels is therefore important for 
disease diagnoses and treatment. In the real world, analysis of complex materials is 
difficult, mainly due to issues of sensitivity, dynamic range, solubility, and complexity.
 3 
Brain tissue is an example of a complex material. It is composed of lipids, peptides, 
proteins, and carbohydrates, as well as other substances
4,5 
that build up the brain structure 
and maintain brain functions. There are also numerous exogenous species accumulating 
in brain tissue, such as drugs from disease treatment or drug addiction.
6
 In addition to the 
fact that the amount of lipids in cells is overwhelmingly higher than proteins,
4,5 the 
structure diversity of lipids is much more significant than other compounds.
7,8
 Therefore 
the analysis of a compound of interest from a complex environment becomes more 
difficult. 
 A number of analytical technologies have been developed to analyze complex 
biological compounds in order to understand property/function relationships. To name a 
few, separation methods such as gas chromatography, liquid chromatography (LC), and 
thin layer chromatography were developed to separate components from complex 
mixtures, with the separation usually taking minutes to hours.
9,10
 Spectroscopy methods 
2 
 
such as ultraviolet-visible absorption spectroscopy is used to detect, identify and quantify 
atoms and molecules, but often lacks sensitivity and specificity.
9
 Nuclear magnetic 
resonance (NMR) spectroscopy elucidates structural information of organic compounds, 
but usually requires milligrams or milliliters of samples.
11
 Immunoassays are commonly 
used in clinical analyses for targeted proteins and have high specificity, but the 
development of antibodies for this purpose is costly and time consuming.
12
 
Mass spectrometry (MS) has a number of advantages for providing molecular 
information relative to other spectroscopic methods, has matched sensitivity and less cost 
for consumables than immunoassays while overcoming problems like cross-reactivity 
with metabolites,
 
and achieving higher speed than traditional separation methods 
applicable for high-throughput analyses.
9- 15  
The disadvantages of MS include the 
relatively costly instrumentation, lack of robustness, and requirement for trained 
operators and expertise.
12,16,17
 Scheme 1.1 lists the challenges that need to be addressed 
to promote MS to have further practical utility, taking clinical analyses as an example.
18
 
Higher sensitivity and dynamic range are required to observe all components from 
complex substrates.
19
 For example, signals from lipids often dominate the mass spectrum, 
while peptides, proteins, and small molecules may not be observable.
20 ,21
 Separation 
technologies prior to MS, e.g. LC-MS, can help to reduce the complexity and improve the 
dynamic range and specificity. Tandem MS with, for example, collision induced 
dissociation (CID) can improve specificity by requiring specific fragmentation transitions.  
This method can also provide structural information for e.g. peptides and drugs.
 22,23
  
Reproducibility and spatial resolution are desired for quantification and exact location, to 
differentiate e.g. the diseased tissue from the healthy area.
24
 Data acquisition of MS for 
3 
 
rapid response in, for example, emergency rooms or surgical facilities need to be fast. 
The instrumentation and consumables should be financially affordable and simple to 
use.
12,17
 Therefore, MS has particular value in biological material characterization. 
Scheme 1.1 Technology development needed to expand the use of MS for 
clinical applications [Adopted from Reference 18]. Points highlighted in red 
will be covered in this thesis. 
 
1.2 General Introduction on Mass Spectrometry and Tandem Mass Spectrometry 
The essential components of a mass spectrometer are the ionization source, the mass 
analyzer, and the detector (Scheme 1.2).  Samples can be introduced into the ion source 
by direct sample introduction. Alternatively, complex materials can be passed through 
other separation methods prior to MS and then introduced via the interface, e.g. LC-MS 
to be discussed in Section 1.3.2. Analyte molecules are converted to gas-phase ions in the 
ion source; the ions are subsequently separated in the mass analyzer according to their 
mass-to-charge ratio (m/z) and are detected by the detector. The result is displayed as a 
mass spectrum of m/z versus relative ion intensity. 
Scheme 1.2. Representation of the basic components of a mass spectrometer. 
 
A. Sensitivity and dynamic range: to observe all components (e.g., 
lipids and proteins, hydrophilic and hydrophobic, low and high 
abundance) directly from native and complex environment (e.g., tissue, 
plasma, serum, urine), improvements needed include:
1. Separation: to deal with complexity and isoforms (LC, mass 
resolution, IMS)
2. Specificity: fragmentation (MS/MS: CID, ETD) for confirmation 
and ID (bottom up, top down)
3. Reproducibility: for quantitation
4. Spatial resolution: for location (with and without a laser)
B. Speed: of data acquisition and interpretation
C. Robust, simple and cheap: automation, disposables
Ion 
source
Mass 
analyzer
Detector
Direct 
sample 
introduction
Pre-
separation 
techniques
Data 
system
Mass spectrometer
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Tandem MS is used for the ions of interest to undergo a second or more mass 
spectrometric analysis. The ions at a certain m/z are selected (MS
1
) and fragmented 
intentionally; the fragment ions are separated by the  mass analyzer (MS
2
). This process 
can be repeated several times for MS
n
 analysis. The intentional fragmentation is typically 
achieved by CID, electron-capture dissociation (ECD), or electron-transfer dissociation 
(ETD).
25
 CID employs a collision gas (e.g. N2, He) to collide with the gas-phase analyte 
ions and results in fragmentation. For example, when a peptide ion encounters the 
collision gas, the peptide N-C bonds are cleaved so that smaller peptide fragments are 
analyzed to provide structural information. This is a harsh process that fragile sites, e.g. a 
phosphate group on a peptide, is easily cleaved off; on the contrary, ETD is a softer 
dissociation process that normally retains the phosphate group on the structure.
26
 The 
radial anion of a small molecule, e.g. flouranthene, is generated and reacts with the 
analyte ions. The electron transfers from flouranthene to the analyte ion, and the excess 
energy obtained by the analyte ion leads to fragmentation. CID and ETD are frequently 
used in structural analysis such as peptide sequencing and proteomics.
26
 
This dissertation is focusing on ionization methods, and specifically coupling a novel 
ionization process with different mass analyzers. Therefore, a more detailed description 
of ionization methods and mass analyzers will be provided in the next sections.  
1.3 Ionization for Mass Spectrometry 
Any form of MS analysis can only occur when molecules are efficiently converted to 
gas-phase ions. Various ionization methods have been developed over decades. Early 
invented ionization methods include electron ionization (EI),
27
 chemical ionization 
(CI),
28
 fast atom bombardment (FAB),
29
 secondary ion mass spectrometry (SIMS),
30
 etc. 
5 
 
Matrix-assisted laser desorption/ionization (MALDI)
31 , 32
 and electrospray ionization 
(ESI),
33
  developed during the 1980’s, are currently the two most widely used “soft” 
ionization methods in MS and are capable of ionizing non-volatile compounds from 
biological materials. The inventors shared the Nobel Prize in Chemistry in 2002.  This 
section focuses on the principles of operation, sample preparation, fundamental, and 
application aspects of MALDI, ESI, and a few ambient ionization methods. 
1.3.1 Matrix-Assisted Laser Desorption/Ionization (MALDI) 
MALDI was developed as a vacuum ionization method (Scheme 1.3.A) and has been 
extended to atmospheric pressure (AP) (Scheme 1.3.B).  
Scheme 1.3.  Schematic representation of the MALDI process in vacuum (A) and at 
atmospheric pressure (B). 
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1) Vacuum MALDI  
  Traditional MALDI utilizes a ultraviolet (UV) laser in vacuum to ablate the surface 
of matrix:analyte crystals on a target plate in reflection geometry. The ions produced are 
accelerated by the voltage (~20 kV) applied on the target sample plate, and guided by 
focusing lens to the mass analyzer (Scheme 1.3.A). Initially, an inexpensive and smaller 
nitrogen laser was used in MALDI,
30,31
 but the laser repetition and life span is limited.
34
 
The demands of higher repetition rate and longer lifetime lasers in MALDI applications 
such as imaging and high-throughput are fulfilled by neodymium-doped yttrium 
aluminum garnet (Nd:YAG) lasers (wavelength ~355 nm, repetition rate >1000 Hz).
34
 
As can be seen in the scheme above, the particles do not leave the target surface at the 
same time, resulting in time dispersion of ions. Delayed extraction reduces the velocity 
distribution.
35
 Before the extraction voltage is applied, the generated ions first pass 
through a field-free region, and after a short delay (normally below a millisecond), the 
extraction voltage is turned on for subsequent time-of-flight (TOF) analysis. 
Solid organic compounds (shown in Scheme 1.4) are used as traditional UV-MALDI 
matrices. α-Cyano-4-hydroxycinnamic acid (CHCA), 2,5-dihydroxybenzoic acid (2,5-
DHB), and sinapinic acid are commonly used for peptides and proteins, 3-
hydroxypicolinic acid is for oligonucleotides, dithronal for polymers, and 9-
nitroanthracene for fullerenes. The aromatic rings in these MALDI matrices absorb light 
at UV wavelengths. 
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Scheme 1.4. Examples of common MALDI matrices. (A) α-Cyano-4-
hydroxycinnamic acid (CHCA), (B) 2,5-dihydroxybenzoic acid (2,5-DHB), (C) 
sinapinic acid, (D) 3-hydroxypicolinic acid , (E) dithranol, (F) 9-nitroanthracene. 
 
 
Traditional solvent-based MALDI sample preparation uses dried-droplet or layer 
method for sample preparation.
31,32
 Homogenous crystals are ideal for MALDI sample 
preparation to avoid the “hotspot” issue. If the laser beam strikes at the hotspot, more 
ions are generated, thus resulting in poor reproducibility from shot to shot. The analyte 
and matrix should be soluble in respective solvents that are compatible with each other.   
A solvent-free sample preparation method has been reported
36
 as an alternative to 
overcome the difficulties with insolubility of analyte, e.g. with membrane proteins
37
 and 
synthetic polymers.
38
 The matrix powder is mixed with dried analyte at higher molar ratio, 
homogenized and transferred to sample holders by a mini ball mill device.
36,37
 This 
approach overcomes the hurdles of the solubility restrictions for traditional MALDI, and 
in some cases yields even better mass spectra than solvent-based methods,
39,40
 without 
the hotspot issue, but generally with lower sensitivity.
41
 
Photoionization
42
 and cluster models
43
 are the most commonly accepted ion 
formation mechanisms in MALDI.
44
 In the photoionization model, the laser energy is 
OH
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absorbed by the matrix, producing a plume about 10 µm above the sample surface, and 
generating primary ions.  Analyte molecules react with the primary ions in the hot plume 
and become ionized by a charge transfer mechanism. In the cluster model, charged 
matrix/analyte clusters are produced upon laser firing, and the clusters are desolvated to 
produce analyte ions. 
Dominant singly charged ions are formed from the solid state. For larger peptides and 
proteins, multiply charged ions can be produced with the matrix CHCA.
45
 However, the 
ions are metastable and dissociate during travel through the analyzer.
46
 The production of 
singly charged ions simplifies data interpretation in a straight-forward fashion. MALDI is 
commonly coupled with a TOF mass analyzer and will be discussed in more details in 
Section 1.4.1. New developments have involved coupling MALDI to other mass 
analyzers, e.g. quadrupole-TOF for tandem MS,
47
or FT-ICR for ultrahigh mass 
accuracy.
48
 More details on mass analyzer will be introduced in Section 1.4. 
MALDI is applicable to the ionization of a wide range of biological compounds such 
as peptides and proteins, lipids, carbohydrates, oligonucleotides, bacteria, etc., directly 
from solid surfaces.
49 -54
 This merit enables MALDI for mass spectrometric imaging 
applications,
55,56
 which is a technique to visualize the spatial distribution of compounds 
by their m/z values. MALDI imaging can provide spatial information of peptides and 
proteins, lipids, metabolites, etc. directly from surfaces like tissue sections.
55,57,58
  Sample 
preparation is critical in MALDI imaging, especially matrix application to the 
surfaces.
57, 59  
Progress including applying small matrix droplets
60
 and subliming dry 
matrix onto the surfaces
57
 has been made to reduce sample delocalization. The spatial 
resolution achieved by MALDI is typically ≥25 µm.55 Development of lasers is also 
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reported to achieve improved spatial resolution. Ablation areas with diameters <10 µm 
can be achieved by sophisticated laser focusing setup
61
 and at the expense of long 
acquisition time.
62
   MALDI imaging not only provides the location of the analyte of 
interest, but also the relative amount by color-coded display. Quantification has been 
reported by spotting internal standard on the tissue sections.
63,64 
2) AP MALDI 
About one decade after the invention of vacuum MALDI, Burlingame and co-workers 
introduced MALDI to be operated at AP (Scheme 1.3 B).
65
 With this configuration, 
common MALDI matrices (Scheme 1.4) and lasers can be used except that the target 
plate and laser ablation take place at AP.
 66
   AP MALDI greatly simplifies the operation 
procedure.
67
 It is “softer” than vacuum MALDI because of the elimination of harsh 
vacuum conditions and lower acceleration voltage (~5 kV).
65
 Galicia et al. have proposed 
laser ablation using transmission geometry to improve laser beam focusing and ion 
transmission.
68
 The ionization efficiency of this approach was reported to be poor. In 
general, the ion efficiency and thus the sensitivity of AP MALDI is lower than vacuum 
MALDI because of the reduced ion transmission from AP to vacuum. It has been 
modeled that 99% of the ions formed are lost in AP MALDI.
69
 
The disadvantages of MALDI mainly include high chemical background resulted 
from the use of matrix in conjunction with a laser,
70
 the production of singly charged ions 
limits the application of high-performance mass spectrometers, the high cost of 
commercial MALDI sources, and not being able to couple to online separation. 
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1.3.2 Electrospray Ionization (ESI) 
In contrast to MALDI as a surface ionization method, ESI ionizes analyte from 
solution.
33,71 
Scheme 1.5 presents the ionization process of ESI operating in positive ion 
mode. The analyte solution is sprayed through a metal capillary on which high voltage (a 
few kV) is applied. A “Taylor cone” is formed at the capillary tip and ejects charged 
droplets. The charged droplets undergo solvent evaporation and Coulombic explosion, 
producing bare analyte ions.
33,72
 The mechanisms for ion production currently accepted 
are the ion evaporation
73
 and charge residue models.
74
 The ion evaporation model 
suggests that ions are ejected from evaporating charged droplets.
73
 The charge residue 
model suggests that the solvent evaporates from the charged droplets producing smaller 
charged droplets, leaving bare analyte ions after a few cycles.
74
 The ions are subsequently 
extracted into the inlet of the mass spectrometer where a few volts of extraction voltage is 
applied. Negative ion mode is applicable by switching the potential on the spray capillary 
and extraction cone. Multiply charged ions are dominantly produced (from all but small 
molecules) by ESI that are beneficial for extending the mass range of high-performance 
mass spectrometers
75
 and efficient intentional fragmentation for improved structural 
characterization.
76
  
Scheme 1.5.  Schematic representation of ESI. 
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Because ESI directly ionizes analyte in solutions, it can be interfaced with 
separation techniques such as LC for online separation and analysis. The eluent eluting 
from the LC column is pushed through the electrospray capillary and the resulting gas-
phase ions ions are introduced into the mass spectrometer. This coupling requires the 
solvent of the eluent to be “sprayable”. Proteomics is one of the most important 
applications to which LC-ESI can be applied.
77
 After enzymatic digestion, large proteins 
are converted to peptides and smaller proteins. The peptide/protein mixture is separated 
by LC and then subsequently ionized by ESI. Tandem MS (CID and ETD) are commonly 
used to obtain sequence information. 
Quantification of small molecules is another application typically achieved by LC-
ESI-MS or tandem MS. The calibration curve is usually obtained by injecting a series of 
standard solutions at different concentrations, and the peak area of the ion of interest is 
plotted against concentration.   
In some cases only very limited amounts of samples are available, e.g. a few µg 
protein can be obtained for mammalian proteomics.
78
 LC and ESI
79
 at nanoliter per 
minute flow rates are necessary for better separation and sensitivity when less material is 
consumed.
80
 Ion efficiency is improved by nanoESI mainly due to the fact that smaller 
charged droplets are produced at the needle tip from which the solvent evaporates more 
rapidly in the time available. Therefore, the tip can be placed closer to the mass 
spectrometer orifice, resulting in higher ion transmission efficiency.
81
 However, the low 
flow rate will increase the time for analysis, and the fragile emitters for use in nanoESI 
with smaller diameters are considerably more expensive.
82
 The nanoESI capillary 
requires more user expertise for proper alignment and is prone to clogging. 
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1.3.3 Ambient Ionization 
A variety of “ambient ionization” techniques have been developed that ionize 
samples from their original states, with little or no sample preparation.
83-89
 To name a few, 
direct analysis in real time (DART)
83
 and atmospheric solids analysis probe (ASAP)
88
 
rapidly ionize materials by vaporizing them in the environment of heated gas (e.g. N2 or 
He). Surface analysis methods based on desorption, e.g. desorption electrospray 
ionization (DESI)
85
 and nanoDESI
89
, ionize a large variety of compounds by spraying 
ESI solvent onto the surface while collecting the desorbed and ejected ions. Direct 
surface liquid-extraction has also been used for sampling followed by ESI.
86
 Laser-based 
approaches
90-93
 have been introduced to combine the advantages of ESI and MALDI  
using solvent to collect laser-ablated materials from surfaces, and producing multiply 
charged ions. However, these AP ionization methods are subject to lower ion transfer 
efficiency due to the rim and dispersion losses as in ESI and MALDI.
69
 
1.4 Mass Analyzers for Mass Spectrometry  
Once the molecules are converted to gas-phase ions, they are guided into the mass 
analyzer and separated according to their m/z. Vacuum is critical in mass analyzers to 
provide a longer mean free path. Better vacuum means less collision occurring between 
ions before they reach the detector. Currently oil based rotary and turbo pumps are 
commonly used to provide high vacuum in mass spectrometers (<10
-7
 mbar). 
Common mass analyzers are sorted by their principle of operation as follows: 1) TOF 
used to separate pulsed ion beams; 2) scanning mass analyzers such as magnetic sector 
and quadrupole to separate continuous ion beams; 3) linear ion trap (LIT) and triple 
quadrupole separate continuous ion beams and can also trap ions; 4) trapped-ion mass 
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analyzers such as Orbitrap, and Fourier transform ion cyclotron resonance (FT-ICR). 
These mass analyzers have different duty cycles, providing mass analysis with different 
mass accuracy and resolution, sensitivity, analysis speed, and mass range. But there is no 
“ideal” mass analyzer for all applications. The principle of operation, resolving power 
(defined as the minimum mass difference between two peaks is calculated as m/Δm at the 
half-maximum peak height), mass range, and applications of several different analyzers 
that are used later in this dissertation, along with examples of hybrid mass spectrometers, 
will be discussed in more details in the following sections.  
1.4.1 Time-of-Flight (TOF)  
TOF analyzers use an electric field to accelerate ions, and the ions fly through a field-
free tube to the detector (Scheme 1.6). The ions are accelerated based on their m/z with 
approximately the same kinetic energy. The time it takes for the ions to fly through the 
field-free tube and reach the detector is measured and converted to m/z of the ions. The 
heavier ions take longer time to reach the detector. It is necessary to let the ions start their 
flight at the same time, therefore TOF is usually coupled with a pulsed ionization method 
(e.g. MALDI). The continuous ion methods (e.g. ESI) employ orthogonal extraction to 
interface to TOF.
94
 The orthogonal extraction uses a “pusher” to accelerate ions 
perpendicularly to their original direction and push them into the flight tube, so that a 
pulsed beam is produced from the continuous ion production.   
In principle, the mass range for TOF is unlimited as eventually all of the ions get to 
fly through the flight tube.
 95
  TOF was introduced as a linear tube for ions to fly through 
a certain distance before being detected. Shown in Scheme 1.6 is the TOF in both linear 
and reflectron ion detection modes, with the reflectron mode to achieve better mass 
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resolution of the smaller ions. The reflectron works as an ion mirror and is made of a set 
of grids on which potential is applied to change the directions of the ions. The use of a 
reflectron not only extends the distance for ions to fly, but also corrects the slightly 
different positions and velocity of ions with the same m/z. As a result, the mass resolving 
power of the TOF mass spectrometer is improved. It has been reported the mass resolving 
power of 80,000 at m/z=2500 was achieved by spiral TOF instrument.
96
  
Scheme 1.6.  Schematic representation of TOF analyzer in both linear and reflectron 
detection modes. The red circles represent “heavier” ions, and the blue ones are 
“lighter” ions. Ions are introduced through either 1) pulsed ion source or 2) a 
continuous ion source and are accelerated by orthogonal extraction. 
 
1.4.2 Quadrupole  
A quadrupole analyzer consists of four rods on which DC and AC voltages are 
applied (Scheme 1.7). Positive and negative potential is applied on the opposite pairs of 
rods, respectively. When ions enter the quadrupole analyzer in the z direction, only the 
ions with certain m/z that resonate with the RF voltage will oscillate and pass through the 
rods (red line), while others are filtered out (blue line). 
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Scheme 1.7.  Schematic representation of a quadrupole analyzer. The red line 
represents the path of ions that pass through the rods, and the blue line represents the 
ions that do not pass through. 
 
The quadrupole is a scanning mass analyzers thus it is not well suited to pulsed 
ionization method. The duty cycle for full scan is very low because only the ions at a 
certain m/z can be projected at a given time.
97
  
Three sets of quadrupole rods in a series (triple quadrupole mass spectrometer) can be 
used in tandem mass spectrometers. The first and third quadrupole serve as mass filters, 
and the center quadrupole works as the collision cell. The ions of interest are selected in 
the first quadrupole, fragmented in the second quadrupole, and the fragments are mass 
analyzed in the third quadrupole. Selected ion monitoring is achieved by fixing the RF 
and can provide 100% duty cycle. Therefore these are more sensitive and suitable for 
targeted analysis.
98
 
1.4.3 Linear Quadrupole Ion Trap (LIT) 
An LIT consists of three sets of hyperbolically shaped rod electrodes similar to the 
quadrupole analyzer. The front and back ends are applied with higher potential that can 
trap ions within the quadrupole region (Scheme 1.8). 
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Scheme 1.8.  Schematic representation of a linear quadrupole ion trap mass analyzer. 
 
The LTQ Velos (Thermo, Bremen, Germany) is a commercial linear ion trap mass 
spectrometer used in most of the studies in this thesis. The scanning linear ion trap 
instrument offers fast scanning speed (typically 33000 amu/s) and improved sensitivity,
 99
 
at the expense of mass resolving power
97
 (e.g. 6000 at m/z 609
100
). The mass range is up 
to m/z 4000 on the LTQ Velos. 
The capability of trapping ions enables LIT to be used for tandem MS. Collision gas 
for CID or radical anions for ETD can be introduced to the trap and react with analyte 
ions during gas-phase collisions for MS
2
. Multiple stages of ion selection and 
fragmentation can take place in the trap, therefore ion trap can achieve MS
n
 for more 
thorough structural analysis.  
1.4.4 Fourier Transform Ion Cyclotron Resonance (FT-ICR) 
When an ion enters a magnetic field perpendicular to its original velocity direction, it 
will move in a circle by Lorentz force. The angular frequency is only dependent on the 
ion’s mass, charge, and the magnetic field. The ions therefore will circulate in the 
cyclotron cell. The FT-ICR detects the ions based on the image currents the ions produce 
when they approach the electric plates. The time-domain current image is converted to 
ion exit slot
y
z
x
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frequency-domain spectrum by Fourier transform, and the frequencies are subsequently 
converted to m/z values (Scheme 1.9).
101
 
Scheme 1.9.  Schematic representation of the principle of FT-ICR MS. Image current 
signals are obtained when the ions approach the electrode plate, and the signals are 
converted to a mass spectrum by Fourier transformation. 
 
The FT-ICR mass spectrometer has the highest resolving power by far. The mass 
resolving power is over 400,000 at m/z 1000.
101
 However, the mass range is limited (e.g. 
m/z 400-2000 for optimal response) and it takes longer (~ 1 s) than other instruments to 
measure ions.
101
   
1.4.5 Hybrid Mass Spectrometer  
Quadrupole time-of-flight (Q-TOF) is an example of a hybrid mass spectrometer that 
combines mass analyzers for better performance and tandem MS capability. Q-TOF 
couples a quadrupole with a TOF analyzer. TOF has a higher duty cycle than the full-
scan quadrupole, therefore Q-TOF is more sensitive than triple quadrupole except in the 
selected ion monitoring mode, and the reflectron TOF increases the mass resolving power 
at the same time.
102
 
The SYNAPT G2 (Waters, Manchester, UK) is a commercial hybrid quadrupole/ion 
mobility spectrometry (IMS)/orthogonal TOF mass spectrometer also used in the work 
reported herein. The configuration is similar to Q-TOF, but adds an IMS device between 
the quadrupole and TOF. Unlike MS, ions are separated according to their number of 
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charges, size, and shape.
103,104
 IMS-MS has advantages for extended dynamic range and 
the ability to separate isomeric compounds.
105,106
 The TriWave region also consists of a 
trap before the IMS cell and a transfer after it. Fragmentation for tandem MS is 
applicable in both trap and transfer regions.   
1.6 Motivation 
In all cases described in the previous section, ionization methods should be efficient 
to produce ions and simple to interface with mass spectrometers to utilize these advanced 
mass analyzer features. Advancement of MS towards the goal of more efficient ionization 
and simpler operation may be achieved through the development of new ionization 
methods. Ionization methods are discovered before and during my PhD period for which 
I contributed in some cases during the initial discovery phase and helped mass 
measurements, but will not be the main focus of this thesis. More details of the 
development, summary of the schemes, and fundamental understandings of these 
methods will be introduced in Chapter 3. 
ESI-like ions can be produced by novel inlet and vacuum ionization methods. Inlet 
ionization methods include laserspray ionization inlet (LSII),
75 107 , 108
 matrix assisted 
ionization inlet (MAII),
109 , 110
 and solvent assisted ionization inlet (SAII).
111 - 114
 
Ionization process occurs in the heated inlet tube linking AP and the first stage of vacuum 
in a mass spectrometer. Solid matrix/analyte (LSII and MAII) or liquid analyte solution 
(SAII) is introduced into the heated inlet tube of the mass spectrometer with (LSII) or 
without (MAII and SAII) laser ablation. ESI-like multiply charged ions are produced by 
either method with sufficient ion abundance for MS and tandem MS analysis, without the 
use of voltage or nebulizing gas. Vacuum ionization, in analogy to LSII and MAII, 
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includes laserspray ionization vacuum (LSIV)
115 , 116
 and matrix assisted ionization 
vacuum (MAIV).
117-120
 Heat is not required in vacuum ionization. With the assistance of 
proper matrix and “softer” instrument settings (e.g. low or no laser power, sample plate 
voltage removed), multiply charged ions can be produced from surfaces in vacuum.  
By the time I started my PhD research, multiply charged ions from peptides/proteins 
had already been observed by laser ablating a mixture of proper matrix and analyte from 
the solid state without using any voltage, but the mechanism of LSII was not yet clear. 
Predominantly solvent-based sample preparation was used, solvent-free preparation was 
only attempted with a vortexer that did not provide efficient homogenization.
108
 Other 
new ionization methods were developed along the way with some limitations at the initial 
discovery stage. For example, the use of a silica tube to infuse analyte solution at the 
hotspot in the capillary tube is not applicable for fast and simple operations. The inlet 
ionization methods are beneficial to mass spectrometers equipped with heated inlet (e.g. 
LTQ Velos), but many high performance mass spectrometers (e.g. Apex II FT-ICR) do 
not have this feature. Fabrication of a heated capillary has been reported by attaching a 
copper tube to the skimmer cone of a SYNAPT G2 but is less analytically useful.
121
 No 
new ionization methods have been used for quantification. These limitations will be 
overcome or at least reduced as reported in this thesis. 
1.7 Scope of This Dissertation   
This dissertation presents the instrumental development, fundamental insights, and 
initial applications of the new ionization method developed by my colleagues and me, 
towards the potential to employ the novel ionization process for their rapid, robust, and 
simple-operated analyses during the course of the work described here.  
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Chapter 2 describes the general experimental procedures including materials, sample 
preparation, instrumentation, data acquisition, software, etc. used during this research. 
More detailed experimental sections relevant to each chapter are included in individual 
chapters.  
Chapter 3 briefly states the history of novel ionization method development. Inlet 
and vacuum ionization is introduced in more detail in this chapter, along with mechanistic 
discussions. Our initial understanding of the unprecedented mechanisms of ion 
production will be revealed in this chapter. 
Chapter 4 presents a total solvent-free analysis approach using LSII-IMS-MS to 
analyze both hydrophobic and hydrophilic compounds. The total solvent-free analysis 
consists of solvent-free sample preparation and solvent-free gas-phase separation using 
IMS coupled with MS. This chapter reports the first example of highly charged 
peptide/protein ions to be produced in MS from solid state without using solvent during 
either sample preparation or separation. TissueLyzer and grinding beads are utilized to 
homogenize dry matrix compounds with dried analytes. Factors such as temperature, and 
homogenization frequency during sample preparation, and thermal requirements for 
different matrices, are investigated to discuss the multiple charging results.     
Chapter 5 reports the construction of a simple and convenient instrumental setup to 
couple LC at very low flow rates (as low as 400 nL min
-1
) with SAII. In contrast to ESI, 
it was demonstrated that no voltage or extra connection is required to interface LC to MS. 
Data dependent tandem MS is also shown in this chapter for rapid sequence analysis of 
BSA digested peptides achieved by SAII-CID. Comparable sensitivity to ESI is achieved 
by this SAII method with much less effort. 
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Chapter 6 reports the development of instrumentation and methods that allow 
multiplexing of a variety of molecules, including small drugs to larger protein. With the 
assistance of heat applied to the inlet tube, 42 samples of 7 analyte solutions in 6 cycles 
were analyzed within 5 min under the same inlet temperature. As a proof of principle, the 
sample holder was carried by an x,y-stage for automation. For convenient observation 
and fast analysis, the sample locations were mapped using the m/z of the ions by imaging 
software so that the content of each solution and relative abundance can be visually 
displayed. The map can provide the m/z for signal identity, tandem MS for specificity, 
and signal intensity for relative amounts of certain compounds in different wells of the 
96-well sample holder. 
Chapter 7 presents the development of matrix assisted ionization vacuum to FT-ICR 
mass spectrometer to establish the capability of ultrahigh performance mass 
measurements. Over 400,000 mass resolving power was achieved for proteins at m/z 800. 
Both the MALDI and ESI source on the commercial dual-source instrument were used. 
Multiply charged ions of peptides and proteins are produced in the MALDI source 
without firing the laser, and on the ESI source without voltage, sheath gas, or heat. 
Chapter 8 describes the development of simple and rapid surface assessment 
methods to quantify a schizophrenia drug from brain tissue sections of a drug-treated 
mouse. The material can be extracted either by solvent and subsequently transferred to 
the heated inlet (SAII), or by proper matrix when exposing the partially matrix-covered 
tissue section to vacuum (MAIV). Compared to the traditional quantification method, 
LC-ESI-MS/MS, similar results were obtained by SAII but at a much faster speed (a few 
minutes for SAII and over an hour for LC-ESI-MS/MS). MAIV is slower but is 
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independent of a heated inlet and more reproducible due to the continuous ion production. 
Both sampling methods demonstrate that only the material from the surface was extracted, 
independent of the tissue thickness.  
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CHAPTER 2 
MATERIALS AND INSTRUMENTATIONS 
2.1 Materials and Sample Preparation 
The analytes and matrices were purchased from Sigma Aldrich (St. Louis, MO) 
unless otherwise noted. Angiotensin I and non-β-amyloid component of Alzheimer’s 
disease (NAC) were obtained from American Peptide Co. (Sunnyvale, CA), trypsin-
digested BSA MS standard (CAM-modified) was purchased from New England BioLabs 
Inc. (Ipswich, MA, USA),  sphingomyelin was from Avanti Polar Lipids, Inc. (Alabaster, 
AL), clozapine and clozapine-d8 were from Santa Cruz Biotechnology (Santa Cruz, CA). 
Leucine enkephalin was provided by Waters Co. (Milford, MA). N-acetylated myelin 
basic protein fragment from Anaspec (Fremont, CA), and phosphopeptide standard I was 
from Protea Biosciences (Morgantown, WV). 3-NBN was from Tokyo Chemical Industry 
Co., Ltd. (Portland, OR). Solvents were obtained from Fisher Scientific Inc. (Bremen, 
Germany) unless otherwise stated. HPLC grade water was purchased from EMD 
Chemicals (Gibbstown, NJ). Microscopy glass slides were obtained from Gold Seal 
Products (Portsmouth, NH). 
Stock solutions of peptides and proteins were prepared by dissolving them in water as 
1 mg mL
-1
 concentrations. The stock solution of bovine insulin was in a 49.5:49.5:1 
MeOH:water:acetic acid solution. Lipids were in methanol, and clozapine was in ethanol. 
Peptides and proteins were diluted to desired concentration by water or 50:50 ACN:water, 
with or without 0.1% formic acid. Lipids were diluted by MeOH with 1% acetic acid. 
Clozapine was diluted by water. The matrices were prepared by dissolving 5 mg of each 
matrix in 100 µL 50:50 ACN:water unless otherwise stated.   
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For solvent-based analysis, the samples were prepared by either the droplet method or 
layer method. In the droplet method, the analyte and matrix solutions were mixed in 1:1 
volume ratio, and 1 µL was spotted on the sample holder (glass slide or MALDI plate) 
and allowed air dry. In the layer method, 1 µL analyte solution was spotted on the sample 
holder first, followed by 1 µL matrix solution and mixed with the pipet tip. For solvent-
free analysis, 10 µL analyte solution was dried overnight in a PCR tube placed in the 
Biodryer, containing 3 stainless steel beads; a spatula tip-full (amount not critical) 2,5-
DHAP powder was added to the dry analyte. Then the dry mixture was homogenized and 
transferred onto the glass slide by TissueLyzer using frequencies 5-25 Hz for 2-10 min. 
More details about solvent-free sample preparation can be found in Chapter 4. 
Mouse Brain Tissue – Mouse brain tissue sections were provided by Prof. Ken 
Mackie and Dr. James Wager-Miller from Indiana University. They were cut with a 
cryostat and mounted on microscopy glass slides. Briefly, mice were injected 
intraperitoneally with 50 mg kg
-1
 clozapine and sacrificed 60 minutes post-dosing with 
isoflurane overdose followed by perfusion of 20 mL of ice cold phosphate buffered saline. 
Brains were rapidly removed and frozen.  Tissue sections were sliced on a Cryostat 
(Leica) to 10 or 20 µm thicknesses and sections were stored at -80 °C prior to analysis.  
All animal procedures were approved by the Indiana University Bloomington 
Institutional Animal Use and Care Committee. 
2.2 Instrumentation 
2.2.1 Mass Spectrometers 
LTQ Velos. On the mass spectrometers that are commercially equipped with an inlet 
tube, e.g. LTQ Velos (Thermo Scientific Inc., Bremen, Germany), the temperature of the 
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inlet was directly heated from 50 ºC to 450 ºC. The ESI source housing was removed and 
the interlock was overridden so that free access to the inlet orifice was available. Helium 
gas was used for collision induced dissociation (CID), and a mixture of ultrapure helium 
and nitrogen (25% helium and 75% nitrogen; purity ~99.995%) was used as the reaction 
gas for electron transfer dissociation (ETD). Fluoranthene was used as electron reagent 
for ETD.  Both positive and negative ion mode were used with the following settings: the 
Auto Gain Control was on, maximum injection time was 20 ms, and each mass spectrum 
was obtained by summing up 5 microscans. The sheath gas, aux gas, sweep gas, and 
capillary voltage were all set at 0. S-lense was 65%. Mass range was set to ‘normal’, scan 
rate was ‘normal’, and scan time was ‘full’. Xcalibur 2.1.0 was used for data analysis. 
For ESI, the commercial housing was used. The capillary voltage was set at 2.5-4 kV, 
depending on the solvent system. Sheath gas around 10. CID was performed for ESI-
MS/MS experiments. 
SYNAPT G2. On those mass spectrometers that are not equipped with an inlet tube 
that can be heated, e.g. SYNAPT G2 (Waters, Manchester, UK), the skimmer cone can 
only be heated up to 150 ºC and is not efficient for inlet ionization methods. Therefore, a 
capillary was attached to the skimmer cone to help desolvation. The source temperature 
was held at 150 ºC, and the nichrome wire which wrapped the copper tube around was 
connected to a Variac for additional heat. More details about fabricating the inlet 
capillary can be found in Chapter 4. 
The SYNAPT G2 was operated in positive and resolution modes. The sample cone 
was set at 40 V and the extraction cone was 4 V. The scan time was set at 1 sec. Nitrogen 
gas was used for drift time separation at a flow of 22 mL min
-1
. The IMS wave velocity 
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was 650 m s
-1
 and wave height of 40 V. The pressure of the drift cell was 3.2 mbar. 
MassLynx 4.1 and DriftScope ver. 2.1 (Waters Corp., Manchester, UK) were used for 
data analysis. 
FT-ICR.  An Apex II FT-ICR mass spectrometer (Bruker, Bremen, Germany) was 
used for MAIV and LSIV as the application of novel ionization methods on high-
performance instruments to take advantage of its ultra-high mass resolving power. The 
dual MALDI/ESI source was used. For MAIV measurements, the laser fluence was set to 
0, and the laser beam was blocked with paper. Voltage on the sample plate (240 V-300 V) 
was applied to assist lifting up ions. For LSIV measurements on the FT-ICR mass 
spectrometer, ubiquitin was combined with 2-NPG. The arbitrary laser fluence was 50%, 
and the plate voltage was 400 V.  
MAIV from AP was performed on the dual MALDI/ESI source. The ESI source, the 
cover, and the cap over the ESI capillary were removed for direct access to the orifice of 
the ESI capillary. The capillary voltage, spray shield, nebulizing gas flow, and dry gas 
flow were all set to 0, and no override was necessary for operation. No added heat was 
applied to the ESI capillary.  
2.2.2 Ultrahigh Performance Liquid Chromatography (UPLC) 
A Waters Corporation NanoAcquity UPLC was used. Columns used include a Waters 
100 μm x 100 mm BEH130 C18 column with 1.7 μm particles, and a Waters 1 mm x 100 
mm BEH 130 C18 column with 1.7 μm particles.  
Water and ACN were used as mobile phase, the gradient can be found in more details 
in Chapters 5 and 8. 
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2.2.3 Other Equipments 
Microscopy. Optical microscopy (Nikon Eclipse LV100) was performed to observe 
droplet production upon LSII, and to determine the analyzed area in surface SAII for 
clozapine quantification. The microscope was operated at 5x magnification. 
Automated x,y-stage. A computer-controlled automated x,y-stage (Newmark Systems, 
Mission Viejo, CA) was used to carry and move sample holders in front of the mass 
spectrometer.  
2.2.4 Other Software 
BioMap 3.7.5.6 imaging software (Novartis Institution for Biomedical Research, 
Basel, Switzerland), typically used for imaging applications, was incorporated to map in 
which solution analyte was present as determined by the m/z ratio values obtained by MS 
or MS/MS. Besides mapping the location of analyte, the software allows relative 
concentrations to be displayed by color code. Thermo XCalibur .RAW files were 
converted to .IMG files using customized imaging software. 
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CHAPTER 3 
FUNDAMENTAL UNDERSTANDING 
Ionization methods are discovered before and during my PhD period. In some cases I 
have contributed during the initial discovery phase. This chapter focuses on a brief 
history of new ionization methods development and our current understanding of the 
mechanistic aspects of the novel ionization process. The experiments I participated in 
which led to the discovery and understanding so the relevant mechanism are included in 
this chapter. Figures and schemes are adopted from my co-authored publications from my 
contribution as follows:   
Inutan, E.D.; Wang, B.; Trimpin, S. Commercial Intermediate Pressure MALDI Ion Mobility 
Spectrometry Mass Spectrometer Capable of Producing Highly Charged Laserspray Ionization 
Ions. Anal. Chem. 2010, 83, 678-684.  
Trimpin, S.; Wang, B.; Inutan, E.D.; Li, J.; Lietz, C.B.; Harron, A.; Pagnotti, V.S.; Sardelis, D.; 
McEwen, C.N. A Mechanism for Ionization of Nonvolatile Compounds in Mass Spectrometry: 
Considerations from MALDI and Inlet Ionization. J. Am. Soc. Mass Spectrom. 2013, 23, 1644-
1660. 
Trimpin, S.; Wang, B.; Lietz, C.B.; Marshall, D.D.; Richards, A.L.; Inutan, E.D. Inroads to New 
Ionization Processes for Use in Mass Spectrometry. Crit. Rev. Biochem. Mol. Biol. 2013, 48, 409-
429.  
Chakrabarty, S.; Pagnotti, V.; Wang, B.; Trimpin, S.; McEwen, C.N. Ionization from Ice in Mass 
Spectrometry and a Possible Connection to Thunderstorms, Anal. Chem. 2014, 86, 7343-7350.  
Trimpin, S.; Lutomski, C. A.; El-Baba, T. J.; Woodall, D. W.; Foley, C. D.; Manly, C. D.; Wang, 
B.; Liu, C.; Harless, B. M.; Kumar, R.; Imperial, L. F.; Inutan, E. D. Magic matrices for 
ionization in mass spectrometry. Int. J. Mass Spectrom. 2014, doi: 10.1016/j.ijms.2014.07.033.  
Trimpin, S.; Wang, B. Inlet and Vacuum Ionization from Ambient Conditions, in: Ambient 
Ionization Mass Spectrometry, Royal Society of Chemistry, by Eds. Marek Domin and Robert 
Cody, 2015, 423-444.  
Reprinted with permissions from American Chemical Society, Springer Science and 
Business Media, Informa Healthcare, Royal Society of Chemistry, and Elsevier.  
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Newly discovered ionization methods at their initial developed phase are summarized 
in Scheme 3.1. The left column represents inlet ionization and right column for vacuum 
ionization. These methods will be introduced respectively in the following sections.  
Scheme 3.1. Schematic representation of: (A) Inlet ionization methods that produce 
ions with the assistance of heat and vacuum drop, ionization occurs in the inlet tube 
of the mass spectrometer (B) Vacuum ionization methods the utilize proper matrix 
occurring by exposing to vacuum. (1) Laserspray ionization that employs laser 
ablation to remove matrix/analyte mixtures from sample holder such as a glass slide; 
(2) matrix assisted ionization of which samples are introduced by mechanical force or 
matrix sublimation; (3) solvent assisted ionization that utilizes solvent instead of 
organic compounds as matrix. [Modified from 18] 
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3.1 Inlet Ionization 
LSII was developed to use a UV laser to dislodge the solid analyte/matrix mixture 
from the sample plate and transfer it into the heated inlet.
75,107,108
 The matrices were first 
thought to have similar features in MALDI that they require an aromatic benzene ring to 
absorb UV laser energy. However, if the same matrix/analyte mixture (e.g. 2,5-
DHAP/ubiquitin mixture) is ablated by UV, visible, and infrared laser respectively 
(Figure 3.1), similar mass spectra are produced indicating that LSII operates with a 
different mechanism than MALDI.
122
  
 
Figure 3.1. LSII-MS spectrum of ubiquitin (MW 8570) using 2,5-DHAP matrix. The 
matrix/analyte mixture was ablated by (A) ultraviolet (B) visible and (C) infrared 
laser at different wavelengths and produced similar ions. The numbers on the right 
top corner denote ion abundances. [Adopted from 122] 
 
Based on this observation, mechanical force, instead of laser ablation, can be 
employed to introduce analyte/matrix mixture to the heated inlet.
109,110
 SAII is a liquid 
sample introduction method that does not require organic compound as matrix and 
directly infuses analyte solution into the heated inlet.
111
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the inlet tube is required as well as the pressure drop from AP to the first stage of vacuum 
of the mass spectrometer.
122
 Depending on the matrix (solid or solvent), up to 450 ºC may 
be required for good analyte ionization.
110,122
 In contrary to traditional ionization methods 
such as MALDI and ESI as described in Chapter 1, no voltage is used in inlet ionization. 
The ionization source of inlet ionization is the heated inlet tube in the mass 
spectrometer.
18
 Gas-phase ions are produced when compounds, preferably in a matrix or 
solvent, pass through a heated tube linking the first vacuum stage of a mass analyzer with 
AP.
122 
A unified mechanism was proposed for all three inlet ionization methods shown in 
Scheme 3.2.
122
 When matrix/analyte (organic matrix/analyte droplets or particles for LSII 
and MAII, solvent/analyte solution for SAII) enter the heated inlet tube, heat and the 
pressure drop result in charge separation that may be caused by superheating and 
bubbling carrying away surface charge into small droplets.
123
 Millions of charges can be 
generated from charge separation. In this mechanism, the progency droplets will have 
opposite charge from the remaining parent droplet. The charged droplets undergo solvent 
evaporation and coulombic fission. They also collide with the inner walls of the inlet tube 
and with each other, and finally matrix/solvent evaporation producing bare gas-phase 
analyte ions.
122
 It was proposed by Vestal in 1983, before the invention of MALDI or ESI, 
that ions are produced from charged clusters.
124
 This solvent removing process is similar 
to ESI after the analyte solution is sprayed from the ESI capillary, but in inlet ionization 
ions are produced without applying any voltage or nebulizing gas.  
Therefore, similar ions can be produced as long as the mixture of matrix (solid or 
liquid) and analyte are transferred into the heated inlet tube, and it does not matter if a 
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laser or organic matrix is used.
125
 Figure 3.2 shows the mass spectra of the myelin basic 
protein fragment peptide introduced to the instrument by LSII, MAII, and SAII, 
respectively. Identical mass spectra were produced. ETD was performed to the quadruply 
charged ions, and similar sequence coverage was obtained with all three methods (Figure 
3.2.B).  
Scheme 3.2. Schematic representation of the fundamental understanding of inlet 
ionization. SAII is displayed in the scheme by pipetting analyte solution right in front 
of the heated inlet tube linking AP and vacuum of the mass spectrometer.  
 
                 
 
Figure 3.2. MS and MS/MS spectra of myelin basic protein fragment (MW 1832) by 
(A) LSII and (B) MAII using 2,5-DHAP as matrix, and (C) SAII using water with 0.1% 
formic acid as solvent. In all cases, the inlet temperature was held at 250 ºC. 
[Adopted from 125] 
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Charge separation also occurs from freezing water droplet (Figure 3.3).
126
 Charged 
particles are produced and ejected from frozen droplet surfaces by surface splintering. 
The sublimation of dry ice helps surface splintering and can produce highly charged 
protein ions directly from a frozen droplet of analyte aqueous solution. An extended inlet 
was used and wrapped by ice bags to assist cold ionization. Up to +10 charge state was 
observed from ubiquitin in aqueous solution.  
 
Figure 3.3. Analysis of ubiquitin aqueous solution by cold ionization. (A) Picture of a 
10 µL ubiquitin aqueous solution spotted on dry ice and introduced into the cold 
extended inlet assisted by dry ice sublimation. (B) Mass spectrum of 
ubiquitin.[Adopted from 126] 
Instruments such as the LTQ Velos have a heated inlet that benefits inlet ionization, 
but many high-performance mass spectrometers are not equipped with commercial heated 
inlet. If the proposed mechanism is correct – that ions are produced from charged 
analyte/matrix clusters, more volatile matrix compounds will efficiently evaporate or 
sublime from charged analyte/matrix droplets or particles in the presence of vacuum and 
without added heat. With such a matrix, it would be necessary to have a means of 
producing the charged particles.  
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3. 2 Vacuum Ionization 
With the proper matrix with a low thermal requirement to produce LSII ions, e.g. 2,5-
DHAP, and “soft” instrument parameters (low laser power and no plate voltage), ESI-like 
ions were first produced from a mixture of lipids, peptides, and proteins employing laser 
ablation on a commercial intermediate pressure (10
-2
 mbar) MALDI-IMS-MS 
instrument.
115
 Although there is no heated inlet or external thermal energy, a pressure 
drop is present inside the mass spectrometer, and absorption of the laser beam provides 
heat. In analogy to laserspray ionization inlet, the ionization occurring in the vacuum 
source is termed laserspray ionization vacuum (LSIV). More volatile matrices, e.g. 2-
nitrophloroglucinol (2-NPG), can be used in high vacuum MALDI-TOF-TOF mass 
spectrometers of which the source is at even lower pressure (10
-6
 mbar).
116 
Among the volatile matrices, 3-nitrobenzonitrile (3-NBN) sublimes in vacuum. When 
the analyte is exposed to the matrix and vacuum, multiply charged ions from peptides and 
proteins are produced without employing the laser or applying extraction voltage.
117-120
 
This method is termed matrix assisted ionization vacuum (MAIV) and produces ESI-like 
ions from a wide range of compounds such as drugs, peptides, lipids, and proteins. A 
number of novel matrices with different functionalities have been discovered to produce 
ions.
127
 Interestingly, the crystal morphologies vary a lot according to the microscopy 
images. Their sublimation capabilities are quite different, too. Shown in Table 3.1 are 
representative microscopy images of 3-NBN, coumarin, and 2-bromo-2-nitro-1,3-
propanediol (bronopol) that sublime differently over 24 hour period. 3-NBN sublimed at 
room temperature and pressure in 3 h; coumarin was partially sublimed after a 24 h, but 
no observable sublimation occurred for bronopol. This method has been extended to 
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operate on slightly or non-modified ESI source to simplify the operation and improve 
throughput.
119 
Table 3.1. Microscopic images of 3-NBN, coumarin and bronopol showing the 
sublimation of these matrices at room temperature and atmospheric pressure. Images 
were taken right after spotting, 3 h, 6 h, and 24 h. [Adopted from 127] 
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CHAPTER 4 
PRODUCING HIGHLY CHARGED IONS WITHOUT SOLVENT USING 
LASERSPRAY IONIZATION: A TOTAL SOLVENT-FREE ANALYSIS 
APPROACH AT ATMOSPHERIC PRESSURE 
First examples of highly charged ions in mass spectrometry (MS) produced from the 
solid state without using solvent during either sample preparation or mass measurement           
are reported. Matrix material, matrix/analyte homogenization time and frequency, 
atmospheric pressure (AP) to vacuum inlet temperature, and mass analyzer ion trap 
conditions are factors that inﬂuence the abundance of the highly charged ions created by 
laserspray ionization (LSI). LSI, like matrix-assisted laser desorption/ionization 
(MALDI), uses laser ablation of a matrix/analyte mixture from a surface to produce ions. 
Preparing the matrix/analyte sample without the use of solvent provides the ability to 
perform total solvent-free analysis (TSA) consisting of solvent-free ionization and 
solvent-free gas-phase separation using ion mobility spectrometry (IMS) MS. Peptides 
and small proteins such as non-β-amyloid components of Alzheimer’s disease and bovine 
insulin are examples in which LSI and TSA were combined to produce multiply charged 
ions, similar to electrospray ionization, but without the use of solvent. Advantages using 
solvent-free LSI and IMS-MS include simplicity, rapid data acquisition, reduction of 
sample complexity, and the potential for an enhanced eﬀective dynamic range. This is 
achieved by more inclusive ionization and improved separation of mixture components as 
a result of multiple charging. 
B. Wang, C. B. Lietz, E. D. Inutan, S. M. Leach, S. Trimpin, Anal. Chem., 2011, 83, 
4076-4084. Reprinted with permission from Copyright (2011) American Chemical 
Society. 
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4.1 Introduction 
Mass spectrometry (MS) at atmospheric pressure (AP) is of analytical interest for 
reasons ranging from rapid data acquisition to sample analysis of biological materials 
under more physiologically relevant conditions.
39,84,128
 Unfortunately, the observation of 
high-mass singly charged ions is limited by the mass-to-charge (m/z) range of most high-
performance mass spectrometers, a major drawback of AP matrix-assisted laser 
desorption/ionization (MALDI).
65
 Laserspray ionization (LSI) MS is a newly introduced 
method capable of soft ionization of small and large molecules such as lipids, peptides, 
proteins, and other high-mass compounds by laser ablation at AP.
75,107,108,121, 129 - 135
 
Advantages include small ablation areas/volumes, AP conditions, speed of analysis, and 
the production of multiply charged ions to extend the mass range of high-performance 
mass spectrometers. The ability to obtain multiply charged ions also provides enhanced 
fragmentation important for structural characterization. For example, sequence analysis 
by electron transfer dissociation (ETD) was obtained on a Thermo LTQ-ETD mass 
spectrometer providing nearly complete sequence coverage of ubiquitin and identiﬁed an 
endogenous peptide directly from mouse brain tissue.
107,134
  
LSI ions have been generated on commercial atmospheric pressure ionization (API) 
sources directly,
75,107,129,130,131,133-135
 after retroﬁtting with a home-built LSI desolvation 
tube,
121,130,132 
and by introducing LSI conditions on a commercial AP-MALDI source.
108
 
Initial solvent-free gas-phase separation results enabled by the ion mobility spectrometry 
(IMS) dimension showed the utility and beneﬁts for the analysis of protein mixtures, 
even when isomeric, directly from surfaces.
121,132
 Recently, LSI has been extended to 
intermediate pressure (IP) MS applications, producing highly charged and high abundant 
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peptide and protein ions.
115
 These ions, especially in mixtures as complex as mouse brain 
tissue, are notably well-separated by IMS-MS using a solvent-based LSI approach. 
Solvent-free sample preparation/ionization operates independent of analyte 
solubility,
38
 a key advantage over any solvent-based MS method. Combined with solvent-
free gas-phase separation using IMS-MS, this provides total solvent-free analysis (TSA) 
by MS.
39,136
 Potential advantages using solvent-free LSI and IMS-MS in a TSA approach 
include simplicity, rapid data acquisition, reduction of sample complexity, and enhanced 
effective dynamic range. Justiﬁcations for exploring solvent-free approaches relate to a 
number of factors that can be broadly deﬁned as (i) the need to perform chemical analysis 
on molecules that are difficult or impossible to solubilize, known collectively as the 
“insolubelome”; 137  (ii) the need to avoid chemical reactions that can spontaneously 
change the structures of certain types of molecules when they are in solution; (iii) the 
need to address problems associated with extreme loss of certain analytes in solution 
during sample preparation; and (iv) the need to address diffusion of analytes within a 
complex matrix such as tissue sections for mass spectrometric imaging, where spatial 
distribution of analytes is a major variable in the analysis. The poorly soluble constituents 
of living organisms, such as membrane proteins, as well as hydrophobic compounds, 
such as lipids, metabolites, synthetic polymers, crude oil, and biofuels, need new 
analytical methods for their analysis. 
Solvent-based LSI, similar to ESI, forms singly charged ions of lipids and low 
molecular weight peptides but for higher molecular weight biological and synthetic 
macromolecules produces highly charged ions.
75,107,108,115,121,129-135
 Using a laboratory 
vortexer
138
 and 2,5-dihydroxybenzoic acid (2,5-DHB) as matrix, LSI was reported to 
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exclusively produce singly charged ions with solvent-free sample preparation and 
employing 350 °C on the heated inlet capillary of a Thermo Scientiﬁc Orbitrap Exactive 
mass spectrometer.
75
 We show here the ﬁrst examples that matrix/analyte materials 
combined in the solid state can produce abundant highly charged peptide and protein ions 
and, when in mixtures, are well-separated in the solvent-free gas-phase dimension 
provided by IMS because of the successful introduction of multiple charging. Further, 
pictorial “snapshots” of this TSA experiment using the dimensions of drift time and m/z 
suggest usefulness for rapid observation of changes in relative sample composition even 
in complex samples such as crude oil without the need of extensive optimization of 
sample preparation and separation. 
4.2 Materials and Methods 
Materials. Besides the general chemicals stated in Chapter 2, oils were obtained 
from a local store. Stainless steel beads (1.2 mm) were obtained from BioSpec Products, 
Inc., Bartlesville, OK, USA.  
LSI Sample Preparation. Stock solutions were prepared as described in Chapter 2. 
For the peptide/lipid mixture, angiotensin I and sphingomyelin were premixed to a 1:1 
volume ratio using the stock solutions. 
Solvent-Free Sample Preparation. The matrix/analyte samples were simultaneously 
homogenized and transferred to the glass microscopy slide using the TissueLyser II 
(Qiagen Inc., 27220 Turnberry Lane, Valencia, CA, USA), similar to published 
procedures.
139,140
 Solutions of 10 μL of 772 pmol μL-1 angiotensin I in water, 10 μL of 
peptide/lipid mixture in MeOH/H2O, 3.26 μL of 307 pmol μLÀ1 NAC in water, and 5.73 
μL of 174 pmol μL-1 bovine insulin in MeOH/H2O with 1% acetic acid were used. 
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Identical to previous solvent-free preparation,
37,41
 the respective analyte samples were 
transferred to individual 0.2 mL PCR tubes containing three stainless steel beads and then 
evaporated in the Biodryer (BioSpec Products Inc., PO Box 788, Bartlesville, OK, USA) 
for 3 h to ensure complete dryness of the samples. The oil samples were prepared without 
solvent by pipetting 1 or 2 μL of the liquid directly to the vial to be used for 
homogenization; waxy and oily materials were previously studied by solvent-free sample 
preparation protocols.
36,138
 After the samples were completely dry, except for the crude 
oil, a spatula tip amount (this is not a critical parameter) of 2,5-DHAP matrix was added 
into each tube, identical to the previously published procedures.
139,140
 The top opening of 
the tube was then covered by the microscopy glass slide and was firmly and securely 
placed in the TissueLyser II sample holder. Each set of sample was homogenized with 
the desired frequency and time. The matrix/analyte mixtures of angiotensin I, NAC, and 
peptide/lipid mixture were homogenized for 10 min at 25 Hz, while bovine insulin and 
oils were ground at 30 Hz.  
Specific Study of Frequency and Time. Angiotensin I was homogenized with the 2,5-
DHAP matrix for time periods of 2, 5, 10, and 20 min at grinding frequencies of 15, 20, 
and 25 Hz. To ensure the most identical matrix/analyte ratio composition, the mixture 
was ground for 2 min so that a reasonably homogeneous powder was obtained before 
removing the glass slide cover with matrix/analyte powder attached. The powdered 
matrix/analyte sample on the glass surface was then analyzed by LSI-IMS-MS. The 
remaining matrix/analyte sample in the tube was covered with a new glass slide and 
rehomogenized for another 3 min to prepare the sample with the second time point (5 
min), and so on. 
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Specific Study of Temperature. Angiotensin I was homogenized with the 2,5-DHB 
matrix for 2 and 10 min and with 2,5-DHAP matrix for 10 min with a grinding frequency 
of 25 Hz. The homogenized matrix/analyte sample was initially analyzed by LSI-IMS-
MS (SYNAPT G2) at 150 °C on the skimmer cone with and without additional heat 
applied on the home-built desolvation device described previously.
121
 To gain more 
accurate temperature values, we also analyzed the homogenized matrix/analyte sample on 
the Thermo LTQ Velos instrument equipped with the commercial desolvation device 
with accurate temperature readings. Temperatures of 40, 150, 275, and 400 °C were 
applied.  
Solvent-Based Sample Preparation. The solvent-based sample preparation was 
carried out for comparison. To ensure the most direct comparison, homogenized 
matrix/analyte powder mixture that remained in each tube from the respective TSA 
experiment was used by adding 5 μL of 50:50 ACN/H2O. The powder and solvent were 
stirred by a micropipet tip. Only some of the analyte/matrix mixture was dissolved, and 
approximately 4 μL of the saturated solution was transferred to the glass slides. After 
complete evaporation of the solvent, LSI-IMS-MS analysis was performed identical to 
the solvent-free prepared samples. Solvent-based crude oil sample was prepared by 
dissolving crude oil in 2:1 toluene/methanol mixture
141
 and then was premixed with 2,5-
DHAP solution with a 1:4 volume ratio. Two times 2 μL of the crude oil/matrix mixture 
was spotted without drying between on the microscopy glass slide and then blow-dried at 
low heat. NAC and bovine insulin were prepared by solvent-based layer method similar 
to previous studies.
132
 
Laserspray Ionization. The nitrogen laser (Spectra Physics VSL-337ND-S, Mountain 
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View, CA, USA) was focused and aligned to the ion entrance of the SYNAPT G2 and 
LTQ Velos mass spectrometers as previously described.
121,135
 The fabrication of the 
desolvation device for the SYNAPT G2 was also described previously.
121
 Briefly, the exit 
end of a 3.175 mm o.d., 1.5875 mm i.d., 19.05 mm copper tube, which was wrapped with 
24 gauge nichrome wire (Science Kit and Boreal Laboratories, Division of Science Kit, 
Inc., Tonawanda, NY, USA) and coated with Saureisen P1 cement (Inso-lute Adhesive 
Cement Powder no. P1) was securely attached to the ion entrance skimmer cone of the 
Waters Z-spray source by Saureisen cement. The source temperature was held at 150 °C, 
indirectly heating the copper desolvation device. To supply additional heat to the 
desolvation device, the nichrome wire was connected to a Variac (Powerstat, the Superior 
Electric Co., Bristol, CT, USA). With analyte/matrix samples facing the mass 
spectrometer, the glass slide was placed in front of the ion entrance of the desolvation 
device using the x,y,z stage of the nanolockspray source (SYNAPT G2) or manually 
(LTQ Velos) and was slowly moved through the focused laser beam aligned with the 
orifice in transmission geometry (180° with the ion entrance capillary) and focused ~2 
mm from the orifice. For allstudies using the laser, gloves and laser safe goggles were 
worn. 
IMS-MS Instrumentation. The SYNAPT G2 HDMS (Waters Corporation, 
Manchester, UK) with a quadrupole having a high mass limit of m/z 8000 was used to 
perform LSI-IMS-MS analysis. The first generation of this instrument has been 
previously described.
142
 The instrument was operated in resolution mode at a cone 
voltage of 0 to 40 V and extraction cone of 4 V. The total acquisition time was set at 1 
min, acquiring 1 mass spectrum per second. The flow rate of nitrogen, which was used 
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for drift time separation, was 22 mL min
-1
. The IMS cell pressure was 3.13 mBar and in 
the Triwave region, wave velocity ranged from 450 to 650 ms
-1
, and wave height from 30 
to 40 V. DriftScope version 2.1 (Waters Corp., Manchester, UK) was used to plot and 
process the two-dimensional (2-D) data of drift time versus m/z using emerald forest and 
hot metal color backgrounds. For acquisitions without IMS, only the source and trap 
gases were on. Other parameter settings used were the same excluding the IMS settings. 
LTQ-MS Instrumentation. The LTQ Velos (Thermo Fisher Scientific Inc., Fitchburg, 
WI, USA) was used to perform LSI-MS for the ion entrance capillary temperature-
dependent studies. The API source housing of the instrument was removed.
133-135
 For the 
temperature-dependent studies, the total acquisition time was 1 min, summing three 
microscans using a maximum injection time of 50 ms for each acquired mass spectrum. 
The matrix/analyte produced by ablation directly enters the heated capillary of the mass 
spectrometer. The capillary temperature was set to 40, 150, 275, and 400 °C for the 
respective studies.  
Microscopy. An optical microscope (Nikon, ECLIPSE, LV 100) was used to study 
the formation of liquid droplets in the LSI plume during the ablation of 2,5-DHAP and 
2,5-DHB. Samples were prepared with the TissueLyser II as previously described in 
solvent-free sample preparation,
139,140
 but with the omission of analyte. The matrix was 
ground using 1.2 mm stainless steel beads and transferred to a glass slide using the 
TissueLyser II at a grinding frequency of 25 Hz. One batch of samples was ground for 30 
s, and a second batch was ground for 10 min. The ablated plume from a single pulse of 
the 337 nm UV laser was collected on a separate glass slide for microscopy analysis. 
Additionally, a third batch of sample was created by a vortexer (Vortex-Genie 1 Touch 
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Mixer, Scientific Industries, Inc., Bohemia, NY, USA). Each matrix was ground in a PCR 
tube with three stainless steel beads for 30 s on the vortexer similar to published 
procedures.
138
 The matrix was pressed onto a glass slide using a metal spatula to provide 
a thin coverage similar to previous protocols used with MALDI.
36-38,41,138
 
4.3 Results and Disscussion 
Method Development for the Production of Multiply Charged Ions of Peptides and 
Proteins by a Total Solvent-Free Analysis (TSA) Approach. Shown in Figure 4.1 is the 
analysis of angiotensin I using a TSA approach consisting of solvent-free sample 
preparation/ionization coupled to solvent-free gas-phase separation by IMS. In the 
extracted mass spectrum (Figure 4.1A), abundant signal intensities for both the doubly 
and triply charged ions are observed. There are no notable differences in the relative 
intensities of the charge state distribution of the multiply charged ions as compared to the  
 
Figure 4.1. LSI-IMS-MS of angiotensin I (Ang. I) with 2,5-DHAP matrix using 
solvent-free sample preparation, a TSA approach: left panel (A) mass spectrum and 
right panel (B) 2-D plot of drift time versus m/z with insets displaying extracted drift 
time distributions for charge state +2 and +3. Reference data for solvent-based ESI-
IMS-MS are included in Figure S4.1 in Appendix A. 
solvent-based LSI analysis (Figure S4.1A in Appendix A) of the identical 2,5-
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DHAP/angiotensin I mixture. Singly charged ions were not produced by either solvent-
free or solvent-based LSI-MS. However, the total abundance of the angiotensin I ions 
produced using solvent-free preparation is lower than when solvent was used. Similar 
observations of relative intensities of soluble, more hydrophilic peptides using solvent-
free sample preparation/ionization for analysis of peptides and proteins with a MALDI 
time-of-flight (TOF) mass spectrometer have been reported.
37,41
  
Figure 4.1B displays the  dataset in a 2-D plot of drift time versus m/z with false color 
plot for the ion intensity showing that the multiply charged ions of angiotensin I obtained 
by solvent-free sample preparation/ionization undergo solvent-free gas-phase separation 
according to the number of charges and cross section (size and shape). This is best seen 
when viewing the extracted drift time distributions of +2 and +3 displayed in the 
respective insets of Figure 4.1B. The TSA results are essentially identical to those 
obtained by the solvent-based LSI-IMS-MS method, as shown by the respective 2-D plot 
and extracted drift time distributions (Figure S4.1B in Appendix A).  
With increasing molecular weight (MW) of the analytes, ions with increasing number 
of charges are produced by TSA. Again, singly charged ions are not observed. Examples 
are shown in Figure 4.2 for the non-β-amyloids component of Alzheimer’s disease 
(NAC) and bovine insulin. The extracted mass spectraare displayed in the left panel, and 
2-D plots are shown in the right panel. NAC (MW 3260) produces multiply charged ions 
ranging from +2 to +5 (Figure 4.2A.1) and bovine insulin (MW 5731) from +3 to +7 
(Figure 4.2.B.1). Unexpectedly, with increasing charge state, an increasing degree of 
metal adduction of sodium cations (e.g., BI charge state +6 has 0-2 Na
+
 ions replacing H
+
 
ions) is observed. Previous LSI studies using solvent-based sample preparation primarily 
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showed protonation of peptides and proteins.
75,107,108,115,121,130-134
 Solvent-free sample 
preparation in conjunction with MALDI-TOF analysis also produces a higher degree of 
metal cation adduction to the analyte, a key beneﬁt for hydrophobic ionization retarded 
molecules.
39,41,143
 Furthermore, oxidation has been described for ESI and solvent-based 
MALDI approaches and was diminished using solvent-free sample preparation 
employing a mini-ball-mill approach with short homogenization times of about 1 min 
using CHCA matrix.
41
 Here, however, in order to have precise control of sample transfer 
to the vial, solvent was used, followed by evaporation of the solvent, allowing oxidation 
processes to take place. We, therefore, tentatively assign one of the adduct species to 
[NACoxidized + 2H + Na]
3+
 instead of [NAC + 2H + K]
3+
.  
The TSA results were also compared with conventional solvent-based analysis 
approaches. Solvent-based LSI-IMS-MS analysis was obtained by adding 4 μL of 2,5-
DHAP matrix solution on top of 1 μL of sample spotted on a glass slide, mixed, and 
blow-dried similar to previous procedures.
132
 This procedure was applied to NAC (in 
50:50 ACN/H2O with 0.1% TFA) and bovine insulin sample (in 50:50 MeOH/H2O with 
1% acetic acid). The solvent-based LSI and the ESI-IMS-MS results for NAC also show 
protonation, metal ion adduction, and the proposed oxidation (Figure S4.2 in Appendix 
A). In contrast, the solvent-based LSI and ESI-IMS for bovine insulin only show 
protonation (Figure S4.3 in Appendix A). Most likely, for NAC, the sample is already 
partially oxidized as purchased.  
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Figure 4.2. LSI-IMS-MS of (A) non-β-amyloid component of Alzheimer’s disease 
(NAC) and (B) bovine insulin (BI) with 2,5-DHAP matrix using solvent-free sample 
preparation, a TSA approach: left panel (1) mass spectrum and right panel (2) 2-D 
plot of drift time versus m/z with insets displaying extracted drift time distributions of 
diﬀerent ionizations for charge states +3 (NAC) and +6 (BI). Reference data for 
solvent-based ESI- and LSI-IMS-MS are included in Figures S4.2 and S4.3 in 
Appendix A. 
 
The relatively high degree of sodiation and oxidation are observed starting at +3, as 
seen by [M + 3H]
3+
, [M + 2H + Na]
3+
, and [Moxid + 2H + Na]
3+, suggesting a speciﬁc 
structural change in the peptide to enhance metal cation adduction. It is therefore 
interesting to examine the drift time distributions (insets in Figure 4.2.A.2) for the 
different adducts at charge state +3 to provide some insight into the structures of NAC 
ions formed by protonation and sodiation. The charge state +3 ions of [NAC + 2H + 
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Na]
3+
 and [NACoxidized + 2H + Na]
3+
 are signiﬁcantly separated in the drift time 
dimension. The sodiated ion shows drift times very similar to the protonated ion 
[NACoxidized + 3H]
3+, while the oxidized ion shows a signiﬁcantly slower drift time 
indicating a more elongated  structure. The extent of the IMS gas-phase separation of 
~7.0 (non-oxidized) and ~8.9 ms (oxidized) indicates a large difference in shape. 
Similarly, the bovine insulin ions with higher charge states show metal adducted ions 
(Figure 4.2.B.2) without a signiﬁcant change in drift time (insets in Figure 4.2.B.2). This 
is in good agreement with previous investigations using an ESI-IMS-MS instrument with 
high drift time resolution
106
 that demonstrated that the drift time distributions of lipid ions 
with different metal adduction frequently fall into families with nearly identical drift 
times (isodrifts), indicating that the cation attached to the molecule has little structural 
inﬂuence.  
A motivation for producing multiply charged LSI ions from solid-state solvent-free 
preparation of the matrix/analyte is its potential application to tissue imaging. The results 
of Figures 4.1 and 4.2 show the relative abundance and ease with which the formation of 
the highly charged LSI ions can be achieved using a solvent-free approach. Compared to 
the production of exclusively singly charged LSI ions using 2,5-DHB without the use of 
solvents as described before,
75
 the important conditions for forming and increasing the 
abundance of multiply charged LSI ions without the use of solvents are described below. 
First, the homogenization conditions of the matrix/analyte were examined in terms of the 
duration and frequency of the grinding process (Figure S4.3A and Figure S4.4 in 
Appendix A). The abundances of the multiply charged ions of angiotensin I are low after 
homogenization for 2 min with 15 Hz frequency using 2,5-DHAP and increase 
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signiﬁcantly with 20 min, 25 Hz homogenization (Figure 4.3.A1 versus A2). The 
abundance of multiply charged ions of angiotensin with 2,5-DHB shows the same trend, 
comparing intensity after homogenization for 10 and 2 min (Figure S4.5A versus B in 
Appendix A). Thus, the abundances of highly charged ions are enhanced when more 
vigorous conditions for the matrix/analyte homogenization are applied. These 
homogenization conditions are well beyond those that can be achieved with a simple 
vortex device.
75
 
A. Increasing Grinding Time and Frequency: DHAP 
 
B. Increasing Temperature in Desolvation Device: for DHB and DHAP matrixes 
 
Figure 4.3. Solvent-free mass spectra of angiotensin I obtained from (A) SYNAPT 
G2, a TSA approach, using a home-built desolvation device and 150 °C source 
temperature after using diﬀerent grinding times and frequencies during 
homogenization of 2,5-DHAP matrix/angiotensin I: (1) 2 min at 15 Hz and (2) 20 min 
at 25 Hz; (B) LSI-LTQ-Velos at 275 °C desolvation temperature homogenized at 25  
Hz and 10 min using (1) 2,5-DHB and (2) 2,5-DHAP matrixes. More details are 
included in Figures S4.4 and S4.5 in Appendix A. 
It is of interest to obtain more detailed information by investigating the LSI plume of 
different matrixes and grinding conditions by collecting the ablated matrix on a nearby 
glass slide. Optical microscopy of the ablated material collected from the solvent-free 
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prepared 2,5-DHB and 2,5-DHAP matrixes on a second microscope slide held at ~2 mm 
distance from the matrix is shown in Figure 4.4 and Figure S4.6 in Appendix A. After 
grinding for 30 s using the TissueLyser II, both matrixes produce liquid droplets upon 
ablation (Figure 4.4). Larger droplets (~5 to 7 μm diameter) are observed for 2,5-DHB 
compared to 2,5-DHAP (~1 μm diameter). The differences in volume of these molten 
droplets correlate with the observed lower temperature required to produce the highly 
charged LSI ions from 2,5-DHAP versus 2,5-DHB matrixes. 
Increasing the grinding time to 10 min, 2,5-DHAP’s liquid droplets maintained the 
same relative size, but 2,5-DHB’s droplets became smaller (Figure S4.6 in in Appendix 
A). The third set of matrix samples were ground in a vortexer for 30 s, similar to the 
method introduced by Hanton and Parees
138 
and used previously for solvent-free LSI.
75
 
The liquid droplets collected for both matrixes are notably less abundant than the droplets 
seen in the TissueLyser II sample (Figure S4.7 in Appendix A). While multiply charged 
ions of angiotensin I were observed in all samples using 2,5-DHAP, samples using 2,5-
DHB and 30 s vortexer grinding times produced predominantly singly charged ions on 
the LTQ Velos, similar to previous observations.
75 
For the study of the thermal requirements within the atmospheric pressure to the 
vacuum transfer region on the formation of highly charged LSI ions of solvent-free 
prepared matrix/analyte samples, a LTQ Velos is used that has a commercial heated inlet 
capillary providing the ability to accurately control the desolvation temperatures (Figure 
4.3.B). We ﬁnd for angiotensin I that the production of multiply charged LSI ions can be 
enhanced with 2,5-DHB, as is shown for a temperature range from 40 to 400 °C (Figure 
S4.5A,B in Appendix A). Only low abundance signal of singly charged ions can be 
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observed at 40 °C using 2,5-DHB (Figure S4.5B in Appendix A), and high abundance of 
both doubly and singly charged ions was produced when the capillary temperature was 
increased to 275 °C (Figure 4.3B.1). In contrast, 2,5-DHAP provides abundant highly 
charged angiotensin I ions at temperatures as low as 40 °C (Figure S4.5C in Appendix 
A). Increasing the capillary temperature up to 400 °C did not have a signiﬁcant effect on 
the charge state distribution but did on the abundance (ion count increased from 5.10 x 
10
3
 to 1.95 x 10
5
) using 2,5-DHAP (Figure 4.3B.2 and Figure S4.5C in Appendix A). 
The 2,5-DHAP matrix shows signiﬁcantly lower thermal requirements than the 2,5-DHB 
using a solvent-free approach. 
 
Figure 4.4. Microscopy images of liquid droplets produced by laser (N2) ablation 
of (A) 2,5-DHAP and (B) 2,5-DHB matrixes after the material was ground 
for 30 s in the TissueLyser II. Reference data for optical microscopy of ablated 2,5-
DHB and 2,5-DHAP after being ground for 10 min in the TissueLyser II (Figure S4.6 
in Appendix A) and 30 s in the vortexer (Figure S4.7 in Appendix A) are included. 
 
Interestingly, with all of the studies performed with angiotensin I using 2,5-DHAP, 
the SYNAPT G2 provides highly charged ions, increasing in abundance with increasing 
time and frequency of matrix/sample homogenization. Singly charged ions are not 
observed, as can be seen in Figures 4.1 and 4.3A. The LTQ Velos, however, frequently 
provides some degree of low abundant singly charged ions along with abundant multiply 
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charged ions as observed in Figure 4.3B. Because enhancement in multiply charged ion 
formation is observed with longer grinding times, higher grinding frequency, and higher 
temperature, the LTQ Velos (Thermo) results displaying both multiply and singly 
charged ions (Figure 4.3B) compare well, considering the conditions used, with the 
previously obtained Orbitrap Exactive results showing singly charged ion formation.
75
 
The SYNAPT G2 was used with and without the IMS dimension by controlling the 
helium gas (Figure S8 ion count increased from). Only low abundant singly charged ions 
are observed without the use of the IMS dimension (no helium), and abundant highly 
charged ions are observed with the use of the IMS dimension (helium on). This 
unexpected result may be related to the unique and delayed ionization phenomena 
occurring inside the ion transfer region
109
 or in the Triwave of the SYNAPT G2 with the 
IMS “on”.115 This could also involve an ion transmission issue. 
Applications of TSA to Mixtures of Peptides/Lipids and Crude Oil. Similar to ESI, 
under LSI conditions, lipids produce singly charged ions, thus, mixing a lipid with a 
peptide should produce both singly and multiply charged ions. The analysis of a mixture 
of angiotensin I and sphingomyelin using a TSA approach is shown in Figure 4.5. In the 
extracted mass spectrum (Figure 4.5.A), the doubly and triply charged ions of 
angiotensin I are observed in abundances similar to the pure sample along with abundant 
singly charged ions of sphingomyelin. In comparison, when the solvent ACN/H2O 
(50:50) was added to the same homogenized matrix/analyte powder, lipid ions were no 
longer detected and the signal intensity for the peptide increased (Figure S4.9A in 
Appendix A). Without the TSA analysis, this would incorrectly suggest that the lipid 
component is not present in the mixture. This result has implications for the analysis of 
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biological materials, such as tissue imaging, in which lipids and peptides (proteins) are 
present and may be analyzed simultaneously. It also demonstrates that, with the IMS 
“on”, singly charged LSI ions are transferred to the MS detector. 
 
Figure 4.5. LSI-IMS-MS of a mixture of angiotensin I and sphingomyelin with 2,5-
DHAP matrix using the solvent-free sample preparation method, a TSA approach: left 
panel (A) mass spectrum and right panel (B) 2-D plot of drift time versus m/z. 
In the 2-D plot of drift time versus m/z (Figure 4.5.B), well-separated singly charged 
lipid (8.3 ms) and multiply charged peptide ions (4.2 ms for +2, 2.9 ms for +3) are 
observed. Previous IMS-MS studies using MALDI showed that lipid and peptide ions fall 
into respective charge state families (trend lines) with some separation.
144
 Further, the 
solvent-based LSI-IMS-MS study (Figure S4.9B in Appendix A) shows in the 2-D plot 
abundant doubly charged angiotensin I ions and a low abundant feature in the area where 
sphingomyelin singly charged ion and doubly charged ion of metal adducted dimer are 
expected based on the results observed in Figure 4.5.B. Without a prior knowledge of the 
sample composition, these ions would not be noticed in the mass spectrum (Figure 
S4.9A in Appendix A). More detailed DriftScope analysis of the solvent-based results 
veriﬁes the identity of the singly charged sphingomyelin ions, demonstrating the 
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enhanced effective dynamic range achieved by incorporating the drift time separation in 
an IMS-MS experiment. The comparison of results of solvent-free and solvent-based 
LSI-IMS-MS analyses of this model mixture demonstrates the more inclusive ionization 
without the use of solvents during sample preparation/ionization. 
Additional samples known to ionize exclusively by singly charged ion formation in 
LSI were used to compare the relative ability of the SYNAPT G2 using the IMS 
dimension versus the LTQ or Orbitrap mass spectrometers to determine if ion 
transmission discrimination by charge state exists. Here, the applicability of TSA by LSI 
for oil samples is examined. These samples are notoriously sticky and of extreme 
complexity and therefore prone to sample loss.
145
 Furthermore, the ionization of crude oil 
samples is frequently limited to ESI, atmospheric solids analysis probe (ASAP), or 
atmospheric pressure photoionization (APPI).
146-148
 MALDI performs poorly because of 
the chemical background introduced with the matrix in the mass range of the oil sample 
and, most notably, the tendency of gas-phase aggregation and coalescence due to use of 
higher laser ﬂuence, as shown with these and similar systems.146,149-154  Additionally, 
solvent-based separation approaches for the reduction of sample complexity are difficult, 
so the analyses are predominantly obtained using ultrahigh mass resolution Fourier 
transform ion cyclotron resonance (FT-ICR) instrumentation
145,146,148,153
 and more 
recently by IMS-MS.
146,147
 
The analyses of liquid oils from various origins were prepared and analyzed by the 
TSA approach using LSI with 2,5-DHAP as matrix. Typical examples are shown in 
Figure 4.6 and Figure S4.10 in Appendix A. The 2-D plot of drift time versus m/z shows 
abundant signals in the expected mass range of m/z 200 and 800 and demonstrates that 
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laser-induced aggregates are not observed, even though the laser ﬂuence is higher using 
LSI compared to MALDI.5 Aggregation and “clustering” have 
 
Figure 4.6. LSI-IMS-MS of crude petroleum oil with 2,5-DHAP matrix using 
solvent-free sample preparation, a TSA approach: left panel (A) mass spectrum and 
right panel (B) 2-D plot of drift time versus m/z with insets displaying extracted drift 
time distributions of m/z 205.18 and 205.24. Reference data for other oily and sticky 
materials are included in Figure S4.10 in Appendix A. 
been reported for laser-based analyses such as MALDI and LDI of crude oil and similar 
materials.
146,149-152
 The LSI-TSA approach does not show aggregation or clustering. The 
chemical background introduced by the matrix is also insigniﬁcant using the LSI-TSA 
approach. The lower chemical background has been described for solvent-free ionization 
approaches for a number of low molecular weight systems including efficient ionization 
of fatty acids, pigments, and polycyclic aromatic hydrocarbon compounds.
36,143,154
 A 
comparison with solvent-based LSI-IMS-MS shows some chemical background related 
to the use of solvent (Figure S4.11 in Appendix A). Again, the observation of singly 
charged ions under LSI conditions with the IMS “on” suggests that transmission 
discrimination is not a detrimental issue. The solvent-free gas-phase separation of small 
structures of isobaric composition is delineated by the extracted drift time distributions of 
m/z 205.18 and 205.24 in the inset of Figure 4.6.B. An initial study on TSA using a 
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MALDI approach delineated isobaric tissue composition at m/z 863.3 to 863.7.
136
 When 
comparing the different oil samples relative to each other, the differences are evident 
(Figure 4.6 and Figure S4.10 in Appendix A). Both the pure vegetable oil and the motor 
oil exhibit the presence of more low mass species, while crude oil shows a more complex 
nature with more abundant high mass species. This indicates the useful nature of the 2-D 
plots when using the snapshot approach as previously indicated for the analysis of 
synthetic polymers.
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4.4 Discussion  
The preparation of supersaturated 2,5-DHAP solution is crucial for the success of 
LSI, though the solubility of 2,5-DHAP is low in most solvents.
132 
As shown here, the 
solvent-free sample preparation is more streamlined, and the solubility of 2,5-DHAP or 
deposition procedure to the sample holder is no longer a setback for obtaining similar and 
in some cases improved mass spectra as compared to solvent-based sample preparation.  
The ability and simplicity of preparation and ionization of even sticky oil samples 
relates well with previous studies of sticky and liquid polymeric samples using a solvent-
free MALDI approach
.36,138,154
 The disadvantage of the solvent-free sample preparation 
used here as well as other solvent-free sample preparation methods developed for surface 
analysis
136
 is the larger sample requirement relative to solvent-based LSI sample 
preparation, which showed sensitivities in the low femtomole range for insulin and mid-
attomole range for peptides.
 75 
The ability to produce highly charged ions without the use 
of a voltage
75,107,108,121,129-135
 is of analytical utility but is also of fundamental importance. 
Previous work showed that the ion production occurs inside the capillary in the AP 
vacuum pressure drop region and that desolvation processes of the matrix occur, leaving 
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behind the multiply charged ions similar to ESI-like processes at AP.
107,131
 Multiply 
charged ions were previously obtainable only by using ionization methods that involve a 
solution state such as in ESI
156
 or solvent-based sample preparation for LSI.
 
75,107,108,115,121,130-134
 Interestingly, adding a drop of solvent to a sample prepared solvent-
free using a vortexer for homogenization of matrix/analyte converts the singly charge 
ionization observed using that procedure to the sole production of multiply charged ions, 
suggesting that analyte incorporation in MALDI might be important in forming multiply 
charged LSI ions.
75
 Here, we show that solvent is also not a necessity to produce multiply 
charged ions of peptides and proteins. The solid matrix/analyte mixture prepared and 
homogenized without employing solvent when ablated from a surface forms molten 
droplets upon the absorption of the laser energy similar to solvent-based LSI 
observations.
131
 Garrison et al. modeled matrix droplets in vacuum laser ablation of solid 
matrix.
 157,158
 
Initial solvent-free results show that multiply charged ions from solvent-free sample 
preparations are easily obtained on the SYNAPT G2 (Figures 4.1 and 4.2), but that the 
reproducibility between instruments and relative to published work
75 
on the Orbitrap is 
low. Exploring different preparation (e.g., grinding time and frequency) and instrument 
parameters (e.g., oriﬁce temperature, IMS gas) on two different mass spectrometers (LTQ 
Velos, SYNAPT G2) elucidated a number of important mechanistic aspects to solvent-
free and multiply charged ion formation (Figure 4.3). 2,5-DHAP solvent-free sample 
preparations are readily obtained and reproducible on the LTQ Velos and SYNAPT G2, 
but the DHB results notably vary between instruments. To elucidate the differences, an 
approach similar to that of published work
131
 on solvent-based LSI-MS was used that 
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showed that signiﬁcant amounts of matrix/analyte materials are transformed by the 
impact of the laser on the solid matrix/analyte to liquid droplets collected on a glass slide 
2 mm distant from the matrix holding glass slide and visualized by microscopy. Here 
(Figure 4.4, Figure S4.6 and S4.7 in Appendix A), ablating solid matrix material from 
the surface shows that both the DHAP and the DHB matrixes produce droplets, though 
not to as large of an extent as with solvent-based sample preparation, and that the droplet 
sizes are signiﬁcantly different for both matrixes prepared solvent-free. DHAP produces 
small droplets under all tested preparation methods that do not signiﬁcantly change in 
size using various grinding conditions. However, the size of DHB’s droplets are large 
relative to the droplets formed from DHAP and are inversely proportional to grinding 
time in the ball-mill device. The smaller droplets likely require less energy for efficient 
desolvation in the ion transfer region and consequently enhance the ease and thus the 
abundance for forming multiply charged ions. The always small sized DHAP droplets 
(Figure 4.4A) also offer a sound argument for the reproducibility of the solvent-free 
experiment using DHAP. Microscopic results are in agreement with our mass 
spectrometric observations. We cannot assert a causal relationship between smaller 
matrix/analyte droplets and the formation of more abundant multiply charged ions, but 
there is a correlative connection. A correlation appears to exist between the production of 
multiply charged LSI ions and the abundance of small liquid droplets formed from 
ablated matrixes. In the case of the DHB matrix, this is achieved with longer grinding 
times (10 min) on the Velos at a temperature of 275 °C for which the doubly charged ion 
is now the base signal relative to the singly charged ion (Figure 4.3). 
Relating the microscopy data to the mass spectrometric results of DHB and DHAP 
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matrixes seems to suggest that the production of highly charged ions is more effcient 
from materials that form smaller droplets. A droplet of ~2 μm (DHAP) versus ~8 μm 
(DHB) diameter has 64 times more matrix material. The difficulty of desolvation of the 
larger droplets may explain the higher temperature requirements in the transfer capillary 
of the mass spectrometer for DHB. It is possible that the thermal energy requirement for 
producing the multiply charged ions is only suffcient for the smaller droplets. Small 
droplets can be achieved from appropriate matrix material by laser ablation at AP from 
samples that were not “incorporated” into the matrix in a conventional way but by the 
grinding forces. Extended grinding times (SYNAPT G2; Velos) and high desolvation 
temperatures (Velos) allow highly charged LSI ions to be formed in the source region as 
well as downstream of the mass spectrometer (SYNAPT G2). 
LSI is a subset of MAII
109 
in which a laser is used to transfer the matrix/analyte 
material to the ion transfer capillary for ionization. Other means of MAII are the use of, 
for example, a center punch or simply a spatula giving identical results as compared to 
LSI. Clearly not all MAII methods start with small molten droplets but produce multiply 
charged ions. Important to success is effcient heating (Figure 4.3.B1 and Figure S4.5A,B 
in Appendix A), low thermal requirements (Figure 4.3.B2 and Figure S4.5C in Appendix 
A), and homogeneity (Figure 4.3A and Figure S4.4 in Appendix A). The singly charged 
ions previously produced using a solvent-free LSI approach are a result of non-
incorporating vortexing conditions.
75
  
Previous MALDI studies discussed ionization, incorporation of analyte into the 
matrix, morphology changes in solvent-free and solvent-based sample 
preparation/ionization for analysis,
36,39,159-166
with some indication that the solvent-free 
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method enhances the effciency of MALDI ion production of compounds diffcult to 
protonate because the analyte and metal cations get close in the solid state through the 
grinding process.
39,41,143,154,157
 Solvent-based LSI-MS and LSI-IMS-MS provides little 
evidence for producing Na
+
 adduction to peptides or proteins similar to MALDI or ESI-
MS, probably because of segregation that occurs upon crystallization on removal of 
solvent. It seems possible that the more aggressive homogenization in solvent-free 
MALDI produces smaller and better mixed matrix/analyte(/metal cation) particles which 
produce the desired “incorporation” and molten state, thus accounting for the observation 
of multiply charged ions formed by proton and metal cation attachment. In contrast to 
MALDI and LDI, the chemical background in TSA by LSI is relatively low and analyte 
aggregation
146,149-152
 is not observed, similar to ESI-IMS-MS, but provides the ability for 
fast, solvent-free, and surface analyses independent of analyte or matrix solubility. 
The structural changes observed in the IMS dimension for protonation versus 
sodiation are small based on the drift time separation, whereas the structural changes of 
oxidized and non-oxidized NAC are signiﬁcant, demonstrating the potential of structural 
diﬀ erentiation of ions directly from the solid state. Because ESI-IMS-MS gives the same 
results, the oxidation or structural changes are not related to one ionization method. 
Morphology changes during sample preparation to produce small molten droplets and the 
absence of sodiation in ESI and LSI-IMS-MS measurements lead us to conclude that the 
attachment of metal cation(s) is a direct result of the homogenization process of the 
matrix/analyte. 
4.5 Conclusion 
We report the ﬁrst observation of multiply charged ions produced from the solid state 
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using solvent-free matrix/analyte sample preparation. Combined with IMS-MS, this TSA 
approach provides greatly improved IMS separation of compound classes that diﬀer by 
charge states (e.g., lipids and peptides). Other advantages of a TSA approach include 
one-step sample preparation and deposition on the target plate, rapid data acquisition for 
simplifying sample complexity relative to ESI and LC-MS, reduction of sample artifacts 
caused by the use of solvents, and enhancement of the eﬀective dynamic range by the 
IMS dimension. The ability to observe multiply charged ions using LSI from solvent-free 
sample preparation will have immense beneﬁts if it can be translated to solvent-free 
matrix deposition for tissue imaging where the use of solvent is detrimental to retaining 
spatial integrity of the more soluble compounds. 
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CHAPTER 5 
A NEW APPROACH TO HIGH SENSITIVITY LIQUID 
CHROMATOGRAPHY-MASS SPECTROMETRY OF PEPTIDES USING 
NANOFLOW SOLVENT ASSISTED INLET IONIZATION 
Liquid chromatography (LC) solvent assisted inlet ionization (SAII) mass 
spectrometry (MS) was previously reported to give good chromatographic resolution and 
MS detection injecting 66 ng of a BSA tryptic digest. In analogy to nano-electrospray 
ionization (nESI), we extend SAII LC/MS to nano-SAII (nSAII) operating at nL min
–1
 
flow rates and demonstrate good quality ion chromatograms and mass spectra from 
injection of as little as 0.7 ng of BSA digest onto a capillary LC column. Data dependent 
fragmentation is demonstrated for injection of 7 ng of a BSA digest. This method has 
advantages over nESI in ease of use and low cost as it requires no voltage and is 
operational without the necessity of connectors or fragile nESI emitters, although similar 
constricted tips can be helpful in nSAII to stabilize the signal at low nanoliter flow. At a 
flow rate of 0.8 μL min–1, the only requirement for nSAII is that the exit-end of 
the capillary LC column be adjusted near the aperture of the heated inlet of the mass 
spectrometer.  
 
 
 
 
 
 
B. Wang, E. D. Inutan, S. Trimpin, J. Am. Soc. Mass Spectrom. 2012, 23, 442-445. 
Reprinted with permission from Springer Science and Business Media. 
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5.1 Introduction 
Modern liquid chromatography/mass spectrometry (LC/MS) almost exclusively uses 
electrospray ionization (ESI) except for low polarity compounds which use atmospheric 
pressure chemical ionization (APCI).
167 ,168 ,169
 For analyses where sample amount is 
limited, ESI LC/MS is performed at nanoliter (nL) min
–1
 mobile phase flow 
rates.
78,170,171,172
 This approach, called nano-ESI (nESI),
173
 is especially important for 
peptide and protein analyses. Because ESI is a concentration sensitive method, lower 
flow rates produce similar signal to higher flow but with consumption of less material.
80
 
However, the low flow condition also enhances ionization, presumably by producing 
smaller solvent droplets with increased charge, thus reducing ion suppression and 
ionizing a wider range of compounds. Because of the importance of nESI, ion sources are 
commercially available. Recently, Smith and coworkers
174 , 175
 reported on nESI at 
subambient pressure using ion funnel technology. However, nESI has a number of 
shortcomings. The low solvent flow greatly increases the time for a complete LC run 
relative to higher flow rates, and achieving a stable ion current is notoriously difficult. 
Special spray emitters are available to help address this issue,
82
 but the emitter tips are 
fragile and add considerable cost to nESI. The sharp tips also reduce the voltage range 
over which a stable ESI spray is observed: too high voltage produces a corona discharge. 
Technical issues generally limit the use of nESI to problems that need its additional 
capabilities. 
Recently, inlet ionization methods have been introduced that have the potential to 
compete with both matrix assisted laser desorption/ionization (MALDI) and ESI. 
Methods that utilize a solid phase matrix similar to those used in MALDI are laserspray 
ionization inlet (LSII)
75,107,121,129,132,135 
and matrix assisted inlet ionization (MAII).
109
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Solvent assisted inlet ionization (SAII) is the equivalent of ESI in that similar mass 
spectra are produced from solvent/analyte solutions introduced into the mass 
spectrometer inlet and ionized.
111
 Just as in ESI, SAII can be used for ionization in 
LC/MS.
112
 It was shown that introducing the LC mobile from a 1 mm i.d. LC column 
directly into a heated inlet transfer tube of the mass spectrometer produced a high quality 
ion chromatogram and corresponding mass spectra with injection of ca. 70 ng of bovine 
serum albumin (BSA) tryptic digest. Here, we extend the applicability of inlet ionization 
to nanoliter flow rates by positioning the LC effluent just outside of the mass 
spectrometer inlet aperture and demonstrate similar results from injection of just 0.7 ng of 
BSA digest. 
5.2 Materials and Methods 
Materials. Chemicals were stated in Chapter 2. 
Methods. 
SAII-MS. One end of a 40 cm length of 25 μm i.d. fused silica tubing (Polymicro 
Technologies, Phoenix, AZ, USA) was connected to a syringe and the exit end taped on 
an x,y,z-stage to control the alignment and distance of the exit end relative to the inlet 
aperture of the heated atmospheric pressure (AP) to vacuum inlet tube of the mass 
spectrometer. A study of the optimum distance of the fused silica exit from the inlet 
orifice was performed by pumping a 1:1 ACN:water 0.1 % FA 1 pmol μL–1 angiotensin 
I solution through the fused silica tube at a flow rate of 1.2 μL min–1. The x,y,z-
stage was used to adjust the exit end of the fused silica from 0.4 mm on the AP side to 
0.2 mm on the vacuum side of the mass spectrometer inlet aperture. 
NanoSAII and nanoESI LC-MS and MS/MS. A Waters Corporation NanoAcquity 
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UPLC was used with a Waters 100 μm×100 mm BEH130 C18 column with 1.7 μm 
particles. Water and ACN both containing 0.1% FA was used as the mobile phases in all 
studies. A 35 min gradient of 1 to 85% ACN was used at mobile phase flow rates varying 
from 0.4 to 0.8 μL min–1, and a 12 min gradient at a flow rate of 1.2 μL min–1. For 
0.4 μL min–1 flow rate, a 6.35 cm long 360 μm o.d. × 20 μm i.d. (with 10 μm i.d. at 
the tip) pre-cut PicoTip emitter (Waters) was employed as an extension to the end of LC 
capillary column and mounted on the x,y,z-stage to be positioned about 0.1–0.2 mm 
outside of the mass spectrometer inlet for optimum results. At flow rates of 0.8 μL min–1 
and higher, the exit-end of the LC capillary column (100 μm i.d. × 360 μm o.d.) was 
used without need of a special emitter or any tubing connections. A Thermo LTQ-Velos 
mass spectrometer with the inlet tube heated to 300 °C was used for LC-nSAII-MS and 
MS/MS. Data dependent MS/MS was obtained using collision induced dissociation 
(CID) with 35 V collision energy. A three point boxcar smoothing was used for the LC 
chromatogram display. A Waters SYNAPT G2 mass spectrometer
109,112,121,132
 was used 
for LC-nESI-MS for relative comparison. The skimmer cone was heated to 150 °C. The 
voltage applied on the nESI capillary is 3.06 kV. BSA tryptic digest solution, 1 μL of a 
100 fmol μL–1, was analyzed using the same LC gradient at a mobile phase flow of 
0.8 μL min–1 and 0.4 μL min–1. 
5.3 Results and Discussion  
SAII was recently interfaced with LC/MS at a mobile phase flow rate of 55 μL min–1 
with chromatographic resolution comparable to ESI LC/MS and produces good 
signal-to-noise with injection of 1 pmol of a BSA digest.
112
 This work was accomplished 
on a LTQ-Velos, which has a heated inlet tube linking AP with the first vacuum region of 
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the mass spectrometer. The higher flow rates used in the previous study requires that the 
exit-end of the fused silica capillary be stripped of its polyimide coating and inserted into 
the heated inlet tube of the mass spectrometer to a ‘sweet spot’ for ion production. Here, 
we demonstrate, in analogy to nESI, that nanoliter mobile phase flow rates are also 
compatible with SAII. The initial ‘tuning’ for the low flow rate was achieved by 
delivering an angiotensin I solution using an infusion pump to the exit end of the fused 
silica tube (25 μm i.d.) so that it could be adjusted (Figure S5.1 in Appendix B) for the 
best stability and abundance of the signal from the triply charged angiotensin I ion (m/z 
433). For flow rates of a few microliters and lower, the best position of the fused silica 
capillary exit-end was found to just at the inlet entrance aperture, and no longer requiring 
the removal of the coating. A stable signal with good sensitivity was achieved with the 
mass spectrometer inlet tube temperature set to 300 °C. The flow of air into the vacuum 
region of the heated mass spectrometer entrance inlet is sufficient to nebulize the solution 
at the tip of the fused silica, sweeping the ensuing mist of solvent droplets into the inlet 
where ions are generated with the assistance of heat and vacuum.  
Laserspray ionization (LSII), potentially useful for imaging at high spatial 
resolution,
75,107,121,129,134,135  
is a subset of matrix assisted inlet ionization (MAII)
109
 in 
which a laser is used to transfer the matrix/analyte mixture to the mass spectrometer inlet 
where ions are produced in the heated pressure drop region having similar charge states 
to ESI.  We hypothesize that ion formation is vacuum and thermal assisted.
107,110,121,122,131
 
SAII
111,112
 is similar to the other inlet ionization methods of LSII 
75,107,121,129,134,135 
and 
MAII
109
 in which any means of introducing matrix/analyte into the heated inlet produces 
ions similar to ESI. In the case of SAII
111
 where the matrix is a solvent, it can be shown 
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(Figure S5.2 in Appendix B) that ions are not produced by a sonic spray mechanism as is 
evident by the requirement that the inlet be heated to produce ions:  heat is not a 
requirement for sonic spray.
176,177
 There are also significant differences between inlet 
ionization with a solvent and thermospray ionization
124
 in addition to the high charge 
states, low flow rates and the high sensitivity achievable with SAII, as was recently 
pointed out.
112
   
Without the need to place the fused silica inside the heated mass spectrometer inlet, it 
is possible to use the exit of the capillary LC column and eliminate all connections, 
unlike in our previous LC-SAII study.
112
 By attaching the exit of the LC column to an 
x,y,z-stage with tape, the end of the LC column capillary tubing is visually adjusted near 
the entrance of the mass spectrometer inlet for optimum ion current stability (Figure 5.1A 
and Figure S5.3 in Appendix B). This procedure can be accomplished in a couple of 
minutes. This arrangement provides stable ion current at flow rates from 0.8 μL min–1 
(Figure S5.4A in Appendix B) to at least 1.2 μL min–1 (Figure S5.4B in Appendix B). 
However, the signal is not sufficiently stable with this arrangement at 0.4 μL min–1 for 
good quality LC/MS. Observationally, it appears that the instability is the result of larger 
droplets exiting the fused silica tubing rather than a fine spray. A stable signal is achieved 
by attaching the LC column to a Waters PicoTip emitter (Figure 5.1B), as is done in 
nESI. Because SAII operates without the requirement for a voltage and at high nanoliter 
flow rates without the necessity of a fragile emitter, it is exceptionally easy to implement. 
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Figure 5.1. Pictures showing the setup for LC-nSAII. Side view of MS inlet in which 
the tip of the fused silica capillary tube of the LC column is placed about 0.1 mm out 
of the orifice inlet entrance of the mass spectrometer (A) directly or (B) by use of a 
“PicoTip” attached to the end of the fused silica capillary tube. Front view of the LC 
and mass spectrometer setup is displayed in Figure S5.3 in Appendix B. 
Using the simple set-up (Figure 5.1A and Figure S5.3 in Appendix B) requiring no 
emitter connected to the LC column and a mobile phase flow rate of 0.8 μL min–1, 
injection of 100 fmol (7 ng) of BSA digest produces roughly equivalent results to those 
reported
112
 for ca. 70 ng injected at 55 μl min–1. The base peak chromatogram for the 100 
fmol injection is shown in Figure S5.5A in Appendix B. The mass spectrum from the 
peak eluting at 17.8 min shows doubly and singly charged analyte ions (Figure S5.5B in 
Appendix B). In order to have a relative comparison, nESI LC/MS was acquired using 
the commercial nESI source on the SYNAPT G2 mass spectrometer at a mobile phase 
flow rate of 0.8 and 0.4 μL min–1 using the same gradient and injecting 100 fmol of the 
same BSA digest used in the SAII study (Figures S5.4 and S5.6 in Appendix B). 
Additionally, data dependent fragmentation for the 100 fmol SAII injection on LTQ 
Velos also produces excellent LC/MS/MS fragmentation as is demonstrated by the high 
sequence coverage using MASCOT for the BSA peptide fragment at m/z 740 having the 
sequence LGEYGFQNALIVR (Figure 5.2). MASCOT identified the protein as BSA 
from this single MS/MS spectrum with a score of 103. The first nSAII LC/MS and 
A. B. 
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MS/MS results, without the necessity of special connections, tips, or voltage, produce 
roughly equivalent results to nESI and in much less set-up time for the experiment. 
 
Figure 5.2. LC-nSAII-MS/MS mass spectrum of 100 fmol μL–1 BSA tryptic digest 
with 1 μL injection at a flow rate of 800 nL min–1 using the setup shown in 
Figure 5.1(A). The sequence shows the Mascot coverage providing a MASCOT score 
of 103. 
Injection of just 10 fmol (0.7 ng) of BSA digest using SAII at 0.8 μL min–1 produces 
the base peak chromatogram in which only the most abundant ions are observed. 
However, connecting the exit of the LC column to a 20 μm i.d. PicoTip with 10 μm i.d. 
on the tip allows a stable signal to be obtained at a flow rate of 0.4 μL min–1. Under these 
conditions, injection of 0.7 ng of BSA digest produced the base peak chromatogram 
shown in Figure 5.3. The signal-to-noise was calculated by the data system for the peak 
eluting at m/z 582 is 277. 
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Figure 5.3. nSAII-LC/MS base beak chromatograms of 10 fmol μL–1 BSA tryptic 
digest with 1 μL injection at a flow rate of 400 nL min-1 using the “PicoTip” 
extension shown in Figure 5.1(B). 
5.4 Conclusion 
Inlet ionization is a new method for producing mass spectra equivalent in charge state 
to those produced by ESI but from solid (LSI or MAII) or solution (SAII) states without 
the need for a laser or voltage for ionization. The sensitivity of inlet ionization is 
demonstrated by the production of good quality base peak chromatograms and clean mass 
spectra with high signal-to-noise with injection of as little as 0.7 ng of a BSA digest using 
nSAII LC/MS. Data-dependent fragmentation was shown for injection of just 7 ng of 
BSA digest using a mobile phase flow rate of 800 nL min
–1
. These results suggest the 
potential of SAII for proteomics and most likely other areas where sample amounts are 
limited. Detailed mechanistic discussion relative to inlet ionization is addressed in a 
forthcoming paper.
122
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CHAPTER 6 
HIGH THROUGHPUT SOLVENT ASSISTED IONIZATION 
INLET (SAII) FOR USE IN MASS SPECTROMETRY 
In this work we developed a multiplexed analysis platform providing a simple high-
throughput means to characterize solutions. Automated analyses, requiring less than 5 s 
per sample without carryover and 1 s per sample, accepting minor cross contamination, 
was achieved using multiplexed solvent assisted ionization inlet (SAII) mass 
spectrometry (MS). The method involves sequentially moving rows of pipet tips 
containing sample solutions in close proximity to the inlet aperture of a heated mass 
spectrometer inlet tube. The solution is pulled from the container into the mass 
spectrometer inlet by the pressure differential at the mass spectrometer inlet aperture. 
This sample introduction method for direct injection of solutions is fast, easily 
implemented, and widely applicable, as is shown by applications ranging from small 
molecules to proteins as large as carbonic anhydrase (molecular weight ca. 29 000). 
MS/MS fragmentation is applicable for sample characterization. An x,y-stage and 
common imaging software are incorporated to map the location of components in the 
sample wells of a microtiter plate. Location within an x,y-array of different sample 
solutions and the relative concentration of the sample are displayed using ion intensity 
maps. 
B. Wang, S. Trimpin, Anal. Chem. 2014, 86, 1000-1006.
1
 Reprinted with permission 
from Copyright (2014) American Chemical Society. 
                                                          
1 This publication has been converted to a provisional patent and later to a patent application, 
pending. “Multiplexing system used to allow high throughput analysis of samples using solvent 
assisted ionization inlet comprises ionizing system for solvent assisted ionization inlet, x,y-stage 
or x,y,z-stage, and software program at maps samples” US2014166875-A1, Trimpin, S. 
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6.1 Introduction 
High-throughput screening is an important need of the pharmaceutical industry 
including drug design and clinical applications.
178-180
 Commonly used technologies are 
fluorescence,
181
 electrophoresis,
182
 and mass spectrometry (MS).
183
 While electrospray 
ionization (ESI) has a number of advantages, matrix-assisted laser desorption/ionization 
(MALDI) is the faster ionization method by simply increasing the frequency of the laser 
used for desorbing/ionizing the matrix/analyte (e.g., 20 kHz).
184
 Work on increasing the 
speed of ESI technology is based on using multiple inlets,
185,186
 an automated chip-based 
work flow (e.g., Nanomate),
187-191
 or segmented flow.
192,193
 Recent years have seen a 
renaissance for ionization approaches used in MS. One result has been many clever ways 
to analyze materials under ambient conditions,
84
 thus providing a convenient and direct 
means of sample analysis.
89, 194
 The novel methods that are capable of ionizing 
nonvolatile compounds are frequently based on ESI.
33,156 
A series of inlet ionization methods
107,109,111
 have been discovered recently that 
produce ESI-like mass spectra from the solution or solid state. Ionization occurs in a 
heated pressure drop region linking atmospheric pressure (AP) with the first vacuum 
stage of a mass spectrometer. The simplicity of inlet ionization methods is that neither a 
high voltage nor a laser is required, and the natural gas flow through the inlet replaces the 
necessity of a nebulizing gas. Multiply charged ions produced by these methods extend 
the mass range of highper formance mass spectrometers,
107
 enhance separations by 
charge states in ion mobility spectrometry (IMS),
132
 and allow advanced fragmentation 
using electron-transfer dissociation (ETD).
134
 Several modes of analyzing surfaces and 
solutions are available with inlet ionization, some providing high spatial resolution or 
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high-speed imaging.
195
 These ionization methods, even in their early development, are 
highly sensitive as has been shown for bovine insulin and steroids.
111,196
 
Solvent assisted ionization inlet (SAII) is the liquid introduction variant of the family 
of inlet ionization operating without a laser or a voltage and capable of coupling with a 
liquid chromatography (LC)
112,196
 and nano-LC/MS/MS
197
 with high sensitivity (7 ng of 
bovine serum albumin (BSA) tryptic digest injected on column,
197
 and low femtograms 
for steroids
196
). Because in SAII, the exit end of a fused-silica capillary is placed inside 
the inlet, a pressure differential drives the flow of solvent into the mass spectrometer 
without the need of a pump.
111
 The best sensitivity was achieved in the initial approach 
by aligning the fused-silica tube to a “hot spot” within the inlet tube.111 Subsequent SAII 
work showed that for nanoliter flow, good sensitivity (e.g., 10 fmol of a BSA digest by 
LC/MS), is achieved simply by placing the LC outlet in front of the inlet aperture of the 
mass spectrometer.
197
 Solution is swept into the inlet in the flow of air, and analyte is 
ionized in the inlet. 
Here, we present a flexible SAII approach based on direct injection and use of 
disposable pipet tips for the analyses of compounds independent of molecular weight and 
volatility. This method can be used to conveniently map solution content, location, and 
relative quantities in a high-throughput manner. 
6.2 Materials and Methods  
Materials and Sample Preparation. 
 Clarithromycin tablet (500 mg) was obtained from local pharmacy and ground to fine 
powder by mortar and pestle. Other general chemicals were stated in Chapter 2. For the 
experiments using directly pipetting, the phosphorylated peptide mixture was prepared in 
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50:50 acetonitrile:water with 0.1% formic acid for positive mode acquisition at 150 °C, 
and in 0.5% ammonia for negative mode acquisition at 400 °C.  Myoglobin and carbonic 
anhydrase were diluted in water with 0.1% formic acid and analyzed at inlet temperature 
of 250 ºC.  In the pH study, bovine insulin and lysozyme solutions at pH of about 3, 4.5, 
6, and 9 were tested.  Bovine insulin stock solutions were prepared in 50:50 
methanol:water with 1% acetic acid and 50:50 methanol:water with 1% ammonia.  Then 
the acidic solution was diluted with methonal:water with acetic acid or water, and the 
basic solution was diluted with methanol:water with ammonia or water.  Lysozyme was 
prepared by dissolving lysozyme in 1% formic acid, 50:50 acetonitrile:water with 0.1% 
formic acid, 50:50 acetonitrile:water with 0.05% formic acid, water, and 0.1% ammonia, 
respectively.  Carbonic anhydrase was diluted in water with 0.1% formic acid. 
For the experiments using the 8-channel pipette, leucine enkephalin and galanin were 
prepared in water with 0.1% formic acid, and ubiquitin was in 50:50 acetonitril:water 
with 0.1% formic acid. Clozapine was diluted by methanol to desired concentrations.  For 
the analysis of tablets, 8 wells in the first row of the 384-well microtiter plate (Greiner 
Bio-One Inc., Monroe, NC) were filled with 100 µL methanol. A pipette tip was used to 
dip into the tablet powder, transferred random amount of the powder and swirled them 
into the second, fifth, and eighth well (Scheme S6.2 in Appendix C). The tablet solutions 
were then diluted 100 fold by methanol in the second row of the microtiter well plate, and 
the diluted tablet solutions were diluted again 100 fold in the third row (Scheme S6.2.A 
in Appendix C).   
For experiments using the 96-well plate, analytes were diluted from their stock 
solutions using the following solvent systems: clozapine was in methanol, sphingomyelin 
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was in methanol with 1% acetic acid, bovine insulin in 50:50 methanol:water with 1% 
acetic acid, and all the others were in 50:50 acetonitrile:water with 0.1% formic acid. 
Methods. 
The SAII-MS and SAII-MS/MS experiments were carried out on an LTQ Velos mass 
spectrometer (Thermo Fisher Scientific, Bremen, Germany), from which the ESI source 
was removed and interlocks overridden as described previously.
135
 The inlet of the mass 
spectrometer was heated between 150 to 450 °C depending on solvent and its pH.  To 
avoid cross contamination, pipet tips filled with only solvent, used for dissolving the 
analyte in the previous pipet tip, were added to alternate pipet tips.  Mass spectra were 
displayed as a single acquisition, generally by acquiring 1 microscan and with the 
maximum injection time of 100 ms for pipetting, 1 microscan and 300 ms maximum 
injection time for multiplexing, unless otherwise stated. Collision induced dissociation 
(CID) and electron transfer dissociation (ETD) were employed for characterization of 
certain analytes by selecting the parent ion using a mass tolerance of 1 m/z unit. Similar 
to a previous study,
198  
 the CID MS/MS spectra were obtained using a normalized 
collision energy setting between 20 to 30 depending on the analyte, and ETD using an 
activation time of 100 ms. 
For these experiments, pipet tips (10 μL micropipet tips, Fisher Scientific, Pittsburgh, 
PA) are aligned with the MS inlet by having them held in an 8-channel pipet holder or the 
96-pipet tip holder in which new pipets are shipped. Solutions containing sample, or 
blank, were loaded by simultaneously dipping the pipet tips into a 96 multivial or well 
plate containing the various analyte solutions; ~3 μL of each solution is drawn into the 
pipet tip by capillary action (based on acetonitrile/water solution). The holder was affixed 
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on the x,y-stage with the first pipet tip (typically empty) placed in close proximity (~0.1 
mm at low inlet temperatures and ~0.5 mm at high inlet temperature) to the inlet aperture. 
Using the control of the x,y-stage, rows of pipet tips were moved automatically in front 
of the inlet aperture so that the solution containing the analyte exits the pipet tip under the 
influence of the pressure differential when the tip is in close proximity with the inlet 
aperture of the mass spectrometer. The x,y-stage movement was continuous, and rate of 
movement was controlled from 1.5 to 18 mm s
−1
. Data were acquired in the mass-to-
charge (m/z) range of 150−2000, unless otherwise stated. Mass spectra were displayed as 
a single acquisition, generally by acquiring 1 microscan and with a maximum injection 
time of 100 ms for pipetting, 1 microscan and 300 ms maximum injection time for 
multiplexing, and 1 microscan and 500 ms maximum injection time for quantitative 
studies. Biomap imaging software (Novartis Institution for Biomedical Research, Basel, 
Switzerland), typically used for imaging applications,
135,195,199
 was incorporated to map in 
which solution analyte was present as determined by the m/z ratio values obtained by MS 
or MS/MS. Besides mapping the location of analyte, the software allows relative 
concentrations to be displayed by color code. 
6.3 Results and Discussion  
Initial results were obtained using a single pipet and purchased standards. Sample 
solution was introduced for mass analysis from a pipet tip held close to the inlet aperture 
of the mass spectrometer. For ease of operation, the source housing was removed and 
interlocks overridden. Analyte ions were observed as soon as the pipet tip was close, but 
not touching, the heated (150 °C) inlet tube entrance of the LTQ Velos and solution was 
77 
 
drawn into the inlet (Scheme 6.1A). Standards, and standard mixtures, of varying 
concentrations were run to acquire initial benchmark results for ongoing improvements. 
Scheme 6.1. Pictures of the SAII source setup using (A) a single pipet, (B) an 8-
channel pipet, (C) a 96-pipet array; loading of the samples through use of the 96 
sample plate is displayed in Scheme S6.1 in Appendix C. (B) and (C) are automated 
by mounting the pipet holder on a xy-stage and mapping of the location is achieved 
through inclusion of the Biomap program.  
 
With phosphorylated peptides, both positive (Figure 6.1A) and negative (Figure 
6.1B) ions were produced using this method without the loss of phosphorylation. 
Fragmentation using collision-induced dissociation (CID) provides good sequence 
coverage of each phosphorylated peptide dispensing 1 μL of a 2.5 pmol μL−1 solution 
(Figure S6.1 in Appendix C). Proteins as large as myoglobin and carbonic anhydrase are 
efficiently ionized and detected using this approach (Figure S6.2 in Appendix C). The 
angle of the pipet relative to the inlet had little effect so long as solution was drawn into 
the inlet. Results from this study demonstrated that SAII is operationally simple and 
tolerant of a wide range of solvents, such as 100% water (Figure S6.3A in Appendix C), 
chloroform (Figure S6.3B in Appendix C), or 90% acetonitrile (Figure S6.3C in 
Appendix C). 
inlet tips x,y-stage
inlet
tips
96-well plate
B.
pipet tip
inlet
A. C.
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Figure 6.1. A mixture of phosphorylated peptides (angiotensin II, molecular weight 
(MW) 1125; cholecystokinin (10-20), MW 1330; and calcitonin (15-29), MW 1800) 
was pipetted into the inlet (Scheme 6.1A).  1 µL of 2.5 pmol µL
-1 
solution was used 
for each acquisition.  Mass spectra of the mixture were obtained in (A) positive 
acquisition mode at 150 °C and (B) negative acquisition mode at 400 °C.  The 
MS/MS spectra (CID) of each peptide are shown in Figure S6.1 in Appendix C.  
Data were acquired in the m/z range of 50-2000 for positive mode and 155-2000 for 
negative mode. 
A pH study using bovine insulin and lysozyme was carried out at an inlet temperature 
of 250 °C showing higher charge state ions were obtained in acidic solutions and that the 
highest intensity for the most abundant charge state was obtained at pH ∼4.5 for 
lysozyme (Figure S6.4 in Appendix C). Basic pH decreased the charge states of bovine 
insulin. A temperature study using bovine insulin and lysozyme solutions is shown in 
Figure S6.5 in Appendix C. Similar charge states but increasing ion abundance are 
observed at higher temperatures (100 °C increments from 150 to 450 °C) as expected 
from previous SAII studies on an Orbitrap with the solution introduced inside the inlet 
tube.
111
 Over a wide range of temperatures, the method shows analytical utility. Higher 
temperature is required to produce abundant ions when less volatile solvent, e.g., water, is 
used (Figure S6.6 in Appendix C). However, “signal tailing” is observed using pure 
water and at high temperature indicating the undesired adduction of sodium cations to the 
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protein. Metal adduction is prevented through the addition of acids (Figure S6.5II in 
Appendix C), as noted in previous SAII studies.
111,114 
The accumulation of results show 
that, although the optimum inlet temperature is somewhat different for certain analytes 
and sample preparation methods, sufficient ion abundance for analytical utility is 
obtained over a wide range of conditions. As is the case with the traditional methods of 
ESI and MALDI, smaller molecules are more easily detected than the larger nonvolatile 
molecules. The optimal inlet temperature of the LTQ Velos is lower than those reported 
for an Orbitrap Exactive in which solution was introduced inside the mass spectrometer 
inlet.
111
 
An advantage of the approach used here is that the volume of solution introduced to 
the inlet can be better controlled using pipet tips relative to using fused-silica tubing, and 
because the tips are disposable, cross contamination caused by sample adhering to the 
walls of the fused silica is eliminated. The initial automation experiment with pipet tips 
used an 8-channel pipet. The setup, designed to operate with the capillary inlet source of 
the LTQ Velos, is shown in Scheme 6.1B. Three microliters of solutions containing 
leucine enkephalin (2.5 pmol μL−1), galanin (1 pmol μL−1), and ubiquitin (1 pmol μL−1) 
were simultaneously drawn from multisample well plates into alternate pipet tips with 
pure solvent between each solution. The dispenser was fastened to an x,y-stage, and each 
tip was sequentially moved in front of the inlet of the mass spectrometer. The setup was 
previously aligned so that all plotting the total ion chronogram (TIC) (Figure 6.2A), 
from which mass spectra of leucine enkephalin, galanin, and ubiquitin were extracted. 
Good ion abundance was observed for each sample without cross contamination (Figure 
6.2B.1−D.1). The Biomap software displays the location of any selected m/z in the 
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sampled multisample well plate, as is commonly performed with imaging of tissue 
sections.
135,195,199
 This is exemplified in Figure 6.2B.2−D.2 for leucine enkephalin (+1, 
m/z 556), galanin (+3, m/z 1053), and ubiquitin (+7, m/z 1224) using 150 °C inlet 
temperature. The mass spectra from the same set of analytes tested at different inlet 
temperatures (250, 350, and 450 °C) are similar (Figure S6.7 in Appendix C).  
 
Figure 6.2. Multiplexing SAII-MS using the 8-channel pipet (Scheme 6.1B) at an 
inlet temperature of 150 °C.  The analysis of 5 tips filled (3 uL) with 3 different 
samples with solvent (S) between each two samples.  (A) Total ion chronogram (TIC): 
(1) Mass spectra and (2) mapping of the location of individual analytes: (B) 2.5 pmol 
µL
-1 
leucine enkephalin (LE, m/z 556), (C) 1 pmol µL
-1
galanin (Gal, m/z 1053), and 
(D) 1 pmol µL
-1
 ubiquitin (Ubi, m/z 1224).  Data were acquired in the m/z range of 
300-2000. 
However, split peaks are observed in the TIC at 350 and 450 °C because the pipet tips 
needed to be further from the inlet to prevent pipet melting which caused the solutions to 
be drawn inconsistently and slowly so that, instead of a liquid stream, droplets are drawn 
into the inlet. The pipet tip size is not critical, but with the present setup, the smaller tips 
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are more difficult to align properly with the inlet. It is interesting to note that the speed of 
the x,y-stage has little impact for any given size of pipet tips tested. As soon as the 
solution is exposed to the vacuum, it is drawn into the mass spectrometer and analyte 
rapidly ionized. However, even smaller size tips than explored here are expected to slow 
the speed of solution exiting the pipet, as has been demonstrated for the picotips using 
nano-ESI.
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The rate of analyses can be paced by adjusting the movement of the x,y-stage and can 
be as short as one sample/s, accepting some cross contamination between samples. In 
principle, one could also actively stop the x,y-stage movement at the expense of time 
requirements. Figure S6.8 in Appendix C displays the analysis of three analytes 
(angiotensin I, bovine insulin, and ubiquitin) in only 2 s with some acceptable carryover 
between samples. For high-throughput screening this performance may already be 
sufficient. Using this construction, three solutions of an antipsychotic drug clozapine at 
25, 250, and 500 fmol μL−1 were mapped for relative amounts (Figure 6.3I). Two 
solvents were used between each two analyte solutions. Different clozapine solutions or 
pure methanol solvent were filled in the tips as indicated in Figure 6.3IA. MS/MS was 
used to enhance the specificity of the experiment. The protonated ion (m/z 327) was 
selected and fragmented by CID. The mass spectral data of the transition, 327 → 
270,
23,200
 is visualized by a mapping display using Biomap (Figure 6.3IB). The color 
trace correctly displays the location of the analytes with little or no carryover in the 
methanol acquisitions. The color code also reflects the relative analyte concentration, 
with blue at lower concentrations and red at higher concentrations. Figure 6.3II shows 
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the TIC (Figure 6.3IIA) and mass spectra with ion abundances (Figure 6.3IIB) for each 
of the samples.  
 
Figure 6.3. Mapping using the 8-channel pipette (Scheme 6.1B). (I): (A) Schematic 
representation of content in each pipette tip. Red boxes indicate tips filled with 2 µL 
clozapine solutions at 25 fmol µL
-1
, 250 fmol µL
-1
, and 500 fmol µL
-1
, respectively; 
grey boxes represent pure solvent methanol; (B) The mapping of m/z 270 peak. (II): 
(A) TIC and (B) Mass spectra extracted from (1) 0.02 min, (2) 0.17 min, and (3) 0.34 
min of the TIC.  Data were acquired in the m/z range of 200-500. 
Using the same approach and concentrations, the more concentrated analyte may have 
an effect on the less concentrated samples as is seen in the mapping display of the 
methanol solutions (Figure S6.9 in Appendix C). If necessary, more tips containing 
methanol blank solutions can be employed to reduce cross contamination between 
samples for quantitative analyses. Using this approach, a 1 μL solution of 1 fmol μL−1 
clozapine was readily detected (Figure S6.10 in Appendix C). This automated method is 
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therefore sensitive, rapid, simple, and robust and can characterize small and large 
molecules. 
The comparison of introducing the same amount of ubiquitin (3 μL) by either 
manually injecting or vacuum drawing (Figure 6.4) shows that both methods produce 
nearly identical results. A tip-to-inlet distance of ca. 0.5 mm allows solution transfer 
without concern for the tip melting at higher inlet temperature, but increasing distance 
beyond this makes drawing the entire content of each pipet problematic. The ability for 
the sample to be dispensed for ionization only when the tip of the pipet is close to the 
entrance aperture, to make use of the mass spectrometer vacuum for sample introduction, 
suggests a simple means for high-throughput sampling. 
 
Figure 6.4. SAII mass spectra of ubiquitin at inlet temperature of 250 °C.  Solutions 
of 3 µL of 1 pmol µL
-1
 were introduced by (A) manually pipetting and (B) vacuum 
drawing (Scheme 6.1A). Data were acquired in the m/z range of 150-2000.  
The number of samples which can be analyzed in a single automated analysis was 
therefore extended using a commercial 96-pipet holder (Scheme 6.1C) to affix the pipet 
tips for sampling 96-well plates. Because of the physical limitations of our x,y-stage 
relative to the mass spectrometer inlet, only 84 samples of the possible 96 positions were 
in the range of the x,y-stage motion. Sample loading is straightforward because the pipet 
tips only need to be placed into the well of a multisample plate containing the various 
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solutions and capillary action loads the pipet tips with approximately the same volume of 
each solution/solvent (Scheme S6.1 in Appendix C) providing the solvents used are of 
approximately the same composition, especially in water content. On the basis of a 1:1 
acetonitrile:water solution, and the pipet tips used in the experiment, ca. 3 μL are drawn 
into each of the pipet tips. Different pipet tips are expected to load different volumes, and 
higher viscosity solvents, such as water, are more problematic using this approach so that 
organic solvents such as acetonitrile or methanol were added to lower viscosity. Again, to 
avoid the possibility of carryover, solvent was placed between any two samples. 
A typical TIC is shown in Figure 6.5I in which 42 tips out of 84 were analyzed with 
seven different analyte solutions providing six analyses of each solution. This 
corresponds to 1 sample per 5 s for the analyses of liquid samples using this approach. 
Individual mass spectra of clozapine, leucine enkephalin, sphingomyelin, galanin, bovine 
insulin, ubiquitin, and lysozyme (Figure 6.5II) are observed with little or no cross 
contamination. Because of multiply charging, proteins can also be analyzed on a limited 
m/z mass spectrometer. The minimal chemical background allows small and large 
molecules to be characterized at subpicomole concentration using an inlet temperature of 
250 °C. All six mass spectra for bovine insulin extracted from each cycle are displayed in 
Figure S6.11 in Appendix C showing poor reproducibility as indicated by the ion 
intensity. We attribute this to the difficulty with our home-built approach to properly 
align all 84 pipet tips in the same position relative to the inlet aperture. 
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Figure 6.5. SAII-MS using 84 tips mounted on a 96-well pipet tip holder (Scheme 
6.1C) with the inlet temperature at 250 °C acquired in ~5 min. (I) Total ion current. 
(II) Mass spectra of (A) 1 pmol µL
-1
 clozapine (in methanol), (B) 2.5 pmol µL
-1 
leucine enkephalin (in acetonitrile:water with formic acid), (C) 1 pmol µL
-1 
sphingomyelin (in methanol with acetic acid), (D) 1 pmol µL
-1 
galanin (in 
acetonitrile:water with formic acid), (E) 5 pmol µL
-1 
bovine insulin (in 
methanol:water with acetic acid), (F) 1 pmol µL
-1 
ubiquitin (in acetonitrile:water with 
formic acid), and (G) 10 pmol µL
-1 
lysozyme (in acetonitrile:water with formic acid). 
Data were acquired in the m/z range of 150-2000. 
Figure S6.12 in Appendix C provides the TIC and mass spectra of the same set of 
samples at lower speed. All 84 pipet tips (42 samples) were analyzed in ∼10 min by 
reducing the x,y-stage movement to 1.5 mm s
−1
. No cross contamination was observed, 
but at the expense of longer analysis time. This approach is also less reproducible for 
larger molecules. However, in these experiments we used compounds ranging in 
molecular weight from 326 to ∼14300. In practice, better reproducibility and higher 
sensitivity is obtained if one only needs to look at a specific mass range for certain 
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compound types such as drugs or peptides. For example, analyzing for the drug clozapine 
in four different substantially lower concentrations (0.5−30 fmol μL−1) using MS/MS and 
mapping m/z 270, the location and the relative amount present are correctly displayed for 
each vial (Figure S6.13 in Appendix C). 
Higher capacity microtiter plates are widely used in pharmaceutical industry. A 384-
well plate was used to analyze the drug clarithromycin in form of a tablet obtained from a 
local pharmacy. Random amounts of tablet powder were dissolved and diluted in the 
microtiter plate wells (Scheme S6.2 in Appendix C) and analyzed using CID with 
solution introduction using the 8-channel pipet approach (Figure 6.6I). The major 
fragment ion at m/z 590
201
 was mapped using Biomap software. The map correctly 
displays the locations where drug was present (Figure 6.6II). The first well with the first 
sample contains the highest amount of tablet and the fourth well with the second sample 
contains the least based on the color code of the map. 
For the pipet tips used in this study, the speed of sample introduction is greatly 
influenced by the exposure to the vacuum, and thus on the distance of the pipet exit to the 
inlet aperture of the mass spectrometer, the scanning nature of the mass spectrometer, and 
little if at all on the speed of movement of the x,y-stage. With increasing numbers of 
samples, reproducibility becomes more challenging to achieve because of alignment 
issues with the current method. Another possible issue is the pulsed nature of the 
ionization, which may be improved using the appropriate analyzer with ion trapping 
synchronized with the ionization event similar to the challenges previously observed with 
MALDI.
202,203
 It is expected that this can be optimized using shorter ion trapping and 
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multiple microscans. Narrower scan windows will increase reproducibility as is the case 
for any targeted ESI analyses approach.
204,205
 
 
Figure 6.6. Mapping of clarithromycin from tablet in a 384-microtiter plate using the 
8-channel pipette (Scheme 6.1B). (I) Picture of loading tablet solution and pure 
solvent from microtiter plate to pipette. (II)(A) Schematic representation of content in 
each pipette tip. Red boxes indicate tips filled with solutions containing 
clarithromycin tablet (CLA); grey boxes represent pure solvent methanol (S); (B) The 
mapping of a major fragment at m/z 590.3.  Data were acquired in the m/z range of 
205-1000. 
At the current stage of development, automation of the SAII method provides a 
simple high-throughput analysis approach for compounds regardless of mass, volatility, 
or “sprayability”. With this approach potentially 4000 samples that can be analyzed per 
day per instrument using profile mode without significant cross contamination. Such an 
achievement will require more reproducible control of sample position relative to the 
mass spectrometer inlet. Higher throughput is envisioned with larger well plate numbers.  
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6.4 Conclusion  
Mapping of select compounds in microtiter plate wells is an obvious application of 
this new technology, but any area in which fast analyses are valued such as proteomics, 
metabolomics, and lipidomics could be impacted. It is our expectation, based on current 
performance, that some of these new ionization technologies in conjunction with 
IMSMS,
206-208
  ETD,
209,210
 and LC,
211-214
 will have considerable advantages relative to 
current analytical methods. The potential of these methods for direct analyses of complex 
mixtures will be achieved using high mass resolution available with Fourier transform 
instruments.
215
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CHAPTER 7 
MATRIX ASSISTED IONIZATION VACUUM FOR HIGH 
RESOLUTION FOURIER TRANSFORM ION CYCLOTRON 
RESONANCE MASS SPECTROMETERS 
Matrix-assisted ionization vacuum (MAIV) produces charge states similar to 
electrospray ionization (ESI) from the solid state without requiring high voltage or added 
heat. MAIV differs from matrix-assisted laser desorption/ionization (MALDI) in that no 
laser is needed and abundant multiply charged ions are produced from molecules having 
multiple basic sites such as proteins. Here we introduce simple modifications to the 
commercial vacuum MALDI and ESI sources of a 9.4 T Fourier transform-ion cyclotron 
resonance (FTICR) mass spectrometer to perform MAIV from both intermediate and 
atmospheric pressure. The multiply charged ions are shown for the proteins bovine 
insulin, ubiquitin, and lysozyme using 3-nitrobenzonitrile as matrix. These are the first 
examples of MAIV operating at pressures as low as 10
−6
 mbar in an FT-ICR mass 
spectrometer source, and the expected mass resolving power of 100000 to 400000 is 
achieved. Identical protein charge states are observed with and without laser ablation 
indicating minimal, if any, role of photochemical ionization for the compounds studied. 
 
 
 
 
 
B. Wang, E. Tisdale, C. L. Wilkins, S. Trimpin, Anal. Chem. 2014, 86, 6792-6796. 
Reprinted with permission from Copyright (2014) American Chemical Society.  
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7.1 Introduction  
High-field Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometry 
(MS) is an important tool used in the analyses of biological materials because of the high 
mass resolving power.
216
 Frequently FT-ICR mass spectrometers are coupled with 
electrospray ionization (ESI)
91
 to take advantage of multiply charged analyte ions which 
bring the mass-to-charge (m/z) within instrumental limits. ESI requires analyte to be 
desolved in a “sprayable” solvent and hundreds of volts applied to achieve analyte 
ionization.
33
 Vacuum matrix-assisted laser desorption/ionization (MALDI) produces gas-
phase ions from the solid state using a vacuum stable matrix that has absorption at the 
laser wavelength.
31,35,217-219
 An advantage of ionization at vacuum is that ion transmission 
losses
65,220
 common with atmospheric pressure ionization (API) methods is mitigated. 
Inlet ionization is an alternative method producing ESI-like multiply charged gas-
phase ions from the solid state with the assistance of a matrix (e.g., 2,5-dihydroxybenzoic 
acid, 2,5-DHB), vacuum, and heat.
18,107,109
 Ionization is initiated in the heated inlet tube 
without use of voltage or laser ablation.
121
 The first examples of coupling laserspray 
ionization inlet (LSII) and matrix-assisted ionization inlet (MAII) to high field FT-ICR 
MS were achieved on a home-built LTQ 14.5 T FT-ICR mass spectrometer by heating a 
∼10 cm long inlet capillary to 350 °C.215 Myoglobin (17 kDa) was detected by MAII. 
The need for applicability on mass spectrometers that do not use a heated inlet tube, 
initiated a quest for more volatile matrix compounds that might operate at lower inlet 
temperature.
110
 
The discoveries of more volatile matrices led to vacuum ionization, which unlike inlet 
ionization, is dependent on matrices that do not require a heated inlet tube to produce ions 
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having ESI-like charge states. The ability to produce highly charged ions by laser 
ablation of the matrix 2,5-dihydroxyacetophenone (2,5-DHAP) was first developed on a 
commercial intermediate pressure (0.21 mbar) MALDI ion source of an ion mobility 
spectrometry-mass spectrometer (SYNAPT G2).
115
 The more volatile matrix, 2-
nitrophloroglucinol (2-NPG), was later shown to produce multiply charged ions from 
proteins upon laser ablation on a high vacuum (10
−6
 mbar) MALDI-TOF mass 
spectrometer.
116
 Charge states observed at high vacuum are lower than at intermediate 
and atmospheric pressure. A similar vacuum (10
−6
 mbar) is used on MALDI sources 
coupled to FT-ICR mass spectrometers.
221
 
One of the more volatile matrix compounds discovered, 3-nitrobenzonitrile (3-NBN), 
produces ions having ESI-like charge states when used as a matrix and introduced with 
incorporated analyte into the intermediate pressure vacuum MALDI source of a 
SYNAPT G2 mass spectrometer without laser ablation.
117
 This method, which eliminates 
the need of a laser, is termed matrix-assisted ionization vacuum (MAIV). MAIV ionizes 
a wide range of compounds, including bovine serum albumin (66 kDaA). 3-NBN is 
amenable to sample introduction from atmospheric pressure with tube or skimmer inlets 
and produces ions at atmospheric pressure simply using mild heat.
119,222
 Working from 
atmospheric pressure, proteinssuch as lysozyme (14.3  kDa) and carbonic anhydrase (28 
kDa) are ionized, and the methods tolerance of salts enables direct analysis of urine and 
blood.
117,120
 
MAIV matrices are hypothesized
117,118
 to require sublimation as well as charge 
separation through the fracturing process that produces triboluminescence; 3-NBN fulfills 
both of these proposed requirements.
223 - 225
 Here, we describe the implementation of 
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MAIV using both the vacuum MALDI and atmospheric pressure ESI sources of a 9.4 T 
FT-ICR mass spectrometer and discuss the role of vacuum in the ionization process. 
7.2 Materials and Methods 
Materials and Sample Preparation. Chemicals were obtained and stock solution 
prepared as stated in Chapter 2. The peptide mixture was prepared by mixing leucine 
enkephalin, angiotensin I, bombesin, allatostatin, and bovine insulin with the volume 
ratio of 3:3:1:1:1. The angiotensin mixture contains 1 mg mL
−1
 of angiotensin I, 
angiotensin II, and angiotensin (1−9) fragment in water solution. The MAIV matrix 3-
nitrobenzonitrile (3-NBN) was prepared by dissolving 5 mg in 50 μL (concentrated) 
identical to the previous study,
117
 or 500 μL (diluted) acetonitrile with 0.1% formic acid. 
The LSIV matrix 2-nitrophloroglucinol (2-NPG) was prepared by dissolving 5 mg in 100 
μL 50:50 acetonitrile:water identical to previous work.116 For MAIV experiments on the 
MALDI source, angiotensin I and bovine insulin were prepared by spotting 1 μL of 
analyte on a AnchorChip plate (Bruker, Bremen, Germany) followed by adding 1 μL 
concentrated matrix solution; 3 μL ubiquitin was spotted on 384 ground steel plate 
(Bruker, Bremen, Germany), and 1 μL diluted matrix solution was added. Samples were 
allowed to air-dry before loading the plate to the vacuum source. For LSIV experiments, 
all analytes were premixed with the matrix 2-NPG in a 1:1 volume ratio on AnchorChip 
target plates. For MAIV experiments from atmospheric pressure using the ESI source 
inlet aperture, angiotensin, bovine insulin, ubiquitin, and lysozyme were premixed with 
the concentrated 3-NBN matrix solution in a 1:1 volume ratio and stir-mixed using a 
pipet tip. The matrix:analyte mixture, 2 μL, was drawn into a pipet tip and allowed to air-
dry at its tip. 
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Vacuum Ionization on FT ICR Mass Spectrometer. The commercial high vacuum 
MALDI and ESI sources on a 9.4 T Apex FT-ICR mass spectrometer (Bruker, Bremen, 
Germany) were used for MAIV and LSIV studies. The source pressure of the high 
vacuum MALDI source was 2.0E−6 mbar. Bruker DataAnalysis was used to determine 
resolving power. 
MAIV from High Vacuum. The sample plate was loaded after the samples were air-dried. 
The laser fluence was set to 0, and the laser beam was blocked with paper. The plate 
voltage was optimized at 240 V for angiotensin I, and 300 V for bovine insulin and 
ubiquitin. Acquisition was started once the matrix:analyte mixture spotted on the target 
plate was loaded. The acquisition size was 2 million points, and the mass spectra are 100 
acquisitions summed for angiotensin I and bovine insulin. For ubiquitin, acquisition was 
stopped when thebackground started to increase; in this case, about 20 acquisitions were 
averaged. 
LSIV from High Vacuum. Ubiquitin solution was mixed with 2-NPG matrix solution and 
spotted on a target plate. The sample plate was loaded after the samples were air-dried. 
For LSIV of ubiquitin, the arbitrary laser fluence was 50%, and the plate voltage was 400 
V. The acquisition size was 512 K points for higher signal abundance. Twenty 
acquisitions were averaged to obtain a mass spectrum. 
MAIV from Atmospheric Pressure. The commercial ESI source housing was removed, as 
well as the cover and the cap on the ESI capillary so that direct access to the capillary 
orifice was obtained. The capillary voltage, spray shield, nebulizing gas flow, and dry gas 
flow were all set to 0. On this dual ESI/MALDI source, the voltage on the MALDI plate 
was set at 300 V and the MALDI source was disabled. The capillary temperature was 
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kept at room temperature without additional heat. The dried matrix:analyte crystals on the 
pipet tip were introduced into the vacuum of the mass spectrometer by gently contacting 
the capillary opening. Acquisition lasted for about 2 min until the crystals were consumed 
from the pipet tip.  
7.3 Results and Discussion 
Inlet ionization methods were previously demonstrated on a high field FT-ICR mass 
spectrometer having a home-built heated inlet tube.
215
 Meanwhile, matrix compounds 
were discovered that produce multiply charged gas-phase ions spontaneously without a 
laser or heat, other than the ambient heat available in the matrix and target plate, when 
exposed to low pressure conditions. Furthermore, the matrix, 3-NBN, produces abundant 
analyte ions when introduced from atmospheric pressure to the subambient pressure inlet 
aperture of a mass spectrometer without the necessity of a heated inlet tube.
119
 Previous 
studies have suggested that pressure may be an important variable in MAIV. The Bruker 
Apex 9.4 T FT-ICR mass spectrometer MALDI source operates at 2E
−6
 mbar, well below 
the source pressure of previous MAIV studies
118
 and provides the opportunity to 
determine if MAIV is compatible with high vacuum and ultrahigh mass resolving power. 
The mass spectrum of ubiquitin (Figure 7.1A), with 3-NBN as matrix, produces a 
measured resolving power of 403000 at +9 (m/z 952.5206) using the vacuum MALDI 
FT-ICR source. The +4 charge state (m/z 1434.1586) of bovine insulin had a mass 
resolving power of 254000, and the +2 charge state of the peptide angiotensin I (m/z 
648.8432) had a resolving power of 185000. The MAIV mass spectra acquired using the 
MALDI source produce the high resolving power characteristic of this FT-ICR mass 
spectrometer.
226
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Figure 7.1. Mass spectra of ubiquitin using 3-NBN as matrix obtained on the high 
vacuum MALDI source of the Apex FT-ICR mass spectrometer (A) without (MAIV) 
and (B) with the use of a laser (LSIV) for matrix:analyte ablation. 
In similar experiments using the intermediate pressure (0.21 mbar) MALDI source of 
a SYNAPT G2 mass spectrometer, the 3-NBN matrix produced analyte ions for ca. 2 min 
after the sample was loaded (3 min, including loading time).
117
 The time over which 
ionization is observed relates to the rate of sublimation of the matrix. In the lower 
pressure MALDI source (2E
−6 
mbar) coupled to the Apex FT-ICR mass spectrometer, 
sublimation of the matrix occurred over a 30 min period. Ions could be observed during 
this time but in lower abundance. 
In contrast to the SYNAPT G2 vacuum MALDI source in which the protein bovine 
serum albumin (66 kDaA) was analyzed using MAIV,
117
 ubiquitin was the largest 
molecule analyzed on the FT-ICR vacuum MALDI source. The most abundant and 
highest charge state ions for ubiquitin were lower on the FT-ICR than SYNAPT G2 for 
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the same compound. The most abundant ion shifts from +10 to +8, and the highest charge 
state shifts from +12 to +10. 
The differences observed with the MAIV analysis using the MALDI source of a 
SYNAPT G2 and Apex FT-ICR logically relates to the pressure difference the sample 
experiences in the two instruments. Under vacuum conditions, sublimation cools the 
surface and at lower pressure heat transfer from the ambient environment is inefficient. 
Thus, an ionization process dependent on sublimation will be inhibited under cooling 
conditions. The higher pressure of the SYNAPT G2 MALDI source counters the cooling 
effect of sublimation through heat transfer to the matrix surface from the residual gas. A 
means of adding thermal energy is therefore expected to reduce the time over which 
ionization occurs, increase the ion abundance, and expand the compounds that act as 
matrices without need of a laser. This concept is supported by three independent studies. 
In the first study, the target plate of the SYNAPT intermediate pressure source was 
cooled, simultaneously inhibiting sublimation and ionization,
118
 but second, warming the 
inlet used with atmospheric pressure sample introduction reduces the time of 
ionization.
127
 In a third study, a warmed gas flow (75 °C) was used to dislodge the 
matrix/analyte from the substrate holder to initiate analyte ionization.
222
 Under the 
current conditions of the high vacuum source of the FT-ICR, proteins larger than 
ubiquitin may not be observed because they cannot be removed from the surface under 
the cooler conditions, or once removed they are not able to shed the matrix that 
accompanies them into the gas phase.
122
  
Although the 3-NBN matrix absorbs 355 nm photons poorly, a Nd:YAG laser was 
used to ablate the matrix crystals over several minutes. Even though the rate of removal 
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of the matrix was increased, no change in charge states and only a small increase in ion 
abundance was observed for ubiquitin (Figure 7.1B). The minimal influence of the laser 
fluence on ionization strongly suggests that the nitrogen discharge related to 
triboluminescence of this matrix
224,225
 is not directly involved with ionization. In other 
words, it is the charge separation that causes triboluminescence that is important and not 
the dinitrogen discharge.  
The 2-NPG matrix was previously shown to produce ESI-like charge states of analyte 
by UV laser ablation using the SYNAPT G2 MALDI source.
116
 This matrix, however, 
performs poorly relative to the more volatile 3-NBN matrix on the FT-ICR MALDI 
source. Both the charge state and ion abundance are lower with the less volatile 2-NPG 
than with the most volatile 3-NBN matrix. For example, FT-ICR of ubiquitin in 2-NPG 
using laser ablation produced up to the +4 charges with +2 as the most abundant (Figure 
S7.2 in Appendix D), while MAIV of the same analyte solution and mass spectrometer 
using 3-NBN as matrix with or without the laser provided up to +10 charges (Figure 7.1) 
and with higher ion abundance and signal-to-noise ratio. The vacuum Apex FT-ICR 
results are similar to high vacuum laser ablation on a MALDI TOF mass spectrometer of 
ubiquitin using the 2-NPG matrix where the most abundant charge state is +3.
116 
The 
experimental observation of dependence of matrix and volatility has been proposed to be 
related to the inability to evaporate matrix from the charged matrix:analyte clusters in the 
time available before mass separation.
110,122
 These results relate well with the 
observations that chemical structure of the matrix is not critical
127
 so long as volatility of 
the matrix is sufficient to remove the matrix from the charged matrix/analyte 
clusters.
110,122
 As observed with inlet ionization,
227
 less energy is needed to remove 
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matrix from smaller compounds which agrees with the ability to readily analyze peptides 
using MAIV on the FT-ICR as shown for a mixture in Figure S7.1 in Appendix D. 
However, for the FT-ICR, the time available for desolvation is much longer than with 
MALDITOF and suggests that pressure may be a more important parameter in producing 
bare ions.  
In the present experiments, different plate voltages (240 and 300 V) and data 
acquisition sizes (2 million and 512 thousand) were examined for MAIV. Nearly 
identical charge state distributions and ion intensities were obtained for bovine insulin 
(Figure S7.2 in Appendix D). Angiotensin I showed some plate voltage dependence 
(Figure S7.3 in Appendix D), with 240 V being optimal forming +2 charge state ions 
with +3 being observed in low abundance (Figure S7.3.II.C in Appendix D). With 200 
(Figure S7.3.I.C in Appendix D) and 500 V (Figure S7.3.I.E in Appendix D) no ions 
were observed for this peptide. Interestingly, at 400 V (Figure S7.3.I.D in Appendix D), 
an abundant singly charged ion is observed. The voltage dependence is in agreement with 
intermediate and atmospheric pressure LSI studies in which the charge states can be 
altered by instrument parameters; lower charge states correspond to increased energy 
input.
108,122
  
Although the continuous ion formation of over 30 min using MAIV with the FT-ICR 
mass spectrometer may benefit some applications (e.g., fragmentation methods for 
characterization),
227 
the inefficiency in ionization at the low source pressure as well as the 
∼1 min sample plate loading time are not favorable for many analytical applications. 
Directly introducing the MAIV matrix from atmospheric pressure into the inlet aperture 
of a mass spectrometer has been shown to be an effective means for rapidly analyzing 
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samples using MAIV matrices.
119,222
 Therefore, introducing the matrix:analyte sample 
from atmospheric pressure on the FT-ICR mass spectrometer provides an intermediate 
pressure region to produce ions and a direct comparison with MAIV on the high vacuum 
MALDI source of the same instrument. Figure 7.2 illustrates the approach. 
 
Figure 7.2. Picture of MAIV operating on the ESI source of the Apex FT-ICR mass 
spectrometer. 
Shown in Figure 7.3 are representative isotopic distributions of ubiquitin (Figure 
7.3A) and lysozyme (Figure 7.3B) obtained when the individual 3-NBN:analyte crystals 
were  introduced to thesource by gently touching the capillary orifice so the vacuum of 
the mass spectrometer can draw the matrix:analyte into the glass inlet tube held at room 
temperature. Each mass spectrum was obtained in less than 2 min until the crystals were 
consumed from the pipet tip. Similar to MAII on an LTQ FTICR instrument using the 
matrix 2,5-DHAP,
215
 the most abundant charge state for ubiquitin using 3-NBN is +8. In 
MAIV, the matrix:analyte introduced into the inlet experiences decreasing pressure as 
well as the natural airflow from atmospheric pressure to the first vacuum region. Under 
these conditions, the charge states and ion abundance of peptides and small proteins are 
ESI-like. This increase in charge state makes larger proteins applicable (e.g., lysozyme, 
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mixture
ESI capillary
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14303 Da, Figure 7.3B as compared to ubiquitin, 8560 Da Figure 7.1A on the high 
vacuum MALDI source) using the same solutions. Further, MAIV from atmospheric 
pressure provides equivalent mass resolving power for insulin (255000, +5 at m/z 
1147.5279) and ubiquitin (376000, +9 at m/z 952.6316) to vacuum conditions, and 
206900 for the +10 charge state of lysozyme (m/z at 1431.4889). Because of multiply 
charging in MAIV, the mass range of the mass spectrometer is extended or compounds 
analyzed from the solid state, as is the case with ESI from solution. 
 
Figure 7.3. MAIV mass spectra of (A) +9 charge state of ubiquitin and (B) +10 
charge state of lysozyme using 3-NBN as matrix obtained on the ESI source of the 
Apex FT-ICR mass spectrometer. 
7.4 Conclusion 
This study indicates the potential utility of MAIV and its applicability to high-
performance FT-ICR mass spectrometers. The results presented here indicate that this 
simple and easy to use ionization method can be widely adapted with a minimum effort. 
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The importance of pressure conditions using MAIV is demonstrated. Because of the 
multiply charging, electron capture dissociation (ECD)
228 , 229
 and electron transfer 
dissociation (ETD)
107,117,134, 230
 of ions sublimed directly from a surface should be 
possible with FT-ICR. Because of the high resolving power, these methods are 
potentially useful in the analysis of complex materials such as tissue and blood.
117,120
 
While the experiments reported here used the standard ESI inlet and MALDI vacuum 
sources, adaptation specifically for MAIV is expected to greatly improve sensitivity. 
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CHAPTER 8 
DRUG DETECTION AND QUANTIFICATION DIRECTLY FROM 
TISSUE USING NOVEL IONIZATION METHODS FOR MASS 
SPECTROMETRY  
Solvent assisted ionization inlet (SAII) and matrix assisted ionization vacuum 
(MAIV) were used to rapidly quantify an antipsychotic drug, clozapine, directly from 
surfaces with minimal sample preparation. This simple surface analysis method based on 
SAII- and MAIV-mass spectrometry (MS) was developed to allow detection of 
endogenous lipids, metabolites, and clozapine directly from mouse brain tissue sections. 
Rapid surface assessment was achieved by SAII with the assistance of heat on the mass 
spectrometer inlet, and MAIV showed capability on heat-limited instruments with better 
reproducibility. In addition, isotope dilution and standard addition were used without 
sample clean-up, and the results correlate well to liquid chromatography (LC)-tandem 
MS with sample work-up. Using the simple surface methods, standard solutions 
containing clozapine and deuterated internal standard (clozapine-d8) at different 
concentration ratios were used to extract and quantify clozapine from brain tissue 
sections of a drug-treated mouse at different thicknesses. The amount of clozapine 
extracted by these surface methods was independent of tissue thickness.  
 
 
 
 
 
 
B. Wang, C. L. Dearring, J. Wager-Miller, K. Mackie, and S. Trimpin, submitted. 
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8.1 Introduction 
An ideal analytical method should be fast, simple, able to quantify material with 
minimal effort, and provide spatial resolution. However, those ideals are difficult to 
achieve in combination. Characterization methods based on mass spectrometry (MS) 
have gained popularity in pharmaceutical industry for speed of analysis, sensitivity, 
selectivity, and the ability to be coupled with separation methods such as liquid 
chromatography (LC).
231,232
 In addition to identification, rapid quantification of drugs is 
important in drug discovery. Quantifying drugs and their metabolites in biological tissue 
is an even more arduous task. MS alone is a semi-quantitative method, since ion intensity 
values can vary significantly during acquisition.
233
 However, the signal ratio with an 
isotopically labeled internal standard is reasonably reproducible.
233
 Isotope dilution is 
commonly used in MS-based quantification methods
234,235
 (e.g. LC tandem MS
236,237
). 
The traditional LC-MS method requires sample work-up,
238,239
 which can be time and 
labor-intensive, and removes the analyte from its native environment, such as a surface. 
MS has been used to provide chemical information directly from surfaces.
55, 240
 
Information on relative amount of analytes from surfaces is achieved by MS 
imaging
241,242
 using the mass to charge ratio (m/z) and a heat map of the ion abundances 
detected. In addition, MS imaging provides location of compounds within a surface. 
Quantification has been reported by spotting internal standard on the tissue section.
63,64
  
Matrix-assisted laser desorption/ionization (MALDI) is widely used in molecular 
imaging, providing relative amount and spatial information for peptides, proteins,
56,243
 
lipids,
57
 and metabolites,
58
 etc. from surfaces such as tissue sections. Critical to the 
success in MALDI-MS is the matrix sample preparation which may result in sample 
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adulteration
244
 and potential chemical delocalization if the surface wets during matrix 
application.
245
 Ambient surface analysis methods, such as desorption electrospray 
ionization (DESI)
85
 and nanospray desorption electrospray ionization (nanoDESI)
89
 
operate without the use of matrix compounds, allowing surface samples to be analyzed at 
atmospheric pressure with no or minor sample preparation and less chemical 
background.
246-248
 For example, the antipsychotic drug clozapine from mouse brain tissue 
has been imaged using DESI
23,233
 with a typical spatial resolution of ~200 µm.
249
 Notable 
exceptions are those that make use of a laser providing improved spatial resolution 
measurements and some with ease in instrumental setup.
24,61,135,195, 250 ,
 Hours and 
sometimes days are required for MS imaging especially at high spatial resolution using 
sophisticated laser focusing setups.
62,251
 
Spatial resolution can be useful, but is often not required. If the exact location of 
surface analytes is not required, a liquid microjunction surface sampling probe can be 
used to extract analytes employing a liquid junction formed between a probe and the 
surface in a more rapid manner.
189
 A solid-phase tissue sampling method achieved by 
thermal evaporation provided rapid volatile analyte identification capabilities.
252
 Some of 
the ionization methods involve critical connections and precise alignments of the 
ionization apparatuses, requiring considerable user expertise to obtain reliable 
performance.
16 
The recently developed solvent assisted ionization inlet (SAII)
111
 and matrix assisted 
ionization vacuum (MAIV)
117
 produce mass spectra similar to electrospray ionization 
(ESI) without the use of any external voltage or a laser. SAII has sensitivity comparable 
to ESI when the position of the capillary, which introduces samples to the mass 
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spectrometer inlet, is at the “hot spot” inside of the heated inlet.111,112,114 A recent study 
showed ESI-like ions can be produced when the analyte solution was pipetted near the 
entrance aperture of a heated mass spectrometer inlet tube.
197,253
 MAIV was demonstrated 
to produce ESI-like ions directly from a surface, e.g. mouse brain tissue sections, by 
simply spotting a MAIV matrix on tissue and exposing it to vacuum without the 
requirements of additional heat, voltage, or a laser.
117,120
 
Here, we report the development of SAII and MAIV for rapid surface analysis of the 
drug clozapine from brain tissue sections of drug-treated mice along with endogenous 
lipids and other small molecules. Isotope dilution and standard addition were employed 
for quantification. 
8.2 Materials and Methods 
       Materials 
 All chemicals and mouse brain tissue sections were obtained as stated in Chapter 2.   
Instrumentation 
The LTQ Velos mass spectrometer (Thermo, Bremen, Germany) was used for SAII 
and LC-ESI studies. For ESI, the voltage was 3 kV, sheath gas was 8, and inlet 
temperature at 275 ºC.
254
  For SAII, the ESI source of the LTQ Velos instrument was 
removed for direct access to the inlet as previously described.
135
 The temperature of the 
inlet can be adjusted through the commercial temperature control of the inlet. In this 
study the inlet tube was operated at 200 ºC to avoid peak broadening while ensuring 
sufficient ion intensity. The sheath gas, auxiliary gas, sweep gas, and capillary voltage 
were all set at 0. The mass spectra were acquired with automatic gain control on, with 5 
microscans maximum injection time of 20. For tandem mass MS, collision energy of 35 
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was applied for collision induced dissociation (CID) to fragment the isolated molecular 
ion. 
The SYNAPT G2 (Waters, Manchester, UK) mass spectrometer was used for MAIV 
study. For MAIV on the MALDI source, the commercial intermediate pressure MALDI 
was used with “LSIV” settings as previously reported.115 Briefly, the sample plate voltage 
was set to 0, the laser power was 0 and was not initiated. An extraction voltage of 10 V 
was applied. For MAIV operating at atmospheric pressure, the LockSpray ESI source 
was removed and overridden.
117
 A modified skimmer cone was used as previously 
introduced to provide better vacuum, with a notch to allow air flow.
255
 
A nanoAcquity UPLC system (Waters, Milford, MA) equipped with a 1 mm x 50 mm 
column packed with 1.7 µm C18 BEH particles was used for LC-ESI-MS/MS 
quantification. A 3 min gradient using ACN/H2O/0.1% formic acid (organic composition 
from 40% to 95%) was employed similar to a previous study using the same system.
112
 
An optical microscope (Nikon, ECLIPSE, LV 100) was used to determine the 
diameters of the surface areas analyzed. Luxol fast blue was doped into extracting solvent 
and matrix solution to enhance the optical microscopic image by leaving the blue color 
on the extraction area. 
Sample Preparation 
Sample Preparation and Clozapine Quantification using LC-ESI-MS/MS 
Half of a tissue section was scraped from the glass slide holding the tissue and 
dissolved in 50 µL MeOH. The mixture was vortexed for 1 min before being loaded in 
centrifuge for 5 min. The supernatant was used for quantification. The other half was 
reserved for surface analysis (Scheme 8.1.I and II.C). 
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The calibration curve was obtained by LC-ESI-MS/MS using clozapine standard 
solutions at concentration of 10, 25, 50, 100, and 200 fmol µL
-1 
plotted
 
against peak area. 
For sample work-up, 1 µL supernatant was diluted by 20-fold and 1 µL was injected onto 
the UPLC column. For the comparison with surface SAII quantification, 1 µL MeOH was 
used to extract material from the tissue section from drug-treated mouse. The 1 µL 
solution was diluted by 147-fold before injected into UPLC system. All the LC-MS/MS 
analyses were performed in triplicates. 
Surface Sample Introduction Methods based on SAII 
Surface SAII in discontinuous mode. Solution of 0.3 µL of MeOH hanging from a 
pipet tip was touched to a control mouse brain tissue section to allow the droplet to 
extract material from the surface (Scheme 8.1. II.A). The MeOH droplet was held still 
touching the surface of the mouse brain tissue for about 3 seconds before it was drawn 
back into the tip. The solvent-containing extracted material was subsequently directly 
transferred into the heated inlet capillary of the LTQ Velos by placing the pipet tip near 
the entrance aperture where the droplet was drawn immediately into the inlet by the 
vacuum of the mass spectrometer, inducing ionization in the inlet tube.  
Surface SAII in continuous mode. Two pieces of 20 cm long fused silica tube (75 µm 
i.d., 360 µm o.d., Polymicro Technologies, Phoenix, AZ) were taped near the ends at 
~90º to keep a distance of about 1 mm between the two ends. Methanol was pumped 
through one piece of fused silica tube by a syringe pump (Fusion 400, Chemyx Inc., 
Stafford, TX) at 5 µL min
-1
 flow from the non-taped end. The non-taped end of the other 
piece of fused silica tube was inserted about 0.2 mm inside the mass spectrometer inlet. A 
liquid junction bridge of the solvent was formed between the tips of the silica tubes with 
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the assistance of the vacuum in the mass spectrometer. A constant flow of MeOH was 
created between the tips so that the formed liquid junction droplet touched against the 
drug-treated mouse brain tissue section. Material from the surface was continuously 
extracted by the liquid junction, and the solvent containing the extracted material was 
transferred to the mass spectrometer through the second fused silica tube (Scheme 8.1. 
II.B).  
Quantification by SAII 
Isotope dilution and standard addition were used to quantify clozapine from drug-
treated mouse brain tissue. Stock solutions of clozapine and clozapine-d8 were prepared 
in EtOH and acetone at 1 mg mL
-1
, respectively. The stock solution was diluted to 20 
pmol µL
-1
 by water, and MeOH was used for further dilutions. Five standard solutions 
were prepared. In each single solution, the concentration of clozapine-d8 was held 
constant at 2 pmol µL
-1
 and the concentration of clozapine was varied. The final 
clozapine:clozapine-d8 molar ratios were 0:1, 0.5:1, 1:1, 1.5:1, and 2:1. 
For the quantification from solution, 0.5 µL of each solution was drawn into the 20 
µL pipet tip (Fisher Scientific, Pittsburgh, PA) and directly introduced into the heated 
inlet tube of the LTQ Velos. Eight repetitive measurements were performed from each 
clozapine/clozapine-d8 standard and the ion intensities of the singly charged protonated 
ions from clozapine (m/z 327) and clozapine-d8 (m/z 335) were recorded. The intensity 
ratio at m/z 327:335 was calculated for each measurement and averaged. The average 
intensity ratio at m/z 327:335 is plotted versus the concentration ratio of m/z 327:335, and 
the standard deviation was used to represent the error bar. 
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For the quantification from mouse brain tissue, 1 µL of each solution was drawn into 
a long-tailed ultra micro gel tip (Genesee Scientific, San Diego, CA) and carefully 
deposited on the sample surface. About 0.8 µL of the standard solution was picked up by 
the same pipet tip after ~3 seconds and introduced into the heated inlet. The signals were 
plotted the same way as using solution directly from the vial. The amount of clozapine 
extracted from the surface is determined by extending the calibration curve to find the 
intersection with the X-axis. Both the vehicle and drug-treated mouse brain tissue 
sections were analyzed with the vehicle mice serving as the control. 
Scheme 8.1. Schematic representation of the workflow of SAII and typical LC-
tandem MS methods. (I) Half of the brain tissue section from drug-treated mouse was 
scraped off from the glass slide, the other half was preserved for surface analysis. (II) 
From the preserved tissue section, surface SAII was performed in (A) discontinuous 
mode – extracting materials by solvent-droplet hanging at the pipet tip, and (B) 
continuous mode – extracting by liquid junction formed at the end of two pieces of 
silica tube. MS and MS/MS were performed in continuous mode. (C) Typical sample 
work-up was performed with the scraped tissue, the supernatant after vortex and 
centrifugation was analyzed by either LC-ESI-MS/MS
 
or SAII direct injection.   
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Surface Analysis and Quantification by MAIV 
MAIV operating from intermediate pressure vacuum: A series of standard mixtures of 
clozapine:clozapine-d8 at different concentration ratios were used. The concentration 
ratios were the same as in SAII (0:1, 0.5:1, 1:1, 1.5:1, 2:1), but at double the 
concentration. The standard clozapine:clozapine-d8 mixture was pre-mixed with a 3-
NBN solution made by dissolving 5 mg in 100 µL ACN at 1:1 volume ratio. A solution 
of 0.5 µL matrix/clozapine:clozapine-d8 mixtures was spotted on the tissue section. The 
tissue section was loaded into the vacuum of the MALDI source after spotting each 
standard, and data acquisition was started as soon as the sample plate was indexed in the 
source. The mass spectrum was acquired for about 2 min. Brain tissue sections from both 
control and drug-treated mice were analyzed the same way. 
Scheme 8.2. Schematic representation of workflow of MAIV methods. (A) The solution 
of 0.5 µL 3-NBN/clozapine:clozapine-d8 mixture was spotted on tissue surface and 
loaded into the vacuum of an intermediate pressure MALDI source. (B) Four 1 µL 3-
NBN/clozapine:clozapine-d8 solutions were spotted on the tissue surface covering half of 
the tissue section, and exposed to vacuum of a modified skimmer cone of the overridden 
ESI source. 
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MAIV operating from atmospheric pressure: The calibration curve was obtained 
using control mouse brain tissue sections. A series of standard solutions of 
clozapine:clozapine-d8 were prepared at the concentration ratio of 0:1, 1:1, 2:1, 3:1, with 
the concentration of clozapine-d8 held at 4 pmol µL
-1
. The standard clozapine:clozapin-
d8 solution was also pre-mixed with the 3-NBN solution. Four 1 µL 
matrix/clozapine:clozapine-d8 mixtures were spotted on the tissue surface. Half of the 
tissue section was covered by this procedure. The tissue with half of it covered by the 
matrix/clozapine:clozapine-d8 mixture was exposed to vacuum. This was accomplished 
by holding the glass slide against the modified skimmer cone where it was held by the 
vacuum for 10 minutes. For the quantification from the brain tissue section of drug-
treated mouse, half of the tissue section was covered by the mixture of 3-NBN and 4 
pmol µL
-1
 clozapine-d8 at 1:1 volume ratio. The signal intensity ratio at m/z 327:335 was 
recorded and the amount of clozapine was quantified by standard addition method from 
the calibration curve.  
8.3 Results and Discussion 
SAII has been reported to produce ESI-like ions by injecting analyte solution into a 
heated inlet of a mass spectrometer.
197,253
 For analytes on a surface, such as tissue 
sections, liquid extraction using proper solvents can be employed prior to SAII. The 
material on the surface of a 20 µm-thick brain tissue section of a drug-treated mouse was 
extracted by a MeOH droplet hanging from the pipet tip followed by transfer to the 
heated inlet tube (Scheme 8.1.II.A). Data acquisition of the software was initiated before 
surface extraction, therefore the total ion chronogram (TIC) reflects the entire duration of 
sample analysis from exposure of solvent to surface to the ionization in inlet, which was 
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only about 25 seconds as shown in Fig. 8.1A. The mass spectrum having good ion 
abundances is dominated by phosphatidylcholines along with protonated clozapine and 
alkali-adducted cholesterol (Fig. 8.1B). The lipid peaks were assigned according to 
previously published data
256
 and no phosphocholine head group fragment (m/z 184) was 
observed, unlike MALDI.
257
 Tandem MS using CID was performed on the most 
abundant lipid peak at m/z 798. MS
2
 on the parent ion produced mainly a loss of 59, and 
MS
3
 on the major fragment ion at m/z 739 generated a fragment with a loss of 183 
(Figure S8.1 in Appendix E). The loss of trimethylamine (Δm/z=59) and phosphocholine 
head group (Δm/z=183) are characteristic for sodiated phosphatidylcholines.258 The inset 
spectrum shows clozapine with its characteristic isotopic distribution. Brain tissue section 
from a drug-treated mouse, which was from the same batch but had been stored frozen 
for months at -80 °C, was analyzed in the same manner. The protonated clozapine ions 
were observed at lower ion abundance, likely because the drug has degraded over time 
(Figure S8.2 in Appendix E).  One of the major clozapine metabolites, clozapine N-
oxide,
259
 was also observed having the characteristic chlorine isotopic distribution. 
Sodiated and potassiated cholesterol were assigned similar to an ambient infrared 
MALDI surface study.
260
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Figure 8.1. Fast surface assessment using a SAII method employing surface 
extraction by 1 µL of MeOH in discontinuous mode as shown in Scheme 8.1. II.A. 
(A) TIC of the entire duration of sample analysis including exposure of solvent to 
surface to ionization in inlet. (B) Mass spectrum extracted from the TIC with the inset 
showing the isotopic distribution of protonated clozapine ions. The blue number on 
the top right corner denotes ion abundance. 
The material was sampled directly from the tissue surface at ambient conditions, and the 
mass analysis was obtained without the requirement of any voltage or extra connections 
between surface sampling and sample introduction. The analysis was soft enough to 
maintain the intact analyte structures with less chemical background. Neither cholesterol 
fragment with the loss of water nor water clusters was detected as observed with 
ionization methods employing matrix and/or a laser.
240,260
 This method is discontinuous 
as solvent/lipid droplets are analyzed individually, yet it is a very simple sampling and 
ionization approach.  
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A continuous surface SAII sampling method was achieved by the configuration 
shown in Scheme 8.1. II.B. A liquid junction is formed at the mouse brain tissue surface 
by interfacing two pieces of fused silica tubing. Here, the glass plate containing the 
mouse brain tissue section was hand held and manually moved over the surface to 
analyze different areas. The TIC in Figure 8.2A shows the constant ion production for 
about 1 min acquisition time. The mass spectrum from time point 0.37-0.86 min was 
extracted from the TIC (Figure S8.3 in Appendix E) showing similar ions from lipids 
and clozapine as discussed above, but at lower ion abundance. This may be due to the 
shorter time the liquid remains on the surface, so that less material is extracted. Structural 
characterization of clozapine present in the drug-treated mouse brain tissue was 
confirmed by fragmenting the peak at m/z 327 (Figure 8.2B.1) using CID. The fragment 
ions produced at m/z 270 and 296 were identical to those of a purchased standard (Figure 
8.2B.2).
23
 
The method development using direct pipetting SAII for quantification of drugs was 
first established using standard clozapine:clozapine-d8 solutions from vials. The solution 
of 0.5 µL clozapine and clozapine-d8 mixture at a certain concentration ratio was directly 
introduced into the inlet of the mass spectrometer. As shown in Figure S8.4 in Appendix 
E, at a concentration ratio of 0.5:1, the protonated peak height of clozapine (m/z 327) 
versus clozapine-d8 (m/z 335) is approximately 0.54 (Figure S8.4A in Appendix E), 
while a 1:1 concentration ratio results in the ion intensity ratio of approximately 1.08 
(Figure S8.4B in Appendix E).  
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Figure 8.2. Fast surface assessment using the SAII method employing surface 
extraction by 1 µL of MeOH in continuous mode as shown in Scheme 8.1. II.B. (A) 
TIC of the whole analysis for ~1.4 min. (B) SAII-CID-MS of the protonated 
clozapine ions (1) directly extracted from tissue surface and (2) from synthesized 
clozapine chemical solution. The blue numbers on the top right corner denote ion 
abundances. 
The average of the signal intensity ratio from 8 repetitive measurements of each standard 
was plotted against the concentration ratio of clozapine:clozapine-d8 in Figure 8.3A. The 
high regression coefficient (R
2
=0.9929) and small error bars demonstrate the 
reproducibility of the SAII method for quantification. Using this calibration curve, an 
unknown sample from a tissue section of a drug-treated mouse was analyzed. One µL 
supernatant from half of the tissue section scraped off the glass slide was mixed with 1 
µL of 4 pmol µL
-1
 clozapine-d8 solution producing a mixture containing 2 pmol µL
-1
 
clozapine-d8. This solution was injected into the heated inlet. A signal intensity ratio of 
0.694:1 at m/z 327:335 was obtained, reflecting the concentration of clozapine in the 1 
µL extraction solution to be 1.27 pmol µL
-1
. In comparison, another 1 µL of the same 
supernatant was further diluted by 20-fold and quantified by LC-MS/MS (Figure 8.3B). 
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The concentration of the supernatant was determined to be 1.33 pmol µL
-1
. The total 
analysis time spent on the SAII approach was only about 1 min for 5 replicates, where the 
LC-MS/MS method took more than 30 min for triplicate analyses. 
 
Figure 8.3. Calibration curves of clozapine (A) using SAII by pipetting standard 
clozapine:clozapine-d8 solutions at different concentration ratio with clozapine-d8 at 
2 pmol µL
-1
, signal intensity ratio is plotted against concentration ratio; and (B) using 
LC-ESI-MS/MS with standard clozapine solutions at different concentration, peak 
area of the fragment ion at m/z 270 is plotted against concentration. 
The other half of the 20 µm-thick tissue section was analyzed by surface analysis 
methods. The same series of standard solutions of clozapine:clozapine-d8 were used to 
extract material from the surface instead of pure MeOH solvent. As a control experiment, 
the control tissue, for which the mouse was not treated with clozapine before sacrificing, 
was analyzed first. When the solution of 1 µL clozapin:clozapine-d8 mixture at the 
concentration ratio of 0.5:1 was used to extract material by contacting the surface for ~ 3 
s and then transferred to the mass spectrometer inlet, the signal intensity ratio at m/z 
327:335 obtained was 0.52:1 (Figure S8.5A in Appendix E), indicating no external 
clozapine was detected after extraction. When the tissue section from drug-treated mouse 
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was extracted by the same standard clozapine:clozapine-d8 mixture, the signal intensity 
ratio increased to 2.20:1 (Figure S8.5B in Appendix E). The concentration ratio (X) was 
plotted against the ion intensity ratio (Y) (Figure 8.4) with control tissue (red square) and 
drug-treated tissue (blue triangle). The curve from drug-treated tissue has a significant 
increase, indicating clozapine was extracted from the surface by the standard solutions. 
Although only one measurement was taken from each standard solution, the linearity 
(R
2
=0.9374) was confirmed by the high reducibility of this method (Figure 8.3A). The 
amount of clozapine extracted by 1 µL solution was calculated by extending the 
calibration curve to the x-axis. The intersection shows 2.68 pmol of clozapine was 
extracted from the surface area of about 1.5 mm in diameter (Figure 8.4 inset) as 
determined using optical microscopy. For a comparison with the LC-MS/MS method, 
one µL pure MeOH was used to extract clozapine from the surface and analyzed by LC-
MS/MS after a 147-fold dilution. The amount of clozapine extracted by the 1 µL MeOH 
was calculated as 2.58 pmol from the calibration curve. 
The amount of clozapine quantified from surface extraction of the right half of the 
tissue section is similar between SAII-MS and LC-MS/MS methods (2.68 pmol using 
SAII vs. 2.58 pmol using LC-MS/MS from surface extraction), indicating the reliability 
of the SAII method but at much faster analysis speed. However, the amount from 1 µL 
solvent extraction on the right half is not reflective of the results obtained from the 1 µL 
supernatant using traditional sample work-up and LC-MS/MS of the left half of the 
section (2.68 pmol using SAII from surface extraction vs. 1.33 pmol using LC-MS/MS 
from supernatant). We hypothesize that only the clozapine on the surface of the tissue 
section was extracted by the surface extraction method. In contrast, when tissue section 
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was scraped off, vortexed and centrifuged, the extracted clozapine is not limited to the 
surface. To test our hypothesis, another set of tissue sections that were 10 µm-thick from 
a drug-treated mouse were analyzed in the same manner.  
 
Figure 8.4. The right half of a 20 µm brain tissue section from drug-treated mouse 
was quantified by SAII method in discontinuous mode as shown in Scheme 8.1. II.A. 
Solution of 1 µL of each of the four standard clozapine:clozapine-d8 mixtures at 
different concentration ratios was used for surface extraction and then pipetted into 
the heated inlet of the mass spectrometer. Calibration curves were obtained by 
plotting the signal intensity ratio against the concentration ratio. A brain tissue section 
from a normal mouse was used as control. The inset shows an optical microscopy 
image to illustrate the extracted area. For enhanced image, 1 µL MeOH was doped 
with Luxol fast blue and the droplet was not removed from surface. 
Table 8.1 shows the comparison of 10 µm and 20 µm-thick tissue sections, using both 
the typical sample work-up and the novel surface SAII method. Thicker tissue results in 
more clozapine extracted by vortex and centrifugation. The amount obtained from the 20 
µm-thick tissue is approximately twice that of the 10 µm tissue as determined by LC-
MS/MS using the traditional tissue work-up. In contrast, the amount of clozapine 
extracted from the surface was not significantly different (2.84 pmol for 10 µm and 2.68 
pmol for 20 µm). This result indicates that the amount of clozapine determined by surface 
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SAII is the amount per unit area that was extracted, and was not limited by tissue 
thickness, at least for sections of 10 µm or greater.  
Table 8.1. Amounts of clozapine quantified by typical LC-ESI-MS/MS (Scheme 8.1. 
II.C) and surface SAII in discontinuous mode (Scheme 8.1. II.A). 10 µm and 20 µm 
tissue sections were analyzed. For LC-ESI-MS/MS, the left half of the tissue section 
was scraped off, dissolved in 50 µL MeOH, vortexed and centrifuged, results showed 
the amount in pmol per µL supernatant. For surface SAII, results showed the amount 
in pmol per µL solution used for surface extraction.  
Thick-
ness 
 
LC-ESI-MS/MS from 
scraped tissue 
Amount of clozapine in  
1 µL supernatant 
Surface SAII 
 
Amount of clozapine extracted 
by 1 µL standard solution 
10 µm  0.725 pmol 2.84 pmol 
20 µm  1.33 pmol 2.68 pmol 
 
SAII used in surface analysis and quantification is a simple and fast assessment but 
limited to mass spectrometers equipped with a heated inlet tube. On instruments without 
a commercially available heated inlet, MAIV has been demonstrated to produce ESI-like 
ions directly from surfaces, including mouse brain tissue sections.
117,120
 The 
quantification of clozapine using MAIV was first achieved on the intermediate pressure 
vacuum MALDI source of a SYNAPT G2 instrument. The mixture of individual standard 
clozapine:clozapine-d8 solutions mixed with 3-NBN matrix solution was spotted on the 
control and drug-treated tissue sections and loaded into the vacuum using a MALDI plate 
loader but without use of the laser. From each single matrix/clozapine:clozapine-d8 spot, 
the mass spectrum was extracted over the sublimation period of time (ca. 2 min). An area 
of about 1 mm
2
 covered by 3-NBN matrix was analyzed: matrix uncoated parts of the 
tissue do not produce ions. The signal intensity ratio at m/z 327:355 was plotted against 
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the concentration ratio of clozapine:clozapine-d8 from the standard solution (Figure 8.5). 
The amount of clozapine from each spotted area was determined as 1.48 pmol from the 
plots. Miniaturization of the tissue area covered by the matrix can be employed to 
improve the spatial resolution of the analysis.
117
  
 
Figure 8.5. 20 µm brain tissue sections from drug-treated and control mice were 
analyzed by MAIV operating at intermediate pressure. Solution of 0.5 µL 3-
NBN/clozapine:clozapine-d8 mixture was spotted on the tissue section and the 
sample was loaded into the commercially available vacuum chamber (Scheme 8.2.A). 
The matrix sublimed in approximately 2 min. The ion intensities of clozapine and 
clozapine-d8 were averaged over the 2 min acquisition, and the intensity ratio was 
plotted against concentration ratio. Insets show the microscopy images of the 
matrix/clozapine:clozapine-d8 spotted on tissue section before and after MAIV 
analysis. 
MAIV on the vacuum source produced better linearity (R
2
=0.9797) than SAII, 
because the average ion intensity summarized over a longer period of time provides 
better reproducibility. However, the operation of MAIV on the commercial vacuum 
MALDI source is time consuming and a significant amount of analyte is potentially 
wasted in the 2 min loading time.
117
 Only one matrix/clozapine:clozapine-d8 mixture can 
be spotted for each loading, otherwise all the spots would sublime simultaneously. To 
achieve the goal of simpler assessment from the surface, the ESI source was overridden 
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and employed for MAIV operating from atmospheric pressure as described previously.
119
  
The source temperature was held at 80 ºC, and a sealed vacuum outer skimmer cone with 
a notch
115
 to allow air flow was used for operation. Four 1 µL clozapine:clozapine-d8 
solutions mixed with 3-NBN were spotted on a tissue section (control and drug-treated, 
respectively) and covered half of the tissue section completely. The glass slide tissue 
holder was sealed to the notched cone by the vacuum for a 10 min analysis. The total 
analysis results of the 10 µm-thick brain tissue from drug-treated mouse are shown in 
Figure S8.6 in Appendix E as an example. The matrix sublimed over this 10 min period 
of time as shown in the TIC (Figure S8.6.I in Appendix E). Extracted clozapine, the 
standard clozapine-d8, cholesterol, and lipids were observed from the total mass 
spectrum and the two-dimensional plot of drift time vs. m/z (Figure S8.6.II in Appendix 
E). Particularly, lipids were not directly observed from mouse brain tissue sections in 
positive mode and the same heat-limited mass spectrometer.195  The nested dataset
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extracted from the two-dimensional plot (Figure S8.6.II.B insets in Appendix E) allows 
the identification of clozapine and clozapin-d8 without additional time requirement. The 
calibration curve was obtained using four standard clozapine:clozapine-d8 mixtures of 
different concentration ratios on control tissue sections (Figure 8.6). The amount of 
clozapine was determined by the standard addition method by spotting four 1 µL 3-
NBN/clozapine-d8 mixture on half of the tissue section. The quantification of this 
method from 10 µm- and 20 µm-thick tissue sections did not show much difference (20.0 
pmol for 10 µm and 19.4 pmol for 20 µm), indicating that the same amount of matrix 
also extracts similar amount of clozapine only from the surface, regardless of the tissue 
thickness.  
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Figure 8.6. Calibration curve obtained by spotting 4 µL 3-NBN/clozapine:clozapine-
d8 mixture on control mouse brain tissue sections. The glass slide holding the half-
covered tissue was then sealed to the vacuum on a modified skimmer cone and let 
sublime for 10 min (Scheme 8.2.B). Ion intensity ratio was plotted against 
concentration ratio. The red triangle and hollow square show the results obtained 
from 10 µm and 20 µm tissue sections, respectively, from the drug-treated mouse 
using standard addition method. The inset shows a picture of the modified skimmer 
cone and a half-covered tissue section. 
In comparison to SAII using liquid extraction, the amount of clozapine extracted by 
MAIV is much higher. This is not only due to the fact that larger area was covered by 
matrix, but also that more material was extracted for the same unit area when matrix was 
employed. To further confirm our observation, the tissue, after surface extraction by SAII 
and MAIV, was cut through the center breaking the glass slide, and the cross section was 
examined under the microscope to determine the depth of droplet and matrix penetration 
(Figure S8.7 in Appendix E). SAII on the 20 µm-thick tissue section, only ~3 µm had the 
color from the doped Luxol fast blue dye indicating the wet area indicating the surface 
extracted area in SAII (Figure S8.7.A in Appendix E). MAIV provides a result with 
larger amount of clozapine than SAII, indicating that the matrix/clozapine:clozapine-d8 
mixture went deeper into the tissue than solvent-extraction. Previous studies have shown 
that MAIV can be destructive to tissue sections,
117
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image shows a deeper extraction for about 7 µm (Figure S8.7.B in Appendix E), more 
than twice as deep compared to SAII liquid extraction.   
8.4 Conclusion 
Rapid and efficient surface assessment is achieved by surface SAII and MAIV 
ionization methods. The surface quantification methods demonstrated in this work are 
potentially useful where fast analysis is valued, e.g. disease diagnosis or drug screening; 
one just needs to have the criterion of amounts of analyte per unit area of the surface 
(instead of per unit weight tissue, or volume) from healthy and diseased/treated tissue.  In 
this case the thickness of the sample (>10 µm) has little impact on the analysis. With this 
approach, the tissue need not be sectioned to a certain thickness for quantification. 
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Chapter 9 
CONCLUSION AND FUTURE PROSPECTUS 
Novel ionization methods have been developed to produce ESI-like ions of biological 
materials from AP and vacuum conditions for use in MS. The newly developed ionization 
methods have been interfaced to a variety of commercially available mass spectrometers 
from different vendors to utilize their features.  
Inlet ionization methods operate from AP and are beneficial for the instruments 
equipped with a heated inlet capillary. Ionization occurs in the heated inlet, with the 
assistance of the pressure drop from AP to the first vacuum stage of the mass 
spectrometer, regardless how the analyte is introduced into the inlet, with or without the 
use of a laser, from the solid or solution state. The first example of total solvent-free 
analysis by LSI-IMS-MS showed the production of multiply charged ions from solid state. 
Insoluble compounds, e.g. membrane proteins from brain tissue, could benefit from the 
solvent-free sample preparation.    
For solution samples, the independence of any extra connection or voltage greatly 
simplified the sample introduction method. Comparable sensitivity can be achieved by 
nanoLC-SAII as by nanoESI, with much less labor force and expense. NanoLC-SAII 
could potentially be employed for e.g. mammalian proteomics where the amount of 
proteins that can be obtained is limited. The automated analysis by multiplexing SAII and 
the mapping approach may potentially advance in any field that fast analyses are valued, 
e.g. pharmaceutical or clinical analyses, for the merit of its simple of use, low 
consumables cost, and little expertise required.  
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Although a liquid sample introduction method, SAII also shows its application in fast 
surface assessment by incorporating liquid-surface extraction. This ionization method is 
not only fast but also softer than traditional ionization techniques. The typical isotope 
dilution and external addition methods were well suited in this SAII approach to quantify 
the drug from drug-treated tissue surface. Comparable results were obtained by SAII and 
typical LC-ESI, but SAII takes much shorter time.   
Vacuum ionization methods operating at AP or vacuum makes use of proper matrix 
and the vacuum which any mass spectrometer has to produce ESI-like ions from solid 
state. High performance mass spectrometer was used to obtain multiply charged ions 
from solid state while maintaining the high mass resolving power. The mass resolution 
achieved by FT-ICR is beneficial for e.g. proteomics by this hyphenated method with 
MAIV, especially for those the solubility in sprayable solvent is restricted. The 
instantaneous and continuous ion formation is favored by electron capture dissociation 
that is currently available on FT-ICR instruments, too.   
 In summary, new ionization methods have shown advantages such as simple of use, 
low cost, and ready to be coupled with other analytical techniques, etc. that provide the 
potential for real world application. As listed in the “Holy Grail” in Scheme 1.1, for 
example, sensitivity and dynamic range should be extended, so that some component in 
low abundance from a complex environment, such as proteins from brain tissue, can be 
detected besides the dominant lipids. The hyphenation of novel ionization methods with 
other analytical techniques and high performance instrument is valuable for the analysis 
of complex materials, e.g. interfacing UPLC with IMS-MS by MAIV could also free the 
ionization from the restriction of spray conditions. Coupling the mentioned techniques 
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with high mass resolution instrument and tandem MS could be greatly advantageous for 
proteomics. Reproducibility should be improved for direct quantifications, ideally 
without the need to add external standards. The spatial resolution of the surface analysis 
approaches should be improved by employing a laser or miniaturizing solvent/matrix 
deposition, so that the methods could be utilized for diagnoses of diseased tissue from the 
healthy. The speed, simplicity, robustness, automation, low-cost will always be favorable 
for e.g. pharmaceutical industry and drug discovery. With these being said, we have just 
begun scratching the surface, there are a lot more needed to be studied. 
Scheme 1.1 Technology development needed to expand the use of MS for 
clinical applications [Adopted from Reference 18]. Points highlighted in blue 
will need further investigation. 
 
 
 
  
A. Sensitivity and dynamic range: to observe all components (e.g., 
lipids and proteins, hydrophilic and hydrophobic, low and high 
abundance) directly from native and complex environment (e.g., tissue, 
plasma, serum, urine), improvements needed include:
1. Separation: to deal with complexity and isoforms (LC, mass 
resolution, IMS)
2. Specificity: fragmentation (MS/MS: CID, ETD) for confirmation 
and ID (bottom up, top down)
3. Reproducibility: for quantitation
4. Spatial resolution: for location (with and without a laser)
B. Speed: of data acquisition and interpretation
C. Robust, simple and cheap: automation, disposables
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APPENDIX A 
TOTAL SOLVENT-FREE ANALYSIS SUPPLEMENTAL INFORMATION 
 
 
Figure S4.1. Solvent-based LSI-IMS-MS analysis of angiotensin I. (A) Total mass 
spectrum and (B) 2-D plot of drift time versus m/z. 
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Figure S4.2. (A) Solvent-based LSI-IMS-MS analysis and (B) ESI-IMS-MS of NAC. (1) 
Total mass spectrum and (2) 2-D plots of drift time versus m/z. 
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Figure S4.3. (A) Solvent-based LSI-IMS-MS analysis and (B) ESI-IMS-MS of BI. (1) 
Total mass spectrum and (2) 2-D plots of drift time versus m/z. 
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Figure S4.4. Total solvent-free analysis spectra of angiotensin I using 2,5-DHAP matrix 
under different grinding time and frequency on SYNAPT
TM
 G2 instrument. 
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Figure S4.5. Total solvent-free analysis spectra of angiotensin I using (A) and (B) 2,5-
DHB matrix, (C) 2,5-DHAP under 25 Hz, different grinding times and capillary 
temperature on LTQ-Velos instrument. 
  
1296.862 min 275℃ 
+1+2
500 1000m/z
0
100
649.01
2 min 400℃
+2
+1
500 1000m/z
0
100
1296.86
649.01
10 min 400℃ 
+1
+2
500 1000m/z
0
100
649.01 1296.94
100
10 min 150℃
+2
+1
500 1000m/z
0
1296.77
648.93
2 min 150℃
+1
500 1000m/z
0
100
1296.77
2 min 40℃
500 1000m/z
0
100
1297.86
+1
10 min 40℃
500 1000m/z
0
100
1296.94
+1
10 min 275℃+2
+1
500 1000m/z
648.93
1296.77
0
100
500 1000m/z
0
100
648.93
433.01
1296.77
10 min 150 ℃
+1
+2
+3
500 1000m/z
0
100
648.93
433.01
1296.77
10 min 275 ℃
+1
+2
+3
500 1000m/z
0
100
648.93
433.01
1296.85
10 min 400 ℃
+1
+2
+3
DHB 25Hz DHB 25Hz
500 1000m/z
0
100
648.93
433.01
1296.77
10 min 40 ℃
+1
+2
+3
DHAP 25HzA. B. C.
Figrure S5
132 
 
 
 
Figure S4.6. Microscopy of liquid droplets produced by the ablation of (A) 2,5-DHB and 
(B) 2,5-DHAP after the matrix had been ground for 10 minutes in TissueLyser II. 
 
 
 
Figure S4.7. Microscopy of the ablation plume from 2,5-DHB after the matrix was 
ground for 30 seconds in (A) TissueLyser II and (B) Vortexer.  
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Figure S4.8. Solvent-free LSI-MS mass spectrum of angiotensin I acquired (A) with IMS 
and (B) using TOF mode only (without IMS). 
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Figure S4.9. Solvent-based LSI-IMS-MS analysis of a lipid (sphingomyelin, SM) and a 
peptide (angiotensin I) mixture. (A) Total mass spectrum and (B) 2-D plots of drift time 
versus m/z. 
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Figure S4.10. Solvent-free LSI-IMS-MS analysis of (A) vegetable oil and (B) motor oil.     
(1) Total mass spectrum and (2) 2-D plots of drift time versus m/z. 
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Figure S4.11. LSI-IMS-MS of (A) crude petroleum oil using solvent-free sample 
preparation with 2,5-DHAP matrix; (B) crude oil using solvent-based sample preparation 
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with 2,5-DHAP matrix and (C) 2:1 toluene/methanol solvent with 2,5-DHAP matrix; left 
panel (1) Total mass spectra and right panel (2) 2-D plots of drift time versus m/z. 
 
  
138 
 
APPENDIX B 
LC-SAII SUPPLEMENTAL INFORMATION 
 
 
 
Figure S5.1. Ion intensity changes with the distance between the silica tube tip and the 
entrance of the inlet to the mass spectrometer.  
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Figure S5.2. SAII-MS of ubiquitin.  The liquid solvent/analyte droplet is placed with a 
pipette tip (10 uL plastic tip) vertically just outside of the mass spectrometer inlet and 
slowly pipetted off.  The droplets formed are vacuum drawn into the inlet of the mass 
spectrometer where inlet ionization of the analyte occurs.  Solutions of 5 pmol ubiquitin 
(10 µL) were used.  Depending on the solution conditions and inlet temperature the 
abundance of the highly charged ubiquitin ions varies; less volatile solvent conditions 
require higher inlet temperatures:  (A) ubiquitin in 100% water solution and (1) 300 °C 
and (2) 450 °C and (B) ubiquitin in 50:50 ACN/H2O in 1% formic acid solution and (1) 
50 °C and (2) 300 °C applied on the inlet of the mass spectrometer. In pure water, Na
+
 
adducts are in high abundance lowering the overall intensity of any single peak.  Addition 
of formic acid as shown in B almost eliminates the Na
+
 adducts.  
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Figure S5.3. Picture showing the setup for LC-nSAII:  Front view of Waters 
NanoAcquity liquid chromatography, Thermo LTQ-Velos mass spectrometer and, here, 
an automated x,y,z-stage for alignment of tip (Figure 1a) and the “picotip” extension 
(Figure 1b) of the fused silica capillary tube of the LC column placed about 0.1 mm out 
of the orifice inlet entrance of the mass spectrometer.   
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Figure S5.4. LC-SAII-MS of 100 fmol µL
-1 
BSA tryptic digest acquired on the Thermo 
LTQ Velos mass spectrometer. (A) The base peak chromatogram of 1 µL injection at 0.8 
µL min
-1 
flow rate; (B) the base peak chromatogram of 1 µL injection at 1.2 µL min
-1 
flow rate. The m/z of the most intense peak from the mass spectra of each LC 
chromatographic peak is labeled at the top of the peak. The mass range for MS data 
acquisition is 555-1600.  
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Figure S5.5.  A 50 min LC run injecting 1 µL of a 100 fmol µL
-1
 BSA tryptic digest 
solution analyzed by LC-nSAII-MS at a mobile phase flow of 800 nL min
-1
.  (A) A 
section of the base peak chromatogram.  The start trigger for the mass spectral acquisition 
was the same as for the LC so that the inject time is included in the X-axis.  The most 
intense m/z obtained on the mass spectra for each chromatographic peak is labeled.  (B) 
Mass spectrum of the chromatographic peak at 17.8 min.    
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Figure S5.6.  Base beak chromatogram of LC-nESI-MS of 100 fmol µL
-1
 BSA tryptic 
digest on Waters SYNAPT G2 mass spectrometer. The skimmer temperature is held at 
150 ºC. (A) The base peak chromatogram of 1 µL injection at 800 nL min
-1 
flow rate; (B) 
the base peak chromatogram of 1 µL injection at 400 nL min
-1 
flow rate. Peaks are 
labeled with m/z values.  
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APPENDIX C 
HIGH THROUGHPUT MULTIPLEXING SAII SUPPLEMENTAL 
INFORMATION 
 
 
 
Scheme S6.1. Pictures of sample loading for SAII multiplexing using a 96-well plate. (A) 
Vials (1) or wells (2) filled with analyte solutions or pure solvents in a 96-well plate 
format. (B) Empty pipette tips mounted on another 96-vial plate (1). (C) Dip the tips into 
the sample vials. (D) Tips filled with about 3 µL solutions by capillary action and are 
ready to mount on the xy-stage.  
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Scheme S6.2. Pictures of sample loading for SAII multiplexing using a 384-well 
microtiter plate. (A) The workflow of sample preparation of clarithromycin tablet in the 
microtiter well plate. (B) 1 µL of each tablet solution and pure solvent was drawn into the 
8-channel pipette. (C) The pipette is mounted on the xy-stage with the tips aligned with 
the inlet orifice. 
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Figure S6.1. A mixture of phosphorylated peptides (angiotensin II, cholecystokinin (10-
20), and calcitonin (15-29)) was pipetted into the inlet (Scheme 1A) which was heated to 
250 °C. MS/MS spectra from the mixture of the doubly charged ions using CID are 
shown in this figure. (A) phosphorylated angiotensin II at collision energy 30, data 
acquired in the mass range of 155-2000; (B) phosphorylated cholecystokinin (10-20) at 
collision energy 20, data acquired in the mass range of 180-2000; and (C) phosphorylated 
calcitonin (15-29) at collision energy 20, data acquired in the m/z range of 245-2000;. 1 
µL of 2.5 pmol µL
-1 
solution was used for each acquisition. 
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Figure S6.2. SAII mass spectra of (A) 1 µL 2.5 pmol µL
-1
 myoglobin and (B) 1 µL 5 
pmol µL
-1
 carbonic anhydrase obtained by pipetting the solution into the inlet (Scheme 
1A) at an inlet temperature of 250 °C.  The blue number in top right corner denotes the 
ion intensity.  Data were acquired in the m/z range of 600-2000. 
  
A.
B.
1.94E3
600 1000 1400 1800m/z
0
100
%
1060.6942.8
1696.0893.4 1211.9
1541.81413.4808.3
1884.4
+15
+10
+20
+25
5.49E2
600 1000 1400 1800m/z
0
100
%
1452.11210.4
1320.1
1117.4
1613.21037.7 1814.5
1935.6
+32
+15
+20
+25
+30
148 
 
 
 
Figure S6.3. SAII mass spectra of (A) 5 pmol µL
-1 
angiotensin I in water at 150 °C, (B) 5 
pmol µL
-1 
 clozapine in chloroform at 250 °C with matching isotopic distribution, data 
acquired in the mass range of 100-1000.and (C) 1 pmol µL
-1 
ubiquitin in 90:10 
acetonitrile:water at 400 °C inlet temperatures.  1 µL solution of each solution was 
pipetted into the inlet (Scheme 1A).  Data were acquired in the m/z range of 150-2000.  
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Figure S6.4. pH study of (I) 5 pmol µL
-1
 bovine insulin and (II) 10 pmol µL
-1
 lysozyme 
using SAII-MS at an inlet temperature of 250 °C: pH: (A) 3 to 3.5, (B) ~4.5, (C) 6 to 6.8, 
(D) 9 to 9.3.  2 µL solution was pipetted into the inlet (Scheme 1A).  Data were acquired 
in the m/z range of 150-2000.  
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Figure S6.5. SAII mass spectra of (I) 5 pmol µL
-1
 bovine insulin in 50:50 
methanol:water with 1% acetic acid and (II) 10 pmol µL
-1
 lysozyme in 50:50 
acetonitrile:water with 0.1% formic acid at different inlet temperatures: (A) 150 °C, (B) 
250 °C, (C) 350 °C, and (D) 450 °C.  2 µL solution was pipetted into the inlet (Scheme 
1A).  Data were acquired in the m/z range of 150-2000. 
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Figure S6.6. SAII mass spectra of 10 pmol µL
-1
 lysozyme in water at different inlet 
temperatures: (A) 150 °C, (B) 250 °C, (C) 350 °C, and (D) 450 °C. 2 µL solution was 
pipetted into the inlet (Scheme 1A).  Data were acquired in the m/z range of 150-2000. 
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Figure S6.7. Multiplexing SAII-MS using the 8-channel pipette (Scheme 1B) at different 
inlet temperatures: (I) 250 °C, (II) 350 °C, and (III) 450 °C in a total of ~15 seconds. (A) 
The TIC and (B) mass spectra of the analysis of tips filled with (1) 2.5 pmol µL
-1
 leucine 
enkephalin, (2) 1 pmol µL
-1
 galanin, and (3) 1 pmol µL
-1
 ubiquitin with solvent between 
each two samples. 2 µL analyte/solvet was drawn into each pipet tip.  The maximum 
injection time was 100 ms.  Data were acquired in the m/z range of 150-2000. 
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Figure S6.8. SAII-MS using the 8-channel pipette (Scheme 1B) and an inlet temperature 
of 150 °C.  All three analytes were analyzed in a total of ~2 seconds. (I) The TIC of 5 tips 
filled with angiotensin I, bovine insulin, and ubiquitin with pure solvent between each 
two analytes. (II) Mass spectra extracted from (A) 0.26 min for 1 pmol µL
-1
 angiotensin 
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I, (B) 0.28 min for 5 pmol µL
-1
 bovine insulin with some angiotensin I cross 
contamination, and (C) 0.29 min for 1 pmol µL
-1
 ubiquitin.  2.5 µL analyte/solvent was 
drawn into each pipet tip.  The maximum injection time was 500 ms.  Data were acquired 
in the m/z range of 150-2000.  
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Figure S6.9. Mapping using the 8-channel pipette (Scheme 1B). The solutions were 
scanned from (I) low to high and (II) high to low concentrations. (A) Schematic 
representation of content in each pipette tip.  Red boxes indicate tips filled with 2 µL 
clozapine solutions at 25 fmol µL
-1
, 50 fmol µL
-1
, and 100 fmol µL
-1
, respectively; grey 
boxes represent pure solvent methanol. (B) The mapping of m/z 270 peak.  Note that the 
methanol solutions (grey boxes) furthest to the right in (I) and (II) are more intense than 
the prior methanol solutions (second last) suggesting that carryover are neglectable in 
both cases for the sample (samples solutions furthest to the right, red boxes).  Data were 
acquired in the m/z range of 90-345.  
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Figure S6.10. SAII-MS/MS of clozapine using the 8-channel pipette (Scheme 1B).  The 
protonated ions were selected and fragmented by CID using normalized collision energy 
of 30.  The maximum injection time was 100 ms. (A) 1 µL of 1 fmol µL
-1
 clozapine and 
(B) 3 µL of 0.5 fmol µL
-1
 clozapine was drawn into the pipette tip.  The inlet temperature 
was 250 °C.  Data were acquired in the m/z range of 100-400.   
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Figure S6.11. All six mass spectra (A to F) of 5 pmol µL
-1 
bovine insulin (in 
methanol/water with acetic acid) extracted from the repetitive six cycles of SAII 
multiplexing using a 96-vial plate (Scheme 1C) at the inlet temperature of 250 °C.  The 
numbers in blue in the top right corner indicate the ion intensity.  Data were acquired in 
the m/z range of 150-2000.  
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Figure S6.12. SAII-MS using 84 tips mounted on a 96-vial plate (Scheme 1C) when the 
inlet temperature was held at 250 °C in a total of ~ 10 min. (I) Total ion current. (II) 
Mass spectra of (A) 1 pmol µL
-1
 clozapine (in methanol), (B) 2.5 pmol µL
-1 
leucine 
enkephalin (in acetonitrile:water with formic acid), (C) 1 pmol µL
-1 
sphingomyelin (in 
methanol with acetic acid), (D) 1 pmol µL
-1 
galanin (in acetonitrile:water with formic 
acid), (E) 1 pmol µL
-1 
bovine insulin (in methanol:water with acetic acid), (F) 1 pmol µL
-
1 
ubiquitin (in acetonitrile:water with formic acid), and (G) 1 pmol µL
-1 
lysozyme (in 
acetonitrile:water with formic acid).  Data were acquired in the m/z range of 150-2000.  
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Figure S6.13. Mapping using the 96-sample plate shown in Scheme 1C. (A) Schematic 
representation of content in each pipet tip.  Red boxes indicate tips filled with clozapine 
solutions at 0.5, 5, 15, and 30 fmol µL
-1
, respectively; grey boxes represent pure solvent 
methanol. (B) The mapping of m/z 270 peak obtained by selecting the m/z 327 ([M+H]
+
 
ion) for CID fragmentation using normalized collision energy of 30.  The maximum 
injection time was 100 ms.  Data were acquired in the m/z range of 90-345.   
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APPENDIX D 
MAIV ON FT-ICR SUPPLEMENTAL INFORMATION 
 
 
 
 
Figure S7.1. MAIV mass spectrum of a mixture of peptides and proteins including: 
leucine enkephalin (Leu-enk), bombesin, allatostatin, and bovine insulin (BI).  The inset 
shows the +5 charge state of bovine insulin. 
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Figure S7.2. MAIV mass spectra (I) and the +4 inset (II) of bovine insulin using 
different plate voltages and data acquisition sizes. (A) 300 V plate voltage and 2 million 
acquisition size; (B) 300 V plate voltage and 512 thousand acquisition size; and (C) 240 
V plate voltage and 512 thousand acquisition size. 
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Figure S7.3. MAIV mass spectra of angiotensin mixture using different plate voltages 
and data acquisition sizes. (I) With 2 million acquisition size at (A) 0 V, (B) 200 V, (C) 
I. 2 million acquisition size II. 512 thousand acquisition size
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300V, (D) 400 V, and (E) 500V; (II) with 512 thousand acquisition size at (A) 210 V, (B) 
230 V, (C) 240 V, (D) 250 V, and (E) 300 V.   
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Figure S7.4. LSIV mass spectrum of 100 pmol ubiquitin using 2-NPG matrix 
summarizing 20 scans.  The laser power was 50%, the voltage applied on the target plate 
is 400 V, and data acquisition size was 512 thousand. 
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APPENDIX E 
QUANTIFICATION SUPPLEMENTAL INFORMATION 
 
 
Figure S8.1. Characterization of phosphotidycholine (34:1) extracted from the brain 
tissue section of a drug-treated mouse and pipetted into the heated inlet (Scheme 8.1. 
II.A). (A) MS
2 
by fragmenting the most abundant peak from Figure 8.1. B ([PC 34:1 + 
K]
+
) and CID was performed with CE=28. (B) MS
3
 by fragmenting the most abundant 
product ion at m/z 739 using CID with CE=28. The blue numbers on the top right corner 
denote ion intensities. 
 
  
M-59
M-183
MS2 @ 798 ([PC 34:1 + K]+ )
M-59
M-183
MS3 @ 798 @739, CE 28
A.
B. 
400 600 800 1000 1200 1400 1600 1800 2000m/z
0
100
%
739.4
615.3
200 300 400 500 600 700 800 900 1000
m/z
0
100
%
615.3
577.3
739.4
2.86E3
2.17E1
166 
 
 
Figure S8.2. Inset mass spectrum showing clozapine and one major metabolite, clozapine 
N-oxide, obtained by surface extraction of an aged brain tissue section from drug-treated 
mouse followed by SAII method in discontinuous mode (Scheme 8.1. II.A). The blue 
number on the top right corner denotes ion intensities.  
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Figure S8.3. Mass spectrum obtained by SAII in continuous surface extraction mode 
(Scheme 8.1. II.B).  A brain tissue section of drug-treated mouse was analyzed. The 
mass spectrum was extracted from 0.37 to 0.86 min from the TIC shown in Figure 8.2A. 
The blue number on the top right corner denotes ion intensity.  The peaks were assigned 
according to previous studies. No cholesterol fragment with the loss of water (at m/z 369) 
or water cluster background was detected as observed in typical MALDI analysis.  
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Figure S8.4. Mass spectra using SAII by pipetting 1 µL standard clozapine:clozapine-d8 
solution from the vial into the heated mass spectrometer inlet. The concentration ratio of 
clozapine:clozapine-d8 is (A) 0.5:1 and (B) 1:1 with the clozapine-d8 at 2 pmol µL
-1
. The 
ion intensity ratio at m/z’s 327:335 is approximately (A) 0.54:1 and (B) 1.08:1. The blue 
numbers on the top right corner denote ion intensities. 
  
7.39E3
310 315 320 325 330 335 340 345 350 355
m/z
0
100
%
335.4
327.4
337.3
329.4
A.
B. 
2.43E3
310 315 320 325 330 335 340 345 350 355
m/z
0
100
%
327.5 335.5
329.4
337.5
169 
 
 
Figure S8.5. Mass spectra using SAII in discontinuous mode (Scheme 8.1. II.A). The 
material was extracted by using 1 µL standard solution (clozapine:clozapine-d8 at 0.5:1 
with the clozapine-d8 at 2 pmol µL
-1
) from tissue section surfaces of (A) control and (B) 
drug-treated mouse and pipette into the heated mass spectrometer inlet. The ion intensity 
ratio at m/z’s 327:335 is approximately (A) 0.52:1 and (B) 2.20:1. The blue numbers on 
the top right corner denote ion intensities. 
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Figure S8.6. Half of a tissue section covered by four 1 µL matrix/clozapine:clozapine-d8 
mixture and analyzed by MAIV operating at atmospheric pressure (Scheme 8.2.B). The 
glass slide holding tissue section was sealed to the modified skimmer cone, and the 
matrix sublimed over 10 min. (I) TIC showing continuous ion formation from a MAIV 
analysis. (II): (A) Total mass spectrum, clozapine, clozapine-d8, cholesterol, and lipids 
were observed; (B) two dimensional plots of drift time vs. m/z with insets showing 
extracted (1) nested dataset and (2) mass spectrum from the blue-boxed area. The ion 
intensity ratio at m/z’s 327:335 is approximately 3.02:1. 
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Figure S8.7. Microscopy images of the glass slides holding 20 µm-thick tissue section 
after (A) solvent-droplet extraction (Scheme 8.1. II.A) and (B) 3-
NBN/clozapine:clozapine-d8 mixture sublimation for 10 min (Scheme 8.2.B). The tissue 
section and the glass slide were cut through the center, and the images show the cross 
section. The scale bar represents 50 µm, and a scale bar representing 20 µm is included to 
indicate the thickness of the tissue section.  
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ABSTRACT 
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Degree: Doctor of Philosophy 
 
Inlet ionization and vacuum ionization are novel ionization methods to produce 
electrospray ionization (ESI)–like ions from the solid or liquid states, operating from 
atmospheric pressure (AP) or vacuum, without the use of voltage or the necessity of high 
energy input such as a laser or particle beam. The fundamental aspects were probed for 
better understanding of the novel ionization processes. Initial applications were attempted 
to utilize the novel ionization methods for fast, robust, and quantitative analyses.  
For inlet ionizations (laserspray ionization inlet, LSII; matrix assisted ionization inlet, 
MAII; and solvent assisted ionization inlet, SAII), small (e.g. drugs) to large (e.g. 
proteins) non-volatile molecules are ionized with the assistance of heat and pressure drop, 
and are operated from AP. The ease of operation, rapidness of data acquisition, and 
simplicity of coupling with other techniques achieved by SAII, have enabled the inlet 
ionization for high throughput multiplexing analyses, hyphenation with liquid 
chromatography (especially at low flow rates), and fast surface assessment and drug 
209 
 
quantifications. LSII has been utilized together with solvent-free sample preparation and 
solvent-free gas-phase separation for total solvent-free analysis.   
The production of multiply charged ions from solid states by vacuum ionization was 
utilized to encompass the advantages from ESI and matrix-assisted laser 
desorption/ionization (MALDI), for better characterization from surfaces and extending 
the mass range of high performance mass spectrometers. Operating from AP provides the 
potential for vacuum ionization to be applied in high throughput analysis. The continuous 
ion formation also benefits matrix assisted ionization vacuum (MAIV) for drug 
quantification with better reproducibility. 
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